Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 441 |
| Prevention | 72 |
| Diagnostic | 31 |
| Other | 31 |
| Supportive Care | 30 |
| Health Services Research | 12 |
| Basic Science | 3 |
| Screening | 2 |
| Device Feasibility | 1 |
regCOVID
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
_See the full regCOVID repository with detailed results at https://github.com/lhncbc/r-snippets-bmi/tree/master/regCOVID —
Study Counts
| Type | Study_count |
|---|---|
| Total_Studies | 1217 |
| interventional | 623 |
| Observational | 501 |
| Registry | 93 |
Studies over Time
Total studies by type over time
```
Interventional Trials
Intervention Type
| intervention_type | Study_Count |
|---|---|
| Drug | 110 |
| Drug|placebo | 86 |
| Drug|Drug | 59 |
| Biological | 45 |
| Other | 41 |
| Behavioral | 22 |
| Device | 22 |
| Drug|Other | 19 |
| Diagnostic Test | 17 |
| Drug|Drug|Drug | 15 |
| Drug|Drug|placebo | 15 |
| Procedure | 14 |
| Biological|placebo | 13 |
| Biological|Biological | 11 |
| Other|Other | 10 |
| Device|Device | 8 |
| Drug|Drug|Drug|Drug | 8 |
| Biological|Other | 6 |
| Behavioral|Behavioral | 5 |
| Biological|Drug | 5 |
| Device|Other | 5 |
| Dietary Supplement | 5 |
| Drug|Drug|Other | 5 |
| Drug|Drug|Drug|placebo | 4 |
| Drug|Drug|placebo|placebo | 4 |
| Procedure|Procedure | 4 |
| Drug|Drug|Drug|Other | 3 |
| Radiation | 3 |
| Behavioral|Behavioral|Behavioral | 2 |
| Biological|Drug|placebo | 2 |
| Device|placebo | 2 |
| Device|Procedure | 2 |
| Diagnostic Test|Diagnostic Test | 2 |
| Dietary Supplement|Dietary Supplement | 2 |
| Dietary Supplement|Drug|placebo | 2 |
| Dietary Supplement|Other | 2 |
| Drug|Drug|Drug|Drug|Drug | 2 |
| Behavioral|Diagnostic Test|Diagnostic Test | 1 |
| Biological|Biological|Biological|Biological | 1 |
| Biological|Biological|Biological|Biological|Biological|Biological|placebo|placebo | 1 |
| Biological|Biological|Biological|Biological|placebo | 1 |
| Biological|Biological|Biological|Biological|placebo|placebo | 1 |
| Biological|Biological|Biological|Drug | 1 |
| Biological|Biological|Biological|Genetic|Other | 1 |
| Biological|Biological|Other | 1 |
| Biological|Biological|placebo | 1 |
| Biological|Device|Device|Other|Other | 1 |
| Biological|Drug|Drug|Drug|Drug|Drug | 1 |
| Biological|Drug|Drug|Drug|placebo|placebo | 1 |
| Biological|Other|placebo | 1 |
| Combination Product | 1 |
| Combination Product|Combination Product|Drug|Drug | 1 |
| Combination Product|Drug | 1 |
| Device|Device|Device | 1 |
| Device|Drug | 1 |
| Device|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Radiation | 1 |
| Device|Drug|Drug|Drug|Drug|Drug|Drug|Radiation | 1 |
| Device|Drug|Drug|Procedure | 1 |
| Device|Drug|Drug|Procedure|Procedure | 1 |
| Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test|Diagnostic Test | 1 |
| Diagnostic Test|Diagnostic Test|Diagnostic Test|Drug|Drug|Other|placebo | 1 |
| Diagnostic Test|Other | 1 |
| Dietary Supplement|Dietary Supplement|Dietary Supplement|Other | 1 |
| Dietary Supplement|Drug | 1 |
| Dietary Supplement|Drug|Drug|Other | 1 |
| Dietary Supplement|placebo | 1 |
| Drug|Drug|Drug|Drug|Drug|Drug | 1 |
| Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug|Drug | 1 |
| Drug|Drug|Drug|Drug|Drug|Drug|Drug|Other|placebo | 1 |
| Drug|Drug|Drug|Drug|Other | 1 |
| Drug|Other|placebo | 1 |
| Drug|placebo|Procedure|Procedure|Procedure|Procedure | 1 |
| Drug|placebo|Radiation | 1 |
| Drug|Procedure | 1 |
| Other|Other|Other | 1 |
| Other|Procedure | 1 |
| Procedure|Procedure|Procedure | 1 |
| Procedure|Procedure|Procedure|Procedure | 1 |
Count of Studies by Intervention (normalized and mapped)
| Intervention_type | intervention | Study_count | Date of First Study |
|---|---|---|---|
| placebo | placebo | 143 | 2020-02-20 |
| Drug | hydroxychloroquine | 97 | 2020-02-06 |
| Other | standard care | 59 | 2020-01-23 |
| Biological | convalescent plasma | 52 | 2020-03-23 |
| Drug | azithromycin | 29 | 2020-03-23 |
| Drug | tocilizumab | 24 | 2020-03-09 |
| Drug | ritonavir | 23 | 2020-01-28 |
| Drug | lopinavir | 20 | 2020-01-28 |
| Drug | lopinavir/ritonavir | 19 | 2020-01-30 |
| Biological | mesenchymal stem cells | 17 | 2020-01-27 |
| Drug | chloroquine | 14 | 2020-03-19 |
| Drug | saline | 13 | 2020-03-25 |
| Device | oxygen | 12 | 2020-03-19 |
| Biological | blood sample | 11 | 2020-03-09 |
| Drug | colchicine | 11 | 2020-03-23 |
| Drug | interferon | 10 | 2020-02-11 |
| Drug | methylprednisolone | 10 | 2020-01-23 |
| Other | prone positioning | 10 | 2020-03-26 |
| Biological | plasma | 9 | 2020-04-09 |
| Biological | control | 8 | 2020-03-24 |
| Drug | favipiravir | 8 | 2020-03-09 |
| Drug | hydroxychloroquine / azithromycin | 8 | 2020-03-23 |
| Drug | remdesivir | 8 | 2020-02-20 |
| Drug | baricitinib | 7 | 2020-03-24 |
| Drug | ivermectin | 7 | 2020-04-05 |
| Drug | sarilumab | 7 | 2020-03-15 |
| Drug | enoxaparin | 6 | 2020-04-07 |
| Drug | losartan | 6 | 2020-03-13 |
| Drug | vitamin c | 6 | 2020-02-04 |
| Drug | anakinra | 5 | 2020-03-25 |
| Biological | bcg | 5 | 2020-03-25 |
| Drug | dexamethasone | 5 | 2020-03-25 |
| Drug | heparin | 5 | 2020-04-24 |
| Drug | nitazoxanide | 5 | 2020-04-03 |
| Drug | nitric oxide | 5 | 2020-03-09 |
| Radiation | radiotherapy | 5 | 2020-05-04 |
| Drug | ruxolitinib | 5 | 2020-04-01 |
| Other | telehealth | 5 | 2020-03-21 |
| Drug | arbidol | 4 | 2020-01-30 |
| Procedure | biological samples | 4 | 2020-03-23 |
| Drug | bromhexine hydrochloride | 4 | 2020-02-14 |
| Drug | clazakizumab | 4 | 2020-04-09 |
| Biological | nk cells | 4 | 2020-02-13 |
| Diagnostic Test | pcr | 4 | 2020-04-02 |
| Other | questionnaire | 4 | 2020-03-08 |
| Other | ace inhibitor | 3 | 2020-03-30 |
| Diagnostic Test | blood test | 3 | 2020-04-24 |
| Drug | budesonide | 3 | 2020-04-15 |
| Drug | corticosteroid | 3 | 2020-05-04 |
| Drug | lenzilumab | 3 | 2020-03-31 |
| Drug | oseltamivir | 3 | 2020-02-02 |
| Drug | peginterferon | 3 | 2020-03-27 |
| Drug | povidone/iodine | 3 | 2020-04-08 |
| Diagnostic Test | serology | 3 | 2020-04-08 |
| Combination Product | NA | 2 | 2020-02-27 |
| Biological | adenovirus type 5 vector | 2 | 2020-03-15 |
| Drug | anticoagulation | 2 | 2020-04-20 |
| Drug | aspirin | 2 | 2020-04-01 |
| Dietary Supplement | ayurveda | 2 | 2020-04-10 |
| Other | best available therapy | 2 | 2020-04-07 |
| Drug | bevacizumab | 2 | 2020-02-14 |
| Other | blood | 2 | 2020-05-01 |
| Behavioral | blood donation sms | 2 | 2020-04-28 |
| Other | blood draw | 2 | 2020-04-03 |
| Biological | bnt162a1 | 2 | 2020-04-27 |
| Biological | bnt162b1 | 2 | 2020-04-27 |
| Biological | bnt162b2 | 2 | 2020-04-27 |
| Biological | bnt162c2 | 2 | 2020-04-27 |
| Drug | camostat mesilate | 2 | 2020-03-23 |
| Drug | canakinumab | 2 | 2020-04-24 |
| Drug | chloroquine/hydroxychloroquine | 2 | 2020-03-06 |
| Drug | cholecalciferol | 2 | 2020-04-09 |
| Drug | clopidogrel | 2 | 2020-04-01 |
| Device | cpap | 2 | 2020-04-09 |
| Diagnostic Test | ct-scan | 2 | 2020-04-22 |
| Device | cytokine adsorption | 2 | 2020-04-21 |
| Dietary Supplement | honey | 2 | 2020-03-23 |
| Drug | hydroxychloroquine/placebo | 2 | 2020-04-05 |
| Drug | ibuprofen | 2 | 2020-04-02 |
| Drug | imatinib | 2 | 2020-04-07 |
| Drug | immunoglobulin | 2 | 2020-04-08 |
| Biological | inactivated sars-cov-2 vaccine | 2 | 2020-04-14 |
| Biological | low | 2 | 2020-04-24 |
| Device | lung ultrasound | 2 | 2020-04-04 |
| Behavioral | meditation | 2 | 2020-05-01 |
| Combination Product | mefloquine | 2 | 2020-04-07 |
| Behavioral | mindfulness | 2 | 2020-05-04 |
| Biological | mrna-1273 | 2 | 2020-02-21 |
| Drug | n-acetylcysteine | 2 | 2020-05-01 |
| Device | nasal rinse | 2 | 2020-04-08 |
| Dietary Supplement | nigella sativa | 2 | 2020-05-21 |
| Procedure | ophthalmologic exam | 2 | 2020-04-29 |
| Other | physical therapy | 2 | 2020-04-24 |
| Dietary Supplement | probiotic | 2 | 2020-04-27 |
| Drug | pul-042 | 2 | 2020-03-16 |
| Drug | rivaroxaban | 2 | 2020-04-01 |
| Diagnostic Test | saliva | 2 | 2020-04-22 |
| Drug | sevoflurane | 2 | 2020-03-26 |
| Drug | siltuximab | 2 | 2020-03-31 |
| Drug | sirolimus | 2 | 2020-04-05 |
| Drug | standard therapy | 2 | 2020-04-08 |
| Dietary Supplement | vitamin d | 2 | 2020-04-25 |
| Dietary Supplement | vitamin super b-complex | 2 | 2020-04-08 |
| Dietary Supplement | zinc | 2 | 2020-04-08 |
| Combination Product | - tocilizumab | 1 | 2020-04-07 |
| Drug | -interferon nebulization | 1 | 2020-02-27 |
| Other | “calm” is a mindfulness meditation mobile app | 1 | 2020-03-26 |
| Drug | 1200 mg) | 1 | 2020-05-23 |
| Biological | 14-day schedule | 1 | 2020-05-21 |
| Drug | 1600 mg) | 1 | 2020-05-23 |
| Drug | 18f-î±vî²6-bp | 1 | 2020-05-03 |
| Biological | 28-day schedule | 1 | 2020-05-21 |
| Biological | aapc | 1 | 2020-03-05 |
| Drug | abx464 | 1 | 2020-05-18 |
| Drug | ace inhibitor, angiotensin receptor blocker | 1 | 2020-04-14 |
| Drug | acetylsalicylic acid | 1 | 2020-04-23 |
| Device | actigraphy | 1 | 2020-04-24 |
| Drug | activase | 1 | 2020-04-18 |
| Other | adjuvant | 1 | 2020-04-24 |
| Other | after-each-case room disinfection | 1 | 2020-05-19 |
| Other | albumine | 1 | 2020-05-26 |
| Drug | allogeneic | 1 | 2020-04-22 |
| Drug | alpha one antitrypsin | 1 | 2020-05-10 |
| Procedure | alveolar | 1 | 2020-04-22 |
| Drug | amiodarone | 1 | 2020-04-14 |
| Drug | anakinra/osoc | 1 | 2020-04-17 |
| Biological | angiotensin peptide (1-7) derived plasma | 1 | 2020-05-01 |
| Drug | anluohuaxian | 1 | 2020-04-01 |
| Biological | anti-coronavirus antibodies (immunoglobulins)obtained with dfpp from convalescent patients | 1 | 2020-04-09 |
| Diagnostic Test | antibody test | 1 | 2020-05-08 |
| Drug | antihypertensives | 1 | 2020-04-10 |
| Behavioral | anxiety reduction training | 1 | 2020-05-11 |
| Other | arb | 1 | 2020-04-14 |
| Drug | arbidol hydrochloride/interferon atomization | 1 | 2020-02-02 |
| Drug | artemic | 1 | 2020-05-07 |
| Dietary Supplement | asbrip | 1 | 2020-05-25 |
| Drug | asc09 | 1 | 2020-02-04 |
| Drug | asc09f/oseltamivir | 1 | 2020-02-04 |
| Dietary Supplement | ascorbic acid/zinc gluconate | 1 | 2020-04-08 |
| Drug | at-001 | 1 | 2020-04-25 |
| Drug | atorvastatin | 1 | 2020-04-01 |
| Drug | atovaquone | 1 | 2020-04-07 |
| Drug | atovaquone/azithromycin | 1 | 2020-04-07 |
| Behavioral | attention bias modification (abm) | 1 | 2020-04-24 |
| Drug | atyr1923 | 1 | 2020-06-01 |
| Procedure | auditory evoked potentials (aep) | 1 | 2020-05-08 |
| Procedure | auricular neuromodulation | 1 | 2020-04-07 |
| Biological | avdoralimab | 1 | 2020-04-29 |
| Drug | aviptadil | 1 | 2020-03-14 |
| Drug | aviptadil/standard care | 1 | 2020-03-14 |
| Drug | azoximer bromide | 1 | 2020-05-07 |
| Biological | bacille calmette-guã©rin (bcg) | 1 | 2020-05-04 |
| Drug | best supportive care | 1 | 2020-04-01 |
| Drug | best supportive care (bsc) / ifx-1 | 1 | 2020-04-01 |
| Drug | bhv-3500 | 1 | 2020-04-09 |
| Device | bidirectional oxygenation mouthpiece | 1 | 2020-03-25 |
| Biological | biological | 1 | 2020-05-01 |
| Device | biosensor | 1 | 2020-04-01 |
| Device | biovitals | 1 | 2020-02-20 |
| Drug | bld-2660 | 1 | 2020-04-02 |
| Procedure | blink | 1 | 2020-05-08 |
| Procedure | blink/masseter inhibitory reflex | 1 | 2020-05-08 |
| Other | blood/derivatives | 1 | 2020-04-02 |
| Drug | bms-986253 | 1 | 2020-04-02 |
| Drug | bromhexine oral tablet and/or hydroxychloroquine tablet | 1 | 2020-04-15 |
| Drug | calcium channel blockers | 1 | 2020-03-30 |
| Drug | candesartan | 1 | 2020-04-10 |
| Device | caption ai | 1 | 2020-04-03 |
| Other | cash transfer | 1 | 2020-04-16 |
| Biological | castem | 1 | 2020-02-06 |
| Drug | cd24fc | 1 | 2020-03-19 |
| Biological | cell therapy protocol 1 | 1 | 2020-04-20 |
| Biological | cell therapy protocol 2 | 1 | 2020-04-20 |
| Device | cellectraâ® 2000 | 1 | 2020-04-03 |
| Device | centricyte 1000 | 1 | 2020-03-26 |
| Biological | chadox1 | 1 | 2020-03-20 |
| Behavioral | chat-based instant messaging support | 1 | 2020-05-26 |
| Other | chemokines profiles of patients with dexmedetomidine administration | 1 | 2020-04-21 |
| Diagnostic Test | chest ct | 1 | 2020-04-30 |
| Drug | chlorhexidine | 1 | 2020-04-08 |
| Drug | clarithromycin | 1 | 2020-05-17 |
| Drug | clevudine | 1 | 2020-04-14 |
| Procedure | clinical examination | 1 | 2020-04-14 |
| Drug | cm4620 | 1 | 2020-04-07 |
| Drug | cobicistat | 1 | 2020-01-29 |
| Drug | colchicine/herbal phenolic monoterpene fractions | 1 | 2020-05-15 |
| Other | collection of samples | 1 | 2020-04-22 |
| Diagnostic Test | complement dosage | 1 | 2020-04-13 |
| Diagnostic Test | conjunctival swab | 1 | 2020-04-22 |
| Other | continuation of acei | 1 | 2020-04-14 |
| Other | continuation of acei/arb | 1 | 2020-04-14 |
| Other | continuation of arb | 1 | 2020-04-01 |
| Drug | continuation of ras blocker | 1 | 2020-03-28 |
| Device | continuous positive airway pressure | 1 | 2020-05-12 |
| Device | control swab | 1 | 2020-04-24 |
| Drug | conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation, | 1 | 2020-01-28 |
| Drug | conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir) | 1 | 2020-01-28 |
| Drug | conventional medicines (oxygen therapy, alfa interferon via aerosol inhalation,/lopinavir/ritonavir)/traditional chinese medicines (tcms) granules | 1 | 2020-01-28 |
| Behavioral | coping strategies video | 1 | 2020-04-29 |
| Device | coviage | 1 | 2020-05-14 |
| Other | covid-19 patients | 1 | 2020-05-10 |
| Procedure | csvf | 1 | 2020-03-26 |
| Diagnostic Test | ctus examination | 1 | 2020-04-30 |
| Drug | cumin | 1 | 2020-04-11 |
| Other | cupping | 1 | 2020-04-20 |
| Other | current care per ucla treating physicians | 1 | 2020-04-14 |
| Drug | cyclosporine | 1 | 2020-05-03 |
| Diagnostic Test | cytokines | 1 | 2020-04-13 |
| Device | cytosorb | 1 | 2020-04-09 |
| Behavioral | daily coping toolkit | 1 | 2020-05-20 |
| Other | daily room disinfection | 1 | 2020-05-19 |
| Procedure | dalargin | 1 | 2020-04-08 |
| Drug | danoprevir | 1 | 2020-04-10 |
| Drug | danoprevir/ritonavir | 1 | 2020-04-10 |
| Drug | dapagliflozin | 1 | 2020-04-14 |
| Drug | darunavir | 1 | 2020-01-29 |
| Drug | darunavir/cobicistat | 1 | 2020-01-29 |
| Drug | das181 | 1 | 2020-03-25 |
| Diagnostic Test | data collection | 1 | 2020-03-20 |
| Diagnostic Test | data collection/rhinopharyngeal swab | 1 | 2020-03-20 |
| Drug | day | 1 | 2020-05-07 |
| Drug | deferoxamine | 1 | 2020-04-01 |
| Drug | defibrotide | 1 | 2020-04-08 |
| Drug | defibrotide 25 mg/kg 24 hours continuous infusion for 15 days | 1 | 2020-04-08 |
| Other | derivatives. | 1 | 2020-04-02 |
| Combination Product | device) | 1 | 2020-04-09 |
| Drug | dexamethasone/hydroxychloroquine | 1 | 2020-04-09 |
| Drug | dfv890 | 1 | 2020-05-08 |
| Behavioral | digital health online platform | 1 | 2020-05-21 |
| Drug | diovan | 1 | 2020-04-02 |
| Drug | dipyridamole | 1 | 2020-05-15 |
| Other | discontinuation of acei | 1 | 2020-04-14 |
| Other | discontinuation of acei/arb | 1 | 2020-04-14 |
| Other | discontinuation of arb | 1 | 2020-04-01 |
| Drug | discontinuation of ras blocker | 1 | 2020-03-28 |
| Other | distance learning | 1 | 2020-04-27 |
| Drug | dociparastat sodium | 1 | 2020-05-13 |
| Drug | dornase alfa | 1 | 2020-05-20 |
| Drug | doxycycline | 1 | 2020-04-26 |
| Device | ecco2r | 1 | 2020-04-09 |
| Drug | eculizumab | 1 | 2020-04-06 |
| Behavioral | educational video | 1 | 2020-04-30 |
| Diagnostic Test | eeg | 1 | 2020-05-26 |
| Biological | emapalumab | 1 | 2020-03-25 |
| Drug | emtricitabine | 1 | 2020-04-02 |
| Drug | emtricitabine/tenofovir disoproxil | 1 | 2020-04-02 |
| Device | endoscopy | 1 | 2020-05-09 |
| Drug | enoxaparin/lovenox | 1 | 2020-04-27 |
| Diagnostic Test | ep | 1 | 2020-05-26 |
| Drug | escin | 1 | 2020-03-23 |
| Drug | estradiol | 1 | 2020-04-21 |
| Drug | etoposide | 1 | 2020-04-17 |
| Other | exercise group | 1 | 2020-05-07 |
| Other | experimental: questionnaire without precaution information | 1 | 2020-03-08 |
| Drug | famotidine | 1 | 2020-04-27 |
| Drug | favipiravir / standard care | 1 | 2020-04-16 |
| Drug | favipiravir/azithromycin | 1 | 2020-05-23 |
| Drug | favipiravir/chloroquine | 1 | 2020-03-20 |
| Drug | favipiravir/hydroxychloroquine | 1 | 2020-05-23 |
| Drug | favipiravir/tocilizumab | 1 | 2020-03-09 |
| Biological | fecal swab | 1 | 2020-04-28 |
| Diagnostic Test | filmarray pneumonia | 1 | 2020-05-06 |
| Drug | fingolimod | 1 | 2020-02-20 |
| Drug | fluoxetine | 1 | 2020-04-18 |
| Drug | fluvoxamine | 1 | 2020-04-08 |
| Drug | folic acid | 1 | 2020-04-16 |
| Drug | fondaparinux | 1 | 2020-04-23 |
| Drug | formoterol | 1 | 2020-03-30 |
| Drug | fuzheng huayu | 1 | 2020-02-15 |
| Device | gammacoreâ® (vagus nerve stimulation) | 1 | 2020-04-20 |
| Device | gammacoreâ® sapphire (non-invasive vagus nerve stimulator) | 1 | 2020-04-14 |
| Drug | ganovo | 1 | 2020-02-27 |
| Drug | ganovo/ritonavir//-interferon nebulization | 1 | 2020-02-27 |
| Drug | gargle | 1 | 2020-04-25 |
| Other | gas exchanges at different peep | 1 | 2020-04-13 |
| Drug | gimsilumab | 1 | 2020-04-15 |
| Drug | gls-1200 | 1 | 2020-05-22 |
| Device | go2 peep mouthpiece | 1 | 2020-03-31 |
| Behavioral | guided online support program | 1 | 2020-03-26 |
| Behavioral | hads | 1 | 2020-04-28 |
| Other | hemodynamics changes at different peep | 1 | 2020-04-13 |
| Drug | herbal phenolic monoterpene | 1 | 2020-05-15 |
| Device | high flow nasal cannula (hfnc) | 1 | 2020-03-26 |
| Other | home-cov rule implementation | 1 | 2020-04-05 |
| Other | home care monitoring | 1 | 2020-04-14 |
| Device | home pulse oximetry monitoring | 1 | 2020-04-30 |
| Behavioral | hope intervention | 1 | 2020-03-31 |
| Drug | hormones | 1 | 2020-03-25 |
| Biological | human amniotic fluid | 1 | 2020-03-22 |
| Drug | hydrocortisone | 1 | 2020-04-11 |
| Device | hydrogen oxygen generator with nebulizer | 1 | 2020-04-29 |
| Combination Product | hydroxychloroquine/azithromycin/ tocilizumab | 1 | 2020-04-07 |
| Drug | hydroxychloroquine/chloroquine | 1 | 2020-03-25 |
| Drug | hydroxychloroquine/clindamycin | 1 | 2020-04-11 |
| Drug | hydroxychloroquine/clindamycin/primaquine | 1 | 2020-04-11 |
| Drug | hydroxychloroquine/doxycycline | 1 | 2020-04-11 |
| Drug | hydroxychloroquine/famotidine | 1 | 2020-04-27 |
| Drug | hydroxychloroquine/ivermectin | 1 | 2020-05-01 |
| Drug | hydroxyvitamin | 1 | 2020-05-11 |
| Combination Product | hyperbaric oxygen | 1 | 2020-04-09 |
| Drug | ibrutinib | 1 | 2020-05-04 |
| Drug | icosapent ethyl | 1 | 2020-05-29 |
| Other | icu recovery | 1 | 2020-05-12 |
| Other | icu recovery / physical therapy | 1 | 2020-05-12 |
| Drug | ifx-1 | 1 | 2020-04-01 |
| Device | igg | 1 | 2020-04-24 |
| Diagnostic Test | igg antibody test | 1 | 2020-04-13 |
| Device | igg/igm rapid test | 1 | 2020-04-24 |
| Drug | igiv | 1 | 2020-05-18 |
| Device | igm antibodytest | 1 | 2020-04-24 |
| Diagnostic Test | igm/igg rapid test | 1 | 2020-04-13 |
| Drug | indomethacin | 1 | 2020-04-08 |
| Other | inflammatory cytokines | 1 | 2020-04-21 |
| Other | inflammatory cytokines/chemokines profiles of patients with dexmedetomidine administration | 1 | 2020-04-21 |
| Biological | injection | 1 | 2020-02-17 |
| Drug | ino-4800 | 1 | 2020-04-03 |
| Drug | interferon-î² 1a | 1 | 2020-04-14 |
| Drug | interleukin | 1 | 2020-05-05 |
| Behavioral | intermittent | 1 | 2020-04-24 |
| Behavioral | internet-based self-help | 1 | 2020-05-07 |
| Behavioral | internet-based self-help after 3 weeks | 1 | 2020-05-07 |
| Behavioral | internet-delivered cognitive behavior therapy (icbt) for dysfunctional worry related to the covid-19 pandemic | 1 | 2020-04-07 |
| Other | interview by psychologists | 1 | 2020-05-19 |
| Device | intraosseous | 1 | 2020-04-23 |
| Device | intravenous | 1 | 2020-04-23 |
| Drug | intravenous drug | 1 | 2020-03-26 |
| Drug | iodine | 1 | 2020-04-08 |
| Drug | ivermectin (iver pâ®) arm will receive ivm 600 âµg | 1 | 2020-05-05 |
| Drug | ivermectin (iver pâ®) arm will receive ivm 600 âµg / kg once daily/standard care. control arm will receive standard care. | 1 | 2020-05-05 |
| Other | kb109 | 1 | 2020-06-01 |
| Other | kb109 / self supportive care (ssc) | 1 | 2020-06-01 |
| Device | kerecis | 1 | 2020-04-20 |
| Device | kerecis oral/nasal spray | 1 | 2020-04-20 |
| Drug | ketamine | 1 | 2020-04-26 |
| Drug | kg | 1 | 2020-06-01 |
| Drug | kg 24 hours continuous infusion for 15 days | 1 | 2020-04-08 |
| Drug | kg once daily | 1 | 2020-05-05 |
| Behavioral | kundalini yoga | 1 | 2020-05-11 |
| Behavioral | kundalini yoga/anxiety reduction training | 1 | 2020-05-11 |
| Biological | lactated | 1 | 2020-04-22 |
| Procedure | laryngoscopy | 1 | 2020-04-24 |
| Drug | leaf-4l6715 | 1 | 2020-05-05 |
| Drug | leaf-4l7520 | 1 | 2020-05-05 |
| Drug | leflunomide | 1 | 2020-04-22 |
| Drug | levamisole | 1 | 2020-03-30 |
| Drug | levamisole / budesonide/formoterol | 1 | 2020-03-30 |
| Drug | levilimab | 1 | 2020-05-19 |
| Drug | liberase enzyme | 1 | 2020-03-26 |
| Drug | lopinavir/ritonavir / hydoxychloroquine | 1 | 2020-03-30 |
| Drug | lovenox | 1 | 2020-04-27 |
| Biological | low/upper respiratory tract sample | 1 | 2020-04-28 |
| Diagnostic Test | lung impedance | 1 | 2020-05-23 |
| Other | lung mechanics at different peep | 1 | 2020-04-13 |
| Biological | lv-smenp-dc vaccine | 1 | 2020-02-17 |
| Biological | lv-smenp-dc vaccine/antigen-specific ctls | 1 | 2020-02-17 |
| Drug | ly3127804 | 1 | 2020-04-10 |
| Drug | ly3819253 | 1 | 2020-05-29 |
| Device | magpro x100 stimulator, b70 fluid-cooled coil | 1 | 2020-05-08 |
| Other | maintenance | 1 | 2020-04-07 |
| Device | marker therapeutics d2000 cartridge (d2000) for use with the spectra optiaâ® apheresis system (optia spd protocol) | 1 | 2020-04-20 |
| Device | mask | 1 | 2020-04-08 |
| Procedure | masseter inhibitory reflex | 1 | 2020-05-08 |
| Drug | mavrilimumab | 1 | 2020-05-21 |
| Other | maximal effort test | 1 | 2020-04-24 |
| Drug | mcn (methylene blue, vitamin c, n-acetyl cysteine) | 1 | 2020-04-29 |
| Procedure | mechanical ventilation | 1 | 2020-04-09 |
| Behavioral | meditation/anxiety reduction training | 1 | 2020-05-11 |
| Biological | medium dosage inactivated sars-cov-2 vaccine on a 0- | 1 | 2020-05-21 |
| Biological | medium dosage inactivated sars-cov-2 vaccine on a 0-/14-day schedule | 1 | 2020-05-21 |
| Biological | medium dosage inactivated sars-cov-2 vaccine on a 0-/28-day schedule | 1 | 2020-05-21 |
| Combination Product | mefloquine/azithromycin/ tocilizumab | 1 | 2020-04-07 |
| Drug | melatonin | 1 | 2020-05-28 |
| Drug | melphalan | 1 | 2020-05-06 |
| Biological | menacwy | 1 | 2020-03-20 |
| Behavioral | mental well-being | 1 | 2020-04-07 |
| Drug | meplazumab | 1 | 2020-02-06 |
| Behavioral | messaging | 1 | 2020-04-28 |
| Drug | metenkefalin | 1 | 2020-04-30 |
| Drug | metenkefalin / tridecactide | 1 | 2020-04-30 |
| Drug | methylene blue/ vitamin c/n-acetyl cysteine | 1 | 2020-04-29 |
| Behavioral | mindfullness training | 1 | 2020-05-04 |
| Behavioral | mindfulness session(s) | 1 | 2020-03-20 |
| Device | mls laser | 1 | 2020-05-04 |
| Diagnostic Test | monitoring visit | 1 | 2020-04-07 |
| Other | moxibustion | 1 | 2020-04-20 |
| Other | moxibustion/cupping | 1 | 2020-04-20 |
| Drug | mstt1041a | 1 | 2020-05-11 |
| Device | multifrequency bioimpedance spectroscopy | 1 | 2020-04-14 |
| Biological | multistem | 1 | 2020-04-27 |
| Device | musclesound ultrasound | 1 | 2020-04-14 |
| Drug | n-acetylcysteine/ fuzheng huayu | 1 | 2020-02-15 |
| Drug | n-acetylcysteine/placebo | 1 | 2020-02-15 |
| Drug | naltrexone | 1 | 2020-04-26 |
| Device | neuromuscular | 1 | 2020-04-24 |
| Other | neuromuscular electrical stimulation | 1 | 2020-05-08 |
| Diagnostic Test | ng test | 1 | 2020-05-27 |
| Dietary Supplement | nicotinamide riboside | 1 | 2020-05-22 |
| Drug | nigella sativa / black cumin | 1 | 2020-04-11 |
| Device | nioâ® (intraosseous access) | 1 | 2020-04-23 |
| Drug | nivolumab | 1 | 2020-04-01 |
| Device | non-contact mce system | 1 | 2020-03-21 |
| Drug | octagam | 1 | 2020-05-29 |
| Drug | olokizumab | 1 | 2020-05-06 |
| Drug | omeprazole | 1 | 2020-04-01 |
| Behavioral | online support group | 1 | 2020-05-05 |
| Diagnostic Test | optical coherence tomography (oct) | 1 | 2020-05-21 |
| Drug | osoc | 1 | 2020-04-17 |
| Biological | otilimab | 1 | 2020-05-04 |
| Other | oxygen-ozone | 1 | 2020-04-22 |
| Device | oxyhydrogen | 1 | 2020-03-25 |
| Procedure | ozone | 1 | 2020-05-11 |
| Drug | paracetamol | 1 | 2020-03-20 |
| Behavioral | patient-centred advice on telephone consultation in tb patients: | 1 | 2020-05-30 |
| Device | pbmt | 1 | 2020-05-08 |
| Device | pbmt/smf | 1 | 2020-05-08 |
| Diagnostic Test | pcr/serology | 1 | 2020-05-15 |
| Biological | pembrolizumab | 1 | 2020-03-31 |
| Diagnostic Test | performance evaluation | 1 | 2020-04-30 |
| Behavioral | personal exercise intervention | 1 | 2020-05-29 |
| Other | phone call | 1 | 2020-04-28 |
| Other | physical exercise | 1 | 2020-05-08 |
| Other | physiotherapy | 1 | 2020-05-22 |
| Drug | piperacillin | 1 | 2020-05-15 |
| Drug | piperacillin/tazobactam | 1 | 2020-05-15 |
| Drug | pirfenidone | 1 | 2020-02-10 |
| Biological | plasma exchange | 1 | 2020-05-02 |
| Drug | plitidepsin | 1 | 2020-05-07 |
| Other | postural positioning | 1 | 2020-04-10 |
| Drug | povidone | 1 | 2020-04-08 |
| Behavioral | prayer | 1 | 2020-04-16 |
| Drug | prazosin | 1 | 2020-04-24 |
| Other | prediction market | 1 | 2020-05-27 |
| Drug | prednisone | 1 | 2020-04-10 |
| Procedure | procalcitonin | 1 | 2020-04-02 |
| Drug | progesterone | 1 | 2020-04-24 |
| Drug | prophylactic | 1 | 2020-05-20 |
| Drug | prophylaxis | 1 | 2020-03-05 |
| Drug | propofol | 1 | 2020-04-21 |
| Device | prototype | 1 | 2020-04-24 |
| Other | psg | 1 | 2020-04-28 |
| Other | pulmonary physiotherapy techniques | 1 | 2020-04-13 |
| Behavioral | pulmonary rehabilitation | 1 | 2020-04-23 |
| Drug | pulmozyme | 1 | 2020-04-15 |
| Diagnostic Test | pulse oximetry | 1 | 2020-05-26 |
| Drug | pyridostigmine bromide | 1 | 2020-04-09 |
| Device | q-nrg metobolic cart device | 1 | 2020-04-14 |
| Dietary Supplement | quercetin | 1 | 2020-05-01 |
| Drug | r tablets | 1 | 2020-03-25 |
| Radiation | radiological | 1 | 2020-05-04 |
| Diagnostic Test | rapid salivary test | 1 | 2020-04-15 |
| Drug | ravulizumab | 1 | 2020-05-08 |
| Drug | recombinant human interferon î±2b spray | 1 | 2020-02-14 |
| Other | rehabilitation | 1 | 2020-04-26 |
| Biological | remestemcel-l | 1 | 2020-04-28 |
| Behavioral | remote cognitive behavioral therapy for insomnia | 1 | 2020-05-28 |
| Biological | respiratory tract sample | 1 | 2020-04-28 |
| Drug | rhace2 | 1 | 2020-04-01 |
| Diagnostic Test | rhinopharyngeal | 1 | 2020-03-20 |
| Drug | ribavirin | 1 | 2020-02-11 |
| Drug | ritonavir/oseltamivir | 1 | 2020-02-04 |
| Drug | roactemra | 1 | 2020-03-24 |
| Procedure | robot assisted percutaneous cardiovascular intervention | 1 | 2020-04-27 |
| Biological | rph-104 | 1 | 2020-05-06 |
| Drug | rtb101 | 1 | 2020-05-28 |
| Biological | saline containing 1% human serum albumin（solution of msc） | 1 | 2020-02-24 |
| Other | saline with baby shampoo nasal irrigation | 1 | 2020-04-11 |
| Drug | saline/standard care | 1 | 2020-03-14 |
| Diagnostic Test | sample collection | 1 | 2020-04-30 |
| Diagnostic Test | sample collection/performance evaluation (a) | 1 | 2020-04-30 |
| Diagnostic Test | sample collection/performance evaluation (b) | 1 | 2020-04-30 |
| Drug | sargramostim | 1 | 2020-03-24 |
| Other | sars-cov-2 infection | 1 | 2020-04-03 |
| Biological | sars-cov-2 rs | 1 | 2020-04-24 |
| Behavioral | self-compassion for chronic pain virtual group treatment program | 1 | 2020-05-21 |
| Behavioral | self-help booklet | 1 | 2020-05-26 |
| Behavioral | self-questionnary | 1 | 2020-05-27 |
| Other | self supportive care (ssc) | 1 | 2020-06-01 |
| Other | self supportive care (ssc) alone | 1 | 2020-06-01 |
| Drug | selinexor | 1 | 2020-04-14 |
| Other | serum | 1 | 2020-04-22 |
| Biological | serum test | 1 | 2020-04-24 |
| Drug | sildenafil citrate | 1 | 2020-02-14 |
| Drug | simvastatin | 1 | 2020-04-13 |
| Drug | sirukumab | 1 | 2020-05-07 |
| Dietary Supplement | sivomixx | 1 | 2020-04-22 |
| Device | sledd with a l-mod | 1 | 2020-04-07 |
| Device | smf | 1 | 2020-05-08 |
| Behavioral | sms message support | 1 | 2020-05-26 |
| Drug | sndx-6352 | 1 | 2020-05-29 |
| Drug | sodium bicarbonate | 1 | 2020-05-02 |
| Other | spin-chat program | 1 | 2020-04-01 |
| Drug | standard care. control arm will receive standard care. | 1 | 2020-05-05 |
| Other | standard interface | 1 | 2020-04-08 |
| Procedure | stellate ganglion block | 1 | 2020-05-22 |
| Biological | stool collection | 1 | 2020-04-28 |
| Drug | sulfamethoxazole | 1 | 2020-04-20 |
| Other | supportive care | 1 | 2020-04-14 |
| Other | surgical facial mask | 1 | 2020-04-02 |
| Behavioral | survey | 1 | 2020-04-28 |
| Other | suspension | 1 | 2020-04-07 |
| Drug | suspension of heat killed (autoclaved) mycobacterium w | 1 | 2020-03-31 |
| Other | suspension/maintenance of angiotensin receptor blockers/angiotensin-converting enzyme inhibitors | 1 | 2020-04-07 |
| Biological | swab | 1 | 2020-04-28 |
| Drug | symbicort | 1 | 2020-03-29 |
| Biological | t cell derived exosom | 1 | 2020-05-12 |
| Drug | t3 solution | 1 | 2020-04-09 |
| Drug | tacrolimus | 1 | 2020-04-07 |
| Drug | tazobactam | 1 | 2020-05-15 |
| Device | tcc-covid mhealth | 1 | 2020-05-21 |
| Drug | td-0903 | 1 | 2020-04-14 |
| Behavioral | tele-interventions related to diabetes management | 1 | 2020-04-07 |
| Behavioral | tele-interventions related to diabetes management/mental well-being | 1 | 2020-04-07 |
| Procedure | telephone follow-up | 1 | 2020-04-14 |
| Drug | telmisartan | 1 | 2020-04-17 |
| Drug | tenofovir disoproxil | 1 | 2020-04-02 |
| Drug | tetrandrine | 1 | 2020-03-04 |
| Behavioral | therapy intervention | 1 | 2020-05-06 |
| Drug | thiazide | 1 | 2020-03-30 |
| Drug | thiazide-like diuretics | 1 | 2020-03-30 |
| Drug | thiazide/thiazide-like diuretics | 1 | 2020-03-30 |
| Drug | thromboprophylaxis | 1 | 2020-04-10 |
| Drug | thymosin | 1 | 2020-03-21 |
| Drug | tirofiban | 1 | 2020-04-23 |
| Drug | tj003234 | 1 | 2020-04-04 |
| Drug | tociliuzumab | 1 | 2020-04-21 |
| Procedure | tracheotomy | 1 | 2020-05-24 |
| Drug | tradipitant | 1 | 2020-03-26 |
| Drug | traditional chinese medicine | 1 | 2020-01-28 |
| Drug | treatment | 1 | 2020-03-05 |
| Drug | treatment/prophylaxis | 1 | 2020-03-05 |
| Drug | tridecactide | 1 | 2020-04-30 |
| Drug | trimethoprim | 1 | 2020-04-20 |
| Drug | trimethoprim/sulfamethoxazole | 1 | 2020-04-20 |
| Procedure | tsvf | 1 | 2020-03-26 |
| Drug | umifenovir | 1 | 2020-04-14 |
| Biological | upper respiratory sample | 1 | 2020-04-28 |
| Other | usual antibiotic treatment | 1 | 2020-04-02 |
| Behavioral | usual care positioning with no instructions | 1 | 2020-04-24 |
| Drug | usual practice / symbicort rapihaler | 1 | 2020-03-29 |
| Biological | utooth btc) | 1 | 2020-03-28 |
| Drug | uttr1147a | 1 | 2020-05-11 |
| Biological | v-sars | 1 | 2020-04-29 |
| Drug | verapamil | 1 | 2020-04-14 |
| Drug | veru-111 | 1 | 2020-05-13 |
| Behavioral | virtual group intervention | 1 | 2020-05-29 |
| Dietary Supplement | viusid | 1 | 2020-05-25 |
| Dietary Supplement | viusid/asbrip | 1 | 2020-05-25 |
| Device | volatile organic compounds analysis | 1 | 2020-04-28 |
| Device | vv-ecmo | 1 | 2020-03-25 |
| Device | vv-ecmo / cytokine adsorption | 1 | 2020-03-25 |
| Drug | water | 1 | 2020-02-04 |
| Other | weekly assessment | 1 | 2020-04-07 |
| Behavioral | who recommendations (waiting condition) | 1 | 2020-03-26 |
| Drug | xcel-umc-beta | 1 | 2020-05-07 |
| Other | yoga | 1 | 2020-05-31 |
| Drug | zidovudine | 1 | 2020-04-08 |
| Drug | zithromax | 1 | 2020-04-08 |
Interventions over Time
Weekly studies for each interventionStudies by Country
| Country | Study_Count |
|---|---|
| United States | 196 |
| France | 63 |
| China | 54 |
| Spain | 33 |
| Italy | 28 |
| Canada | 22 |
| Mexico | 18 |
| Iran, Islamic Republic of | 15 |
| United Kingdom | 13 |
| Brazil | 12 |
| Russian Federation | 10 |
| Denmark | 9 |
| Germany | 9 |
| Greece | 9 |
| Turkey | 9 |
| Belgium | 8 |
| Pakistan | 7 |
| Netherlands | 6 |
| Switzerland | 6 |
| Argentina | 5 |
| Israel | 5 |
| Poland | 5 |
| Sweden | 5 |
| Egypt | 4 |
| Hong Kong | 4 |
| India | 4 |
| Saudi Arabia | 4 |
| Australia | 3 |
| Norway | 3 |
| Austria | 2 |
| Bangladesh | 2 |
| Chile | 2 |
| United States|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 2 |
| United States|Germany|Spain|United Kingdom | 2 |
| Argentina|Canada|Chile|France|Germany|Israel|Italy|Japan|Russian Federation|Spain | 1 |
| Austria|Denmark|Germany | 1 |
| Austria|Germany | 1 |
| Bahrain | 1 |
| Belarus | 1 |
| Belgium|France|Monaco | 1 |
| Bosnia and Herzegovina | 1 |
| Canada|Mongolia | 1 |
| China|Italy | 1 |
| Czechia | 1 |
| Denmark|Germany|Hungary | 1 |
| Ecuador | 1 |
| France|Luxembourg | 1 |
| France|Monaco | 1 |
| French Guiana | 1 |
| Germany|Sweden | 1 |
| Gibraltar | 1 |
| Hungary | 1 |
| Iceland | 1 |
| Indonesia | 1 |
| Iraq | 1 |
| Ireland | 1 |
| Jordan | 1 |
| Korea, Republic of | 1 |
| North Macedonia | 1 |
| Puerto Rico | 1 |
| Romania | 1 |
| Singapore | 1 |
| Slovenia | 1 |
| South Africa | 1 |
| Taiwan | 1 |
| Thailand | 1 |
| Tunisia | 1 |
| United States|Austria|France|Israel|Spain|United Kingdom | 1 |
| United States|Brazil|Canada|Mexico | 1 |
| United States|Canada | 1 |
| United States|Canada|Denmark|France|Germany|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Canada|Spain | 1 |
| United States|Denmark|Germany|Greece|Japan|Korea, Republic of|Mexico|Singapore|Spain|United Kingdom | 1 |
| United States|Israel | 1 |
| United States|Japan|Korea, Republic of|Mexico|Singapore | 1 |
| United States|Puerto Rico | 1 |
| United States|Spain | 1 |
| Vietnam | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 401 |
| 2 | 67 |
| 3 | 23 |
| 4 | 21 |
| 5 | 10 |
| 6 | 14 |
| 7 | 10 |
| 8 | 10 |
| 9 | 10 |
| 10 | 4 |
| 11 | 1 |
| 12 | 8 |
| 13 | 1 |
| 14 | 5 |
| 15 | 5 |
| 16 | 2 |
| 17 | 1 |
| 18 | 1 |
| 20 | 1 |
| 21 | 2 |
| 22 | 1 |
| 24 | 3 |
| 25 | 2 |
| 26 | 1 |
| 27 | 1 |
| 28 | 3 |
| 31 | 1 |
| 32 | 1 |
| 33 | 1 |
| 34 | 1 |
| 40 | 2 |
| 47 | 1 |
| 52 | 1 |
| 60 | 2 |
| 62 | 1 |
| 63 | 1 |
| 68 | 1 |
| 183 | 1 |
| 184 | 1 |
Phase
| Phase | Study_Count |
|---|---|
| N/A | 197 |
| Phase 2 | 167 |
| Phase 3 | 103 |
| Phase 2/Phase 3 | 42 |
| Phase 4 | 40 |
| Phase 1/Phase 2 | 33 |
| Phase 1 | 30 |
| Early Phase 1 | 11 |
Number of Arms
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 120 |
| 2 | 385 |
| 3 | 56 |
| 4 | 39 |
| 5 | 4 |
| 6 | 6 |
| 7 | 1 |
| 8 | 2 |
| 9 | 2 |
| 11 | 1 |
| 13 | 1 |
| 17 | 1 |
| 21 | 1 |
| NA | 4 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 172 |
| 2 | 197 |
| 3 | 117 |
| 4 | 68 |
| 5 | 26 |
| 6 | 14 |
| 7 | 11 |
| 8 | 9 |
| 10 | 3 |
| 11 | 2 |
| 13 | 1 |
| 18 | 2 |
| 19 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 1049 | 451 | 2.325942 |
| Contacts/Locations | 641 | 344 | 1.863372 |
| None (earliest Version on record) | 623 | 623 | 1.000000 |
| Recruitment Status | 344 | 315 | 1.092064 |
| Outcome Measures | 235 | 178 | 1.320225 |
| Oversight | 213 | 203 | 1.049261 |
| Eligibility | 211 | 154 | 1.370130 |
| Study Identification | 177 | 146 | 1.212329 |
| Study Description | 172 | 138 | 1.246377 |
| Arms | 139 | 112 | 1.241071 |
| Interventions | 139 | 112 | 1.241071 |
| Study Design | 132 | 105 | 1.257143 |
| Sponsor/Collaborators | 72 | 62 | 1.161290 |
| Conditions | 59 | 53 | 1.113207 |
| IPDSharing | 20 | 20 | 1.000000 |
| References | 18 | 17 | 1.058823 |
| Documents | 5 | 4 | 1.250000 |
Enrollment Metrics by Phase
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 10.00000 | 4.000 | 5.0000 | 5.0000 | 5.0000 | 12.000 | 10.0000 | 10.0 |
| 1st Qu. | 10.00000 | 41.000 | 21.7500 | 20.0000 | 60.0000 | 120.000 | 240.0000 | 75.0 |
| Median | 60.00000 | 100.000 | 40.0000 | 50.0000 | 120.0000 | 335.000 | 462.0000 | 175.0 |
| Mean | 62.72727 | 5676.858 | 307.0667 | 168.2424 | 217.3713 | 818.881 | 993.1942 | 449.4 |
| 3rd Qu. | 100.00000 | 314.000 | 97.5000 | 144.0000 | 229.0000 | 518.000 | 1185.0000 | 525.5 |
| Max. | 150.00000 | 506517.000 | 7600.0000 | 1090.0000 | 2900.0000 | 12000.000 | 10078.0000 | 2414.0 |
Trial Group Type
| group_type | Group_Count |
|---|---|
| Experimental | 748 |
| Active Comparator | 220 |
| Placebo Comparator | 185 |
| No Intervention | 145 |
| Other | 70 |
| Sham Comparator | 5 |
| NA | 4 |
Intervention Model
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 451 |
| Single Group Assignment | 135 |
| Sequential Assignment | 17 |
| Crossover Assignment | 10 |
| Factorial Assignment | 10 |
Vaccines
| nct_id | brief_title | link |
|---|---|---|
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
Phase
| phase | Study_Count |
|---|---|
| Phase 1 | 6 |
| Phase 1/Phase 2 | 6 |
| Phase 2 | 2 |
Country
| country | Study_Count |
|---|---|
| Australia | 1 |
| Canada | 1 |
| China | 6 |
| Germany | 1 |
| Mongolia | 1 |
| United Kingdom | 1 |
| United States | 4 |
Site Count
| Site_count | Study_Count |
|---|---|
| 1 | 6 |
| 2 | 2 |
| 3 | 3 |
| 5 | 1 |
| 6 | 1 |
| 10 | 1 |
Arms
| number_of_arms | Study_Count |
|---|---|
| 1 | 3 |
| 3 | 3 |
| 4 | 2 |
| 5 | 1 |
| 6 | 1 |
| 8 | 1 |
| 9 | 1 |
| 13 | 1 |
| 21 | 1 |
Enrollment
| Measure | Vaccine |
|---|---|
| Min | 20.0 |
| 1st Qu | 111.0 |
| Median | 177.5 |
| Mean | 887.0 |
| 3rd Qu | 708.0 |
| Max | 7600.0 |
Model
| intervention_model | Study_Count |
|---|---|
| Crossover Assignment | 1 |
| Parallel Assignment | 4 |
| Sequential Assignment | 6 |
| Single Group Assignment | 3 |
Group Types
| group_type | Group_Count |
|---|---|
| Experimental | 67 |
| Placebo Comparator | 9 |
| Active Comparator | 6 |
Update Count
| Count of Versions | Count of Studies |
|---|---|
| 1 | 2 |
| 2 | 3 |
| 3 | 2 |
| 4 | 3 |
| 5 | 2 |
| 8 | 1 |
| 10 | 1 |
Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 40 | 12 | 3.333333 |
| Contacts/Locations | 22 | 10 | 2.200000 |
| None (earliest Version on record) | 14 | 14 | 1.000000 |
| Study Design | 12 | 6 | 2.000000 |
| Recruitment Status | 11 | 8 | 1.375000 |
| Study Identification | 11 | 7 | 1.571429 |
| Arms | 10 | 5 | 2.000000 |
| Eligibility | 10 | 4 | 2.500000 |
| Interventions | 10 | 5 | 2.000000 |
| Study Description | 7 | 3 | 2.333333 |
| Oversight | 6 | 6 | 1.000000 |
| Conditions | 5 | 2 | 2.500000 |
| Outcome Measures | 4 | 3 | 1.333333 |
| Sponsor/Collaborators | 4 | 4 | 1.000000 |
| IPDSharing | 1 | 1 | 1.000000 |
| References | 1 | 1 | 1.000000 |
Observational Studies
Studies by Country
| Country | Study_Count |
|---|---|
| France | 127 |
| United States | 74 |
| Italy | 36 |
| China | 31 |
| United Kingdom | 25 |
| Egypt | 23 |
| Spain | 22 |
| Turkey | 18 |
| Germany | 15 |
| Switzerland | 15 |
| Belgium | 11 |
| Denmark | 10 |
| Austria | 7 |
| Canada | 7 |
| India | 7 |
| Norway | 7 |
| Hong Kong | 6 |
| Brazil | 4 |
| Sweden | 4 |
| Argentina | 3 |
| Israel | 3 |
| France|French Guiana | 2 |
| Luxembourg | 2 |
| Monaco | 2 |
| Netherlands | 2 |
| Poland | 2 |
| Portugal | 2 |
| Singapore | 2 |
| Algeria | 1 |
| Australia | 1 |
| Australia|Canada|China|France|Gambia|Germany|Israel|Italy|Malaysia|Poland|Portugal|Romania|Singapore|Switzerland | 1 |
| Austria|Belgium|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Lithuania|Netherlands|Poland|Portugal|Russian Federation|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Belgium|Italy|United Kingdom | 1 |
| Brazil|Chile|Uruguay | 1 |
| Colombia | 1 |
| Croatia | 1 |
| Czechia | 1 |
| Denmark|France|Germany|Norway | 1 |
| Ecuador | 1 |
| Finland|France|Germany|Italy|Sweden|United Kingdom | 1 |
| France|Guadeloupe|Martinique | 1 |
| France|Martinique | 1 |
| Germany|Romania | 1 |
| Greece | 1 |
| Hungary | 1 |
| Iran, Islamic Republic of | 1 |
| Italy|Romania|United Kingdom | 1 |
| Italy|San Marino | 1 |
| Jordan | 1 |
| Korea, Republic of | 1 |
| Mexico | 1 |
| Pakistan | 1 |
| Russian Federation | 1 |
| Slovenia | 1 |
| United States|Albania|Australia|Czechia|France|Germany|Hong Kong|Israel|Italy|Lebanon|Norway|Poland|Spain|Sweden|Taiwan | 1 |
| United States|Argentina|Australia|Bolivia|Chile|Costa Rica|Czechia|Germany|Guatemala|Italy|Lebanon|Mexico|Netherlands|Nigeria|Puerto Rico|Saudi Arabia|Spain|Tunisia|Turkey|Venezuela | 1 |
| United States|Egypt|Germany|Peru|Singapore | 1 |
| United States|Egypt|Iran, Islamic Republic of | 1 |
| United States|Peru | 1 |
| United States|United Kingdom | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 406 |
| 2 | 28 |
| 3 | 15 |
| 4 | 3 |
| 5 | 10 |
| 6 | 5 |
| 7 | 5 |
| 8 | 3 |
| 9 | 3 |
| 10 | 1 |
| 11 | 2 |
| 12 | 1 |
| 13 | 1 |
| 14 | 1 |
| 16 | 1 |
| 17 | 3 |
| 19 | 2 |
| 20 | 1 |
| 21 | 1 |
| 23 | 1 |
| 27 | 1 |
| 34 | 1 |
| 41 | 1 |
| 69 | 1 |
| 81 | 1 |
| 97 | 1 |
| 128 | 1 |
| 324 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 234 |
| 2 | 166 |
| 3 | 52 |
| 4 | 27 |
| 5 | 8 |
| 6 | 3 |
| 7 | 3 |
| 9 | 2 |
| 10 | 1 |
| 11 | 1 |
| 15 | 1 |
| 22 | 1 |
| 34 | 1 |
| 40 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| Study Status | 558 | 267 | 2.089888 |
| None (earliest Version on record) | 501 | 501 | 1.000000 |
| Contacts/Locations | 200 | 156 | 1.282051 |
| Recruitment Status | 130 | 120 | 1.083333 |
| Study Description | 104 | 88 | 1.181818 |
| Outcome Measures | 99 | 87 | 1.137931 |
| Study Identification | 98 | 89 | 1.101124 |
| Oversight | 64 | 61 | 1.049180 |
| Eligibility | 59 | 50 | 1.180000 |
| Study Design | 53 | 51 | 1.039216 |
| Sponsor/Collaborators | 37 | 34 | 1.088235 |
| Groups | 33 | 28 | 1.178571 |
| Interventions | 33 | 28 | 1.178571 |
| Conditions | 31 | 29 | 1.068966 |
| References | 11 | 11 | 1.000000 |
| IPDSharing | 3 | 3 | 1.000000 |
Enrollment Metrics
| Measure | Observational |
|---|---|
| Min | 5.0 |
| 1st Qu | 100.0 |
| Median | 345.0 |
| Mean | 38589.8 |
| 3rd Qu | 1000.0 |
| Max | 10000000.0 |
Observation Model
| observational_model | Study_Count |
|---|---|
| Cohort | 314 |
| Case-Only | 66 |
| Other | 51 |
| Case-Control | 40 |
| Ecologic or Community | 20 |
| Family-Based | 5 |
| Case-Crossover | 4 |
| NA | 1 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 304 |
| Retrospective | 104 |
| Cross-Sectional | 56 |
| Other | 36 |
| NA | 1 |
Registries
Studies by Country
| Country | Study_Count |
|---|---|
| France | 15 |
| United States | 14 |
| Spain | 10 |
| Italy | 8 |
| Turkey | 7 |
| Belgium | 5 |
| Germany | 5 |
| China | 3 |
| Denmark | 3 |
| Switzerland | 3 |
| Austria | 2 |
| Mexico | 2 |
| Norway | 2 |
| United Kingdom | 2 |
| Bangladesh | 1 |
| Canada | 1 |
| Egypt | 1 |
| Hungary | 1 |
| Netherlands | 1 |
| Poland | 1 |
| Russian Federation | 1 |
| Sweden | 1 |
| Tunisia | 1 |
| Ukraine | 1 |
| United States|Brazil|Colombia|France|Spain | 1 |
| United States|Poland | 1 |
Sites per Study
| Site_count | Study_Count |
|---|---|
| 1 | 74 |
| 2 | 7 |
| 3 | 1 |
| 4 | 1 |
| 6 | 1 |
| 7 | 1 |
| 11 | 1 |
| 15 | 1 |
| 17 | 1 |
| 18 | 1 |
| 37 | 1 |
| 39 | 1 |
| 61 | 1 |
| 75 | 1 |
Number of Updates
| Count of Versions | Count of Studies |
|---|---|
| 1 | 40 |
| 2 | 28 |
| 3 | 19 |
| 4 | 4 |
| 5 | 1 |
| 11 | 1 |
Update History Change Type
| Change Type | Count_of_Changes | Count_of_Studies | ratio |
|---|---|---|---|
| None (earliest Version on record) | 93 | 93 | 1.000000 |
| Study Status | 92 | 53 | 1.735849 |
| Contacts/Locations | 47 | 28 | 1.678571 |
| Recruitment Status | 22 | 21 | 1.047619 |
| Study Design | 18 | 16 | 1.125000 |
| Outcome Measures | 17 | 15 | 1.133333 |
| Study Description | 17 | 15 | 1.133333 |
| Study Identification | 17 | 16 | 1.062500 |
| Eligibility | 9 | 9 | 1.000000 |
| Oversight | 9 | 9 | 1.000000 |
| Groups | 7 | 7 | 1.000000 |
| Interventions | 7 | 7 | 1.000000 |
| Conditions | 5 | 5 | 1.000000 |
| Sponsor/Collaborators | 5 | 5 | 1.000000 |
| References | 3 | 3 | 1.000000 |
| Documents | 2 | 2 | 1.000000 |
| IPDSharing | 2 | 2 | 1.000000 |
| Results | 1 | 1 | 1.000000 |
Enrollment Metrics
| Measure | Registries |
|---|---|
| Min | 10.00 |
| 1st Qu | 100.00 |
| Median | 300.00 |
| Mean | 37637.91 |
| 3rd Qu | 1000.00 |
| Max | 3000000.00 |
Registry Model
| observational_model | Study_Count |
|---|---|
| Cohort | 67 |
| Case-Control | 13 |
| Case-Only | 8 |
| Other | 4 |
| Ecologic or Community | 1 |
Time Perspective
| time_perspective | Study_Count |
|---|---|
| Prospective | 71 |
| Other | 14 |
| Cross-Sectional | 8 |
Follow-up
| target_duration | Study_Count |
|---|---|
| 1 Year | 12 |
| 1 Month | 11 |
| 12 Months | 10 |
| 3 Months | 9 |
| 6 Months | 9 |
| 2 Months | 6 |
| 2 Years | 4 |
| 4 Weeks | 4 |
| 1 Day | 3 |
| 30 Days | 3 |
| 20 Years | 2 |
| 28 Days | 2 |
| 3 Weeks | 2 |
| 5 Years | 2 |
| 10 Days | 1 |
| 14 Weeks | 1 |
| 18 Months | 1 |
| 2 Weeks | 1 |
| 20 Days | 1 |
| 20 Months | 1 |
| 24 Months | 1 |
| 6 Weeks | 1 |
| 60 Days | 1 |
| 7 Days | 1 |
| 7 Months | 1 |
| 8 Weeks | 1 |
| 9 Months | 1 |
| 9 Weeks | 1 |
Overview of trials
Interventional Trials
| nct_id | brief_title | link |
|---|---|---|
| NCT04244591 | Glucocorticoid Therapy for COVID-19 Critically Ill Patients With Severe Acute Respiratory Failure | https://ClinicalTrials.gov/show/NCT04244591 |
| NCT04252118 | Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04252118 |
| NCT04251871 | Treatment and Prevention of Traditional Chinese Medicines (TCMs) on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04251871 |
| NCT04252274 | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04252274 |
| NCT04252885 | The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04252885 |
| NCT04263402 | The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia | https://ClinicalTrials.gov/show/NCT04263402 |
| NCT04255017 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04255017 |
| NCT04254874 | A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04254874 |
| NCT04264533 | Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia | https://ClinicalTrials.gov/show/NCT04264533 |
| NCT04261270 | A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04261270 |
| NCT04331613 | Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDS | https://ClinicalTrials.gov/show/NCT04331613 |
| NCT04275245 | Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04275245 |
| NCT04261517 | Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04261517 |
| NCT04269525 | Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia | https://ClinicalTrials.gov/show/NCT04269525 |
| NCT04282902 | A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04282902 |
| NCT04276688 | Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment | https://ClinicalTrials.gov/show/NCT04276688 |
| NCT04280224 | NK Cells Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04280224 |
| NCT04304313 | A Pilot Study of Sildenafil in COVID-19 | https://ClinicalTrials.gov/show/NCT04304313 |
| NCT04275414 | Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04275414 |
| NCT04273763 | Evaluating the Efficacy and Safety of Bromhexine Hydrochloride Tablets Combined With Standard Treatment/ Standard Treatment in Patients With Suspected and Mild Novel Coronavirus Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04273763 |
| NCT04279197 | Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu | https://ClinicalTrials.gov/show/NCT04279197 |
| NCT04273321 | Efficacy and Safety of Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04273321 |
| NCT04276896 | Immunity and Safety of Covid-19 Synthetic Minigene Vaccine | https://ClinicalTrials.gov/show/NCT04276896 |
| NCT04343794 | Using Biovitals® Sentinel to Monitor Disease Progression in Subjects Quarantined for Suspected COVID-19 | https://ClinicalTrials.gov/show/NCT04343794 |
| NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | https://ClinicalTrials.gov/show/NCT04280705 |
| NCT04280588 | Fingolimod in COVID-19 | https://ClinicalTrials.gov/show/NCT04280588 |
| NCT04283461 | Safety and Immunogenicity Study of 2019-nCoV Vaccine (mRNA-1273) for Prophylaxis of SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04283461 |
| NCT04288102 | Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19) | https://ClinicalTrials.gov/show/NCT04288102 |
| NCT04291729 | Evaluation of Ganovo （Danoprevir ） Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04291729 |
| NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | https://ClinicalTrials.gov/show/NCT04292730 |
| NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734â„¢) in Participants With Severe Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04292899 |
| NCT04308317 | Tetrandrine Tablets Used in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04308317 |
| NCT04304053 | Treatment of COVID-19 Cases and Chemoprophylaxis of Contacts as Prevention | https://ClinicalTrials.gov/show/NCT04304053 |
| NCT04299724 | Safety and Immunity of Covid-19 aAPC Vaccine | https://ClinicalTrials.gov/show/NCT04299724 |
| NCT04303507 | Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting | https://ClinicalTrials.gov/show/NCT04303507 |
| NCT04306055 | Blood Donor Recruitment During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04306055 |
| NCT04310228 | Favipiravir Combined With Tocilizumab in the Treatment of Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04310228 |
| NCT04305457 | Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04305457 |
| NCT04305106 | Bevacizumab in Severe or Critically Severe Patients With COVID-19 Pneumonia-RCT | https://ClinicalTrials.gov/show/NCT04305106 |
| NCT04304690 | COVID-19 Seroconversion Among Front Line Medical and Paramedical Staff in Emergency, Intensive Care Units and Infectious Disease Departments During the 2020 Epidemic | https://ClinicalTrials.gov/show/NCT04304690 |
| NCT04306393 | Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 | https://ClinicalTrials.gov/show/NCT04306393 |
| NCT04308668 | Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04308668 |
| NCT04311177 | Losartan for Patients With COVID-19 Not Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04311177 |
| NCT04316377 | Norwegian Coronavirus Disease 2019 Study | https://ClinicalTrials.gov/show/NCT04316377 |
| NCT04315948 | Trial of Treatments for COVID-19 in Hospitalized Adults | https://ClinicalTrials.gov/show/NCT04315948 |
| NCT04312009 | Losartan for Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04312009 |
| NCT04315480 | Tocilizumab for SARS-CoV2 (COVID-19) Severe Pneumonitis | https://ClinicalTrials.gov/show/NCT04315480 |
| NCT04311697 | Intravenous Aviptadil for Critical COVID-19 With Respiratory Failure | https://ClinicalTrials.gov/show/NCT04311697 |
| NCT04315298 | Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04315298 |
| NCT04313322 | Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04313322 |
| NCT04313127 | Phase I Clinical Trial of a COVID-19 Vaccine in 18-60 Healthy Adults | https://ClinicalTrials.gov/show/NCT04313127 |
| NCT04313023 | The Use PUL-042 to Reduce the Infection Rate and Progression to COVID-19 in Adults Exposed to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04313023 |
| NCT04312997 | The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04312997 |
| NCT04323514 | Use of Ascorbic Acid in Patients With COVID 19 | https://ClinicalTrials.gov/show/NCT04323514 |
| NCT04321174 | COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir | https://ClinicalTrials.gov/show/NCT04321174 |
| NCT04315896 | Hydroxychloroquine Treatment for Severe COVID-19 Pulmonary Infection (HYDRA Trial) | https://ClinicalTrials.gov/show/NCT04315896 |
| NCT04323527 | Chloroquine Diphosphate for the Treatment of Severe Acute Respiratory Syndrome Secondary to SARS-CoV2 | https://ClinicalTrials.gov/show/NCT04323527 |
| NCT04320056 | Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) | https://ClinicalTrials.gov/show/NCT04320056 |
| NCT04318015 | Hydroxychloroquine Chemoprophylaxis in Healthcare Personnel in Contact With COVID-19 Patients (PHYDRA Trial) | https://ClinicalTrials.gov/show/NCT04318015 |
| NCT04317092 | Tocilizumab in COVID-19 Pneumonia (TOCIVID-19) | https://ClinicalTrials.gov/show/NCT04317092 |
| NCT04317040 | CD24Fc as a Non-antiviral Immunomodulator in COVID-19 Treatment | https://ClinicalTrials.gov/show/NCT04317040 |
| NCT04324606 | A Study of a Candidate COVID-19 Vaccine (COV001) | https://ClinicalTrials.gov/show/NCT04324606 |
| NCT04319900 | Clinical Trial of Favipiravir Tablets Combine With Chloroquine Phosphate in the Treatment of Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04319900 |
| NCT04319445 | Mindfulness During COVID-19 | https://ClinicalTrials.gov/show/NCT04319445 |
| NCT04318444 | Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04318444 |
| NCT04318431 | Prevalence of SARS -Cov2 Carriage in Asymptomatic and Mildly-symptomatic Children | https://ClinicalTrials.gov/show/NCT04318431 |
| NCT04325867 | Integrated Distance Management Strategy for Patients With Cardiovascular Diseases in the Context of COVID-19 | https://ClinicalTrials.gov/show/NCT04325867 |
| NCT04320953 | Non-contact Endoscopy at Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04320953 |
| NCT04320238 | Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff | https://ClinicalTrials.gov/show/NCT04320238 |
| NCT04319731 | A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04319731 |
| NCT04328961 | Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) | https://ClinicalTrials.gov/show/NCT04328961 |
| NCT04328129 | Household Transmission Investigation Study for COVID-19 in French Guiana | https://ClinicalTrials.gov/show/NCT04328129 |
| NCT04323345 | Efficacy of Natural Honey Treatment in Patients With Novel Coronavirus | https://ClinicalTrials.gov/show/NCT04323345 |
| NCT04322682 | Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) | https://ClinicalTrials.gov/show/NCT04322682 |
| NCT04322396 | Proactive Prophylaxis With Azithromycin and hydroxyChloroquine in Hospitalized Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04322396 |
| NCT04322344 | Escin in Patients With Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04322344 |
| NCT04321616 | The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients | https://ClinicalTrials.gov/show/NCT04321616 |
| NCT04321278 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) | https://ClinicalTrials.gov/show/NCT04321278 |
| NCT04321096 | The Impact of Camostat Mesilate on COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04321096 |
| NCT04321421 | Hyperimmune Plasma for Critical Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04321421 |
| NCT04320615 | A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04320615 |
| NCT04330690 | Treatments for COVID-19: Canadian Arm of the SOLIDARITY Trial | https://ClinicalTrials.gov/show/NCT04330690 |
| NCT04327349 | Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical Trial | https://ClinicalTrials.gov/show/NCT04327349 |
| NCT04326920 | Sargramostim in Patients With Acute Hypoxic Respiratory Failure Due to COVID-19 (SARPAC) | https://ClinicalTrials.gov/show/NCT04326920 |
| NCT04322773 | Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure | https://ClinicalTrials.gov/show/NCT04322773 |
| NCT04322565 | Colchicine Counteracting Inflammation in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04322565 |
| NCT04321993 | Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04321993 |
| NCT04322123 | Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) | https://ClinicalTrials.gov/show/NCT04322123 |
| NCT04371601 | Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04371601 |
| NCT04353271 | Trial of Hydroxychloroquine In Covid-19 Kinetics | https://ClinicalTrials.gov/show/NCT04353271 |
| NCT04336462 | Hydrogen-Oxygen Generator With Nebulizer in the Improvement of Symptoms in Patients Infected With COVID-19 | https://ClinicalTrials.gov/show/NCT04336462 |
| NCT04327206 | BCG Vaccination to Protect Healthcare Workers Against COVID-19 | https://ClinicalTrials.gov/show/NCT04327206 |
| NCT04326452 | Treating COVID-19 With a Bidirectional Oxygenation Valve | https://ClinicalTrials.gov/show/NCT04326452 |
| NCT04325893 | Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease | https://ClinicalTrials.gov/show/NCT04325893 |
| NCT04325061 | Efficacy of Dexamethasone Treatment for Patients With ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04325061 |
| NCT04324996 | A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19 | https://ClinicalTrials.gov/show/NCT04324996 |
| NCT04324528 | Cytokine Adsorption in Severe COVID-19 Pneumonia Requiring Extracorporeal Membrane Oxygenation | https://ClinicalTrials.gov/show/NCT04324528 |
| NCT04324489 | DAS181 for Severe COVID-19: Compassionate Use | https://ClinicalTrials.gov/show/NCT04324489 |
| NCT04324463 | Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial | https://ClinicalTrials.gov/show/NCT04324463 |
| NCT04324073 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI | https://ClinicalTrials.gov/show/NCT04324073 |
| NCT04324021 | Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. | https://ClinicalTrials.gov/show/NCT04324021 |
| NCT04328285 | Chemoprophylaxis of SARS-CoV-2 Infection (COVID-19) in Exposed Healthcare Workers | https://ClinicalTrials.gov/show/NCT04328285 |
| NCT04327505 | Safety and Efficacy of Hyperbaric Oxygen for ARDS in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04327505 |
| NCT04355962 | Sevoflurane in COVID-19 ARDS (SevCov) | https://ClinicalTrials.gov/show/NCT04355962 |
| NCT04329533 | Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04329533 |
| NCT04326790 | The GReek Study in the Effects of Colchicine in Covid-19 cOmplications Prevention | https://ClinicalTrials.gov/show/NCT04326790 |
| NCT04326426 | ODYSSEY: A Study to Investigate the Efficacy of Tradipitant in Treating Severe or Critical COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326426 |
| NCT04326036 | Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04326036 |
| NCT04325906 | Early PP With HFNC Versus HFNC in COVID-19 Induced Moderate to Severe ARDS | https://ClinicalTrials.gov/show/NCT04325906 |
| NCT04324190 | DIgital Online SuPport for COVID-19 StrEss | https://ClinicalTrials.gov/show/NCT04324190 |
| NCT04327388 | Sarilumab COVID-19 | https://ClinicalTrials.gov/show/NCT04327388 |
| NCT04327401 | COVID-19-associated ARDS Treated With Dexamethasone: Alliance Covid-19 Brasil III | https://ClinicalTrials.gov/show/NCT04327401 |
| NCT04344379 | Prevention of SARS-CoV-2 in Hospital Workers s Exposed to the Virus | https://ClinicalTrials.gov/show/NCT04344379 |
| NCT04331899 | Single-Blind Study of a Single Dose of Peginterferon Lambda-1a Compared With Placebo in Outpatients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04331899 |
| NCT04328467 | Pre-exposure Prophylaxis for SARS-Coronavirus-2 | https://ClinicalTrials.gov/show/NCT04328467 |
| NCT04328441 | Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine | https://ClinicalTrials.gov/show/NCT04328441 |
| NCT04328012 | COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04328012 |
| NCT04328493 | The Vietnam Chloroquine Treatment on COVID-19 | https://ClinicalTrials.gov/show/NCT04328493 |
| NCT04336254 | Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04336254 |
| NCT04329195 | ACE Inhibitors or ARBs Discontinuation in Context of SARS-CoV-2 Pandemic | https://ClinicalTrials.gov/show/NCT04329195 |
| NCT04333368 | Cell Therapy Using Umbilical Cord-derived Mesenchymal Stromal Cells in SARS-CoV-2-related ARDS | https://ClinicalTrials.gov/show/NCT04333368 |
| NCT04331054 | Protective Role of Inhaled Steroids for Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04331054 |
| NCT04329611 | ALBERTA HOPE COVID-19 for the Prevention of Severe COVID19 Disease | https://ClinicalTrials.gov/show/NCT04329611 |
| NCT04348370 | BCG Vaccine for Health Care Workers as Defense Against COVID 19 | https://ClinicalTrials.gov/show/NCT04348370 |
| NCT04332107 | Azithromycin for COVID-19 Treatment in Outpatients Nationwide | https://ClinicalTrials.gov/show/NCT04332107 |
| NCT04331600 | Chloroquine as Antiviral Treatment in Coronavirus Infection 2020 | https://ClinicalTrials.gov/show/NCT04331600 |
| NCT04331470 | Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04331470 |
| NCT04330300 | Coronavirus (COVID-19) ACEi/ARB Investigation | https://ClinicalTrials.gov/show/NCT04330300 |
| NCT04329923 | The PATCH Trial (Prevention And Treatment of COVID-19 With Hydroxychloroquine) | https://ClinicalTrials.gov/show/NCT04329923 |
| NCT04328480 | The ECLA PHRI COLCOVID Trial. Effects of Colchicine on Moderate/High-risk Hospitalized COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04328480 |
| NCT04329832 | Hydroxychloroquine vs. Azithromycin for Hospitalized Patients With Suspected or Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04329832 |
| NCT04376515 | Harnessing Online Peer Education Online Support Intervention for COVID-19 (HOPE COVID-19) | https://ClinicalTrials.gov/show/NCT04376515 |
| NCT04352348 | Cohort of Patients Infected With SARS-CoV2 (COVID-19) or Suspected of Being | https://ClinicalTrials.gov/show/NCT04352348 |
| NCT04347174 | A Clinical Trial of Mycobacterium w in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04347174 |
| NCT04342182 | Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) | https://ClinicalTrials.gov/show/NCT04342182 |
| NCT04336332 | Randomized Comparison of Combination Azithromycin and Hydroxychloroquine vs. Hydroxychloroquine Alone for the Treatment of Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04336332 |
| NCT04335123 | Study of Open Label Losartan in COVID-19 | https://ClinicalTrials.gov/show/NCT04335123 |
| NCT04333355 | Safety in Convalescent Plasma Transfusion to COVID-19 | https://ClinicalTrials.gov/show/NCT04333355 |
| NCT04332094 | Clinical Trial of Combined Use of Hydroxychloroquine, Azithromycin, and Tocilizumab for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04332094 |
| NCT04331808 | CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI) | https://ClinicalTrials.gov/show/NCT04331808 |
| NCT04331366 | Bidirectional Oxygenation Valve in the Management of Pulmonary Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04331366 |
| NCT04330638 | Treatment of COVID-19 Patients With Anti-interleukin Drugs | https://ClinicalTrials.gov/show/NCT04330638 |
| NCT04329650 | Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04329650 |
| NCT04343651 | Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04343651 |
| NCT04335305 | Checkpoint Blockade in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04335305 |
| NCT04332991 | Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease | https://ClinicalTrials.gov/show/NCT04332991 |
| NCT04339712 | Personalised Immunotherapy for SARS-CoV-2 (COVID-19) Associated With Organ Dysfunction | https://ClinicalTrials.gov/show/NCT04339712 |
| NCT04338009 | Elimination or Prolongation of ACE Inhibitors and ARB in Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04338009 |
| NCT04335279 | Evaluation of the Scleroderma Patient-centered Intervention Network COVID-19 Home-isolation Activities Together Program | https://ClinicalTrials.gov/show/NCT04335279 |
| NCT04335136 | Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04335136 |
| NCT04335097 | Sensor Based Vital Signs Monitoring of Covid 19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04335097 |
| NCT04334265 | Efficacy and Safety of Anluohuaxian in the Treatment of Rehabilitation Patients With Corona Virus Disease 2019 | https://ClinicalTrials.gov/show/NCT04334265 |
| NCT04334044 | Treatment of SARS Caused by COVID-19 With Ruxolitinib | https://ClinicalTrials.gov/show/NCT04334044 |
| NCT04333914 | Prospective Study in Patients With Advanced or Metastatic Cancer and SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04333914 |
| NCT04333589 | Corona Virus Disease 2019 Patients Whose Nucleic Acids Changed From Negative to Positive | https://ClinicalTrials.gov/show/NCT04333589 |
| NCT04333550 | Application of Desferal to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04333550 |
| NCT04333420 | Open-label, Randomized Study of IFX-1 in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04333420 |
| NCT04333407 | Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial. | https://ClinicalTrials.gov/show/NCT04333407 |
| NCT04333225 | Hydroxychloroquine in the Prevention of COVID-19 Infection in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04333225 |
| NCT04331834 | Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331834 |
| NCT04331795 | Tocilizumab to Prevent Clinical Decompensation in Hospitalized, Non-critically Ill Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04331795 |
| NCT04347226 | Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347226 |
| NCT04345523 | Convalescent Plasma Therapy vs. SOC for the Treatment of COVID19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345523 |
| NCT04340349 | Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04340349 |
| NCT04339660 | Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04339660 |
| NCT04337541 | Reduction in COVID-19 Infection Using Surgical Facial Masks Outside the Healthcare System | https://ClinicalTrials.gov/show/NCT04337541 |
| NCT04335786 | Valsartan for Prevention of Acute Respiratory Distress Syndrome in Hospitalized Patients With SARS-COV-2 (COVID-19) Infection Disease | https://ClinicalTrials.gov/show/NCT04335786 |
| NCT04335071 | Tocilizumab in the Treatment of Coronavirus Induced Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04335071 |
| NCT04334928 | Randomized Clinical Trial for the Prevention of SARS-CoV-2 Infection (COVID-19) in Healthcare Personnel | https://ClinicalTrials.gov/show/NCT04334928 |
| NCT04334850 | Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04334850 |
| NCT04334460 | Safety and Antiviral Activity of BLD-2660 in COVID-19 Hospitalized Subjects | https://ClinicalTrials.gov/show/NCT04334460 |
| NCT04334382 | Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 | https://ClinicalTrials.gov/show/NCT04334382 |
| NCT04334629 | LIBERATE Trial in COVID-19 | https://ClinicalTrials.gov/show/NCT04334629 |
| NCT04348409 | Efficacy and Safety of Nitazoxanide for the Treatment of Hospitalized Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04348409 |
| NCT04343053 | Pro-thrombotic Status in Patients With SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04343053 |
| NCT04340544 | Hydroxychloroquine for the Treatment of Mild COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04340544 |
| NCT04337008 | Renin Angiotensin System - CoronaVirus | https://ClinicalTrials.gov/show/NCT04337008 |
| NCT04336904 | Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 | https://ClinicalTrials.gov/show/NCT04336904 |
| NCT04336774 | CAPTION AI to Minimize Risk of COVID Exposure | https://ClinicalTrials.gov/show/NCT04336774 |
| NCT04335552 | Pragmatic Factorial Trial of Hydroxychloroquine, Azithromycin, or Both for Treatment of Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04335552 |
| NCT04336410 | Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers | https://ClinicalTrials.gov/show/NCT04336410 |
| NCT04342650 | Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04342650 |
| NCT04341116 | Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04341116 |
| NCT04338568 | Screening COVID-19 by Point-of-care Lung Ultrasound: a Validation Study | https://ClinicalTrials.gov/show/NCT04338568 |
| NCT04345861 | Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) | https://ClinicalTrials.gov/show/NCT04345861 |
| NCT04341675 | Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04341675 |
| NCT04338828 | Nitric Oxide Inhalation Therapy for COVID-19 Infections in the ED | https://ClinicalTrials.gov/show/NCT04338828 |
| NCT04338841 | HOME-CoV: Hospitalization or Outpatient ManagEment of Patients With a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04338841 |
| NCT04343092 | Efficacy of Ivermectin as Add on Therapy in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04343092 |
| NCT04349631 | A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04349631 |
| NCT04346797 | CORIMUNO19-ECU: Trial Evaluating Efficacy and Safety of Eculizumab (Soliris) in Patients With COVID-19 Infection, Nested in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04346797 |
| NCT04337918 | Nitric Oxide Releasing Solutions to Prevent and Treat Mild/Moderate COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04337918 |
| NCT04344951 | Chloroquine Phosphate Against Infection by the Novel Coronavirus SARS-CoV-2 (COVID-19): The HOPE Open-Label, Non Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04344951 |
| NCT04340557 | Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04340557 |
| NCT04339816 | Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care With COVID-19: Randomised Controlled Trial | https://ClinicalTrials.gov/show/NCT04339816 |
| NCT04384380 | Efficacy and Tolerability of Hydroxychloroquine in Adult Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384380 |
| NCT04364893 | Angiotensin Receptor Blockers and Angiotensin-converting Enzyme Inhibitors and Adverse Outcomes in Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04364893 |
| NCT04361552 | Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) | https://ClinicalTrials.gov/show/NCT04361552 |
| NCT04353674 | Modulation of Hyperinflammation in COVID-19 | https://ClinicalTrials.gov/show/NCT04353674 |
| NCT04352933 | PROLIFIC ChemoprophylaxisTrial (COVID-19) | https://ClinicalTrials.gov/show/NCT04352933 |
| NCT04347031 | A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04347031 |
| NCT04346147 | Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04346147 |
| NCT04345848 | Preventing COVID-19 Complications With Low- and High-dose Anticoagulation | https://ClinicalTrials.gov/show/NCT04345848 |
| NCT04345614 | A Study of CM4620-Injectable Emulsion (IE) in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345614 |
| NCT04344210 | Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus | https://ClinicalTrials.gov/show/NCT04344210 |
| NCT04342169 | University of Utah COVID-19 Hydrochloroquine Trial | https://ClinicalTrials.gov/show/NCT04342169 |
| NCT04341493 | Hydroxychloroquine vs Nitazoxanide in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04341493 |
| NCT04341441 | Will Hydroxychloroquine Impede or Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04341441 |
| NCT04341415 | Impact of Auricular Vagus Nerve Neuromodulation on COVID-19 Positive Inpatients Outcome | https://ClinicalTrials.gov/show/NCT04341415 |
| NCT04341389 | A Phase II Clinical Trial to Evaluate the Recombinant Vaccine for COVID-19 (Adenovirus Vector) | https://ClinicalTrials.gov/show/NCT04341389 |
| NCT04341038 | Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury | https://ClinicalTrials.gov/show/NCT04341038 |
| NCT04340050 | COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04340050 |
| NCT04339426 | Atovaquone and Azithromycin Combination for Confirmed COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04339426 |
| NCT04338958 | Ruxolitinib in Covid-19 Patients With Defined Hyperinflammation | https://ClinicalTrials.gov/show/NCT04338958 |
| NCT04341922 | A Online-delivered Cognitive-behavioral Intervention for Dysfunctional Worry Related to the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341922 |
| NCT04358081 | Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04358081 |
| NCT04350580 | Polyvalent Immunoglobulin in COVID-19 Related ARds | https://ClinicalTrials.gov/show/NCT04350580 |
| NCT04348383 | Defibrotide as Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome of Covid 19. | https://ClinicalTrials.gov/show/NCT04348383 |
| NCT04347681 | Potential Efficacy of Convalescent Plasma to Treat Severe COVID-19 and Patients at High Risk of Developing Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04347681 |
| NCT04346693 | An Open Randomized Study of Dalargin Effectiveness in Patients With Severe and Critical Manifestations of SARS-COVID-19 | https://ClinicalTrials.gov/show/NCT04346693 |
| NCT04346420 | Impact of the Double-Trunk Mask on Oxygenation Titration in COVID-19 | https://ClinicalTrials.gov/show/NCT04346420 |
| NCT04345653 | Hydroxychloroquine as Chemoprevention for COVID-19 for High Risk Healthcare Workers | https://ClinicalTrials.gov/show/NCT04345653 |
| NCT04344587 | Awake Prone Position for Early Hypoxemia in COVID-19 | https://ClinicalTrials.gov/show/NCT04344587 |
| NCT04344457 | Evaluate the Efficacy and Safety of Oral Hydroxychloroquine, Indomethacin and Zithromax in Subjects With Mild Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04344457 |
| NCT04344236 | Gargling and Nasal Rinses to Reduce Oro- and Nasopharyngeal Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344236 |
| NCT04344106 | Prone Positioning in Spontaneously Breathing Nonintubated Covid-19 Patient: a Pilot Study | https://ClinicalTrials.gov/show/NCT04344106 |
| NCT04343768 | An Investigation Into Beneficial Effects of Interferon Beta 1a, Compared to Interferon Beta 1b And The Base Therapeutic Regiment in Moderate to Severe COVID-19: A Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04343768 |
| NCT04343755 | Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343755 |
| NCT04343261 | Convalescent Plasma in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343261 |
| NCT04342728 | Coronavirus 2019 (COVID-19)- Using Ascorbic Acid and Zinc Supplementation | https://ClinicalTrials.gov/show/NCT04342728 |
| NCT04342663 | A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04342663 |
| NCT04342221 | Hydroxychloroquine for COVID-19 | https://ClinicalTrials.gov/show/NCT04342221 |
| NCT04341207 | Epidemiology of SARS-CoV-2 and Mortality to Covid19 Disease in French Cancer Patients | https://ClinicalTrials.gov/show/NCT04341207 |
| NCT04343248 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post-Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses in Elderly Residents of Long-Term Care Facilities (LTCF) | https://ClinicalTrials.gov/show/NCT04343248 |
| NCT04341142 | Assessment of Serological Techniques for Screening Patients Regarding COVID-19-COVID-SER | https://ClinicalTrials.gov/show/NCT04341142 |
| NCT04353037 | PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04353037 |
| NCT04351906 | Low-flow Extracorporeal Carbon Dioxide Removal in COVID-19-associated Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04351906 |
| NCT04347980 | Dexamethasone Treatment for Severe Acute Respiratory Distress Syndrome Induced by COVID-19 | https://ClinicalTrials.gov/show/NCT04347980 |
| NCT04346615 | Safety and Efficacy Trial of Vazegepant Intranasal for Hospitalized Patients With COVID-19 Requiring Supplemental Oxygen | https://ClinicalTrials.gov/show/NCT04346615 |
| NCT04346589 | Convalescent Antibodies Infusion in Critically Ill COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04346589 |
| NCT04344730 | Dexamethasone and Oxygen Support Strategies in ICU Patients With Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04344730 |
| NCT04344431 | Management by Hyperbaric Oxygen Therapy of Patients With Hypoxaemic Pneumonia With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04344431 |
| NCT04344080 | Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04344080 |
| NCT04344041 | COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) | https://ClinicalTrials.gov/show/NCT04344041 |
| NCT04344015 | COVID-19 Plasma Collection | https://ClinicalTrials.gov/show/NCT04344015 |
| NCT04343989 | A Randomized Placebo-controlled Safety and Dose-finding Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04343989 |
| NCT04343963 | Pyridostigmine in Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04343963 |
| NCT04343729 | Methylprednisolone in the Treatment of Patients With Signs of Severe Acute Respiratory Syndrome in Covid-19 | https://ClinicalTrials.gov/show/NCT04343729 |
| NCT04348513 | Triiodothyronine for the Treatment of Critically Ill Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04348513 |
| NCT04345692 | A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04345692 |
| NCT04390178 | Convalescent Plasma as Treatment for Acute Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04390178 |
| NCT04351724 | Austrian CoronaVirus Adaptive Clinical Trial (COVID-19) | https://ClinicalTrials.gov/show/NCT04351724 |
| NCT04348929 | Birth Experience During COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04348929 |
| NCT04345991 | Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort | https://ClinicalTrials.gov/show/NCT04345991 |
| NCT04345549 | Ayurveda Self-Management for Flu Like Symptoms During the Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04345549 |
| NCT04344535 | Convalescent Plasma vs. Standard Plasma for COVID-19 | https://ClinicalTrials.gov/show/NCT04344535 |
| NCT04344444 | Treatment in Patients With Suspected or Confirmed COVID-19 With Early Moderate or Severe Disease | https://ClinicalTrials.gov/show/NCT04344444 |
| NCT04344288 | Corticosteroids During Covid-19 Viral Pneumonia Related to SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04344288 |
| NCT04344561 | Incline Positioning in COVID-19 Patients for Improvement in Oxygen Saturation | https://ClinicalTrials.gov/show/NCT04344561 |
| NCT04342897 | A Study of LY3127804 in Participants With COVID-19 | https://ClinicalTrials.gov/show/NCT04342897 |
| NCT04345289 | Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04345289 |
| NCT04345276 | Efficacy and Safety of Ganovo (Danoprevir) Combined With Ritonavir in the Treatment of SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04345276 |
| NCT04344600 | Peginterferon Lambda-1a for the Prevention and Treatment of SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04344600 |
| NCT04349410 | The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol | https://ClinicalTrials.gov/show/NCT04349410 |
| NCT04348305 | Hydrocortisone for COVID-19 and Severe Hypoxia | https://ClinicalTrials.gov/show/NCT04348305 |
| NCT04347538 | Impact of Nasal Saline Irrigations on Viral Load in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04347538 |
| NCT04347382 | Honey & Nigella Sativa-COVID-Pakistan Trial Against COVID-19 | https://ClinicalTrials.gov/show/NCT04347382 |
| NCT04349371 | Saved From COVID-19 | https://ClinicalTrials.gov/show/NCT04349371 |
| NCT04346355 | Efficacy of Early Administration of Tocilizumab in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346355 |
| NCT04359251 | Different PEEP Settings of COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04359251 |
| NCT04355728 | Use of UC-MSCs for COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355728 |
| NCT04350281 | Double Therapy With IFN-beta 1b and Hydroxychloroquine | https://ClinicalTrials.gov/show/NCT04350281 |
| NCT04348864 | COVID-19 Antibody Self-testing Using Virtual Point-of-care | https://ClinicalTrials.gov/show/NCT04348864 |
| NCT04348695 | Study of Ruxolitinib Plus Simvastatin in the Prevention and Treatment of Respiratory Failure of COVID-19. | https://ClinicalTrials.gov/show/NCT04348695 |
| NCT04348656 | CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) | https://ClinicalTrials.gov/show/NCT04348656 |
| NCT04346667 | Post-Exposure Prophylaxis for Asymptomatic SARS-CoV-2 COVID-19 Patients With choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04346667 |
| NCT04346017 | Evaluation of Interleukine 6 (and Other Cytokines and Inflammatory Markers) in COVID-19 Patients With a Systemic Inflammatory Response Syndrome | https://ClinicalTrials.gov/show/NCT04346017 |
| NCT04357340 | The Effects of Pulmonary Physiotherapy Treatments on Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04357340 |
| NCT04348500 | Clazakizumab (Anti-IL- 6 Monoclonal) Compared to Placebo for COVID19 Disease | https://ClinicalTrials.gov/show/NCT04348500 |
| NCT04347239 | Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347239 |
| NCT04382391 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04382391 |
| NCT04361916 | Home Care for Patients With COVID-19: Active Monitoring in Two Italian Health Units (Casale Monferrato and Torino) | https://ClinicalTrials.gov/show/NCT04361916 |
| NCT04357808 | Efficacy of Subcutaneous Sarilumab in Hospitalised Patients With Moderate-severe COVID-19 Infection (SARCOVID) | https://ClinicalTrials.gov/show/NCT04357808 |
| NCT04357106 | COPLA Study: Treatment of Severe Forms of COronavirus Infection With Convalescent PLAsma | https://ClinicalTrials.gov/show/NCT04357106 |
| NCT04355143 | Colchicine to Reduce Cardiac Injury in COVID-19 (COLHEART-19) | https://ClinicalTrials.gov/show/NCT04355143 |
| NCT04354831 | A Study Evaluating the Efficacy and Safety of High-Titer Anti-SARS-CoV-2 Plasma in Hospitalized Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354831 |
| NCT04354610 | Cardiovascular and Renal Biomarkers to Predict Acute Heart or Kidney Injury in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04354610 |
| NCT04353596 | Stopping ACE-inhibitors in COVID-19 | https://ClinicalTrials.gov/show/NCT04353596 |
| NCT04352608 | Safety and Immunogenicity Study of Inactivated Vaccine for Prophylaxis of SARS CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04352608 |
| NCT04351763 | Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms | https://ClinicalTrials.gov/show/NCT04351763 |
| NCT04351620 | High-dose Hydroxychloroquine for the Treatment of Ambulatory Patients With Mild COVID-19 | https://ClinicalTrials.gov/show/NCT04351620 |
| NCT04351542 | Ayurveda for Flu Like Illness During Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351542 |
| NCT04351191 | PRophylaxis of Exposed COVID-19 Individuals With Mild Symptoms Using choloroquinE Compounds | https://ClinicalTrials.gov/show/NCT04351191 |
| NCT04350736 | First in Human SAD and MAD Study of Inhaled TD-0903, a Potential Treatment for ALI Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04350736 |
| NCT04350684 | Umifenovir in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350684 |
| NCT04350671 | Interferon Beta 1a in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04350671 |
| NCT04350593 | Dapagliflozin in Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350593 |
| NCT04350320 | Trial to Study the Benefit of Colchicine in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04350320 |
| NCT04350073 | Longitudinal Energy Expenditure and Metabolic Effects in Patients With COVID-19 (LEEP-COVID) | https://ClinicalTrials.gov/show/NCT04350073 |
| NCT04349228 | Assessment of the Efficacy and Safety of (HCQ) as a Prophylaxis for COVID19 for Health Professionals | https://ClinicalTrials.gov/show/NCT04349228 |
| NCT04349098 | Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04349098 |
| NCT04348435 | A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Allogeneic Mesenchymal Stem Cell Therapy (HB-adMSCs) to Provide Protection Against COVID-19 | https://ClinicalTrials.gov/show/NCT04348435 |
| NCT04347915 | The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04347915 |
| NCT04351581 | Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04351581 |
| NCT04346446 | Efficacy of Convalescent Plasma Therapy in Severely Sick COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04346446 |
| NCT04357327 | Rapid Salivary Test to Detect SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04357327 |
| NCT04356534 | Convalescent Plasma Trial in COVID -19 Patients | https://ClinicalTrials.gov/show/NCT04356534 |
| NCT04355897 | CoVID-19 Plasma in Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355897 |
| NCT04355637 | Inhaled Corticosteroid Treatment of COVID19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04355637 |
| NCT04355026 | Use of Bromhexine and Hydroxychloroquine for Treatment of COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04355026 |
| NCT04351516 | Test and Treat COVID 65plus+ | https://ClinicalTrials.gov/show/NCT04351516 |
| NCT04351152 | Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Hospitalized Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04351152 |
| NCT04351243 | A Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE). | https://ClinicalTrials.gov/show/NCT04351243 |
| NCT04355364 | Efficacy and Safety of Aerosolized Intra-tracheal Dornase Alfa Administration in Patients With COVID19-induced ARDS (COVIDORNASE) | https://ClinicalTrials.gov/show/NCT04355364 |
| NCT04367662 | Study of the Vascular Compartment and Hypercoagulability During Coronavirus Infection COVID-19 | https://ClinicalTrials.gov/show/NCT04367662 |
| NCT04361344 | Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361344 |
| NCT04359264 | Direct Income SupporT and Advice Negating Spread of Epidemic COVID-19: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04359264 |
| NCT04358939 | Prone Position in Patients on High-flow Nasal Oxygen Therapy for COVID-19 (HIGH-PRONE-COVID-19) | https://ClinicalTrials.gov/show/NCT04358939 |
| NCT04358549 | Study of the Use of Favipiravir in Hospitalized Subjects With COVID-19 | https://ClinicalTrials.gov/show/NCT04358549 |
| NCT04354870 | COVID-19 PrEP HCW HCQ Study | https://ClinicalTrials.gov/show/NCT04354870 |
| NCT04354259 | Interferon Lambda for Immediate Antiviral Therapy at Diagnosis in COVID-19 | https://ClinicalTrials.gov/show/NCT04354259 |
| NCT04353206 | Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure | https://ClinicalTrials.gov/show/NCT04353206 |
| NCT04352751 | Experimental Use of Convalescent Plasma for Passive Immunization in Current COVID-19 Pandemic in Pakistan in 2020 | https://ClinicalTrials.gov/show/NCT04352751 |
| NCT04354428 | Treatment for COVID-19 in High-Risk Adult Outpatients | https://ClinicalTrials.gov/show/NCT04354428 |
| NCT04361838 | The COVID-19 ICU PRAYER Study | https://ClinicalTrials.gov/show/NCT04361838 |
| NCT04364009 | Anakinra for COVID-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04364009 |
| NCT04363853 | Tocilizumab Treatment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04363853 |
| NCT04361942 | Treatment of Severe COVID-19 Pneumonia With Allogeneic Mesenchymal Stromal Cells (COVID_MSV) | https://ClinicalTrials.gov/show/NCT04361942 |
| NCT04357782 | Administration of Intravenous Vitamin C in Novel Coronavirus Infection (COVID-19) and Decreased Oxygenation | https://ClinicalTrials.gov/show/NCT04357782 |
| NCT04356690 | Etoposide in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356690 |
| NCT04355247 | Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm | https://ClinicalTrials.gov/show/NCT04355247 |
| NCT04373044 | Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04373044 |
| NCT04356482 | CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 | https://ClinicalTrials.gov/show/NCT04356482 |
| NCT04355936 | Telmisartan for Treatment of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04355936 |
| NCT04377308 | Fluoxetine to Reduce Intubation and Death After COVID19 Infection | https://ClinicalTrials.gov/show/NCT04377308 |
| NCT04357730 | Fibrinolytic Therapy to Treat ARDS in the Setting of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04357730 |
| NCT04376034 | Convalescent Plasma Collection and Treatment in Pediatrics and Adults | https://ClinicalTrials.gov/show/NCT04376034 |
| NCT04358614 | Baricitinib Therapy in COVID-19 | https://ClinicalTrials.gov/show/NCT04358614 |
| NCT04368845 | Telerehabilitation in Patients With COVID-19 After Hospitalization. The ATHLOS Study | https://ClinicalTrials.gov/show/NCT04368845 |
| NCT04368156 | Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms | https://ClinicalTrials.gov/show/NCT04368156 |
| NCT04366063 | Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04366063 |
| NCT04362332 | Chloroquine, Hydroxychloroquine or Only Supportive Care in Patients AdmItted With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04362332 |
| NCT04362085 | Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care | https://ClinicalTrials.gov/show/NCT04362085 |
| NCT04359797 | COVID-19 Patient Positioning Pragmatic Trial | https://ClinicalTrials.gov/show/NCT04359797 |
| NCT04359537 | Efficacy of Various Doses of Hydroxychloroquine in Pre-Exposure Prophylaxis for COVID 19 | https://ClinicalTrials.gov/show/NCT04359537 |
| NCT04359277 | A Randomized Trial of Anticoagulation Strategies in COVID-19 | https://ClinicalTrials.gov/show/NCT04359277 |
| NCT04357990 | Kerecis Oral and Nasal Spray for Treating the Symptoms of COVID-19 | https://ClinicalTrials.gov/show/NCT04357990 |
| NCT04357366 | suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE) | https://ClinicalTrials.gov/show/NCT04357366 |
| NCT04358068 | Evaluating the Efficacy of Hydroxychloroquine and Azithromycin to Prevent Hospitalization or Death in Persons With COVID-19 | https://ClinicalTrials.gov/show/NCT04358068 |
| NCT04374084 | Moxibustion Plus Cupping in Convalescent Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374084 |
| NCT04359680 | Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04359680 |
| NCT04359901 | Sarilumab for Patients With Moderate COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04359901 |
| NCT04358003 | Plasma Adsorption in Patients With Confirmed COVID-19 | https://ClinicalTrials.gov/show/NCT04358003 |
| NCT04362176 | Passive Immunity Trial of Nashville II for COVID-19 | https://ClinicalTrials.gov/show/NCT04362176 |
| NCT04361526 | Pilot Study on Cytokine Filtration in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04361526 |
| NCT04359862 | Sedation With Sevoflurane Versus Propofol in Patients With Acute Respiratory Distress Syndrome Caused by COVID19 Infection | https://ClinicalTrials.gov/show/NCT04359862 |
| NCT04359810 | Plasma Therapy of COVID-19 in Critically Ill Patients | https://ClinicalTrials.gov/show/NCT04359810 |
| NCT04359329 | Estrogen Patch for COVID-19 Symptoms | https://ClinicalTrials.gov/show/NCT04359329 |
| NCT04358926 | Hyperbaric Oxygen Therapy Effect in COVID-19 RCT (HBOTCOVID19) | https://ClinicalTrials.gov/show/NCT04358926 |
| NCT04358783 | Convalescent Plasma Compared to the Best Available Therapy for the Treatment of SARS-CoV-2 Pneumonia | https://ClinicalTrials.gov/show/NCT04358783 |
| NCT04363736 | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04363736 |
| NCT04413864 | Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19 | https://ClinicalTrials.gov/show/NCT04413864 |
| NCT04366882 | Minimal Invasive Autopsies to Investigate Changes in Deceased COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366882 |
| NCT04366089 | Oxygen-Ozone as Adjuvant Treatment in Early Control of COVID-19 Progression and Modulation of the Gut Microbial Flora | https://ClinicalTrials.gov/show/NCT04366089 |
| NCT04365101 | Natural Killer Cell (CYNK-001) Infusions in Adults With COVID-19 (CYNK-001-COVID-19) | https://ClinicalTrials.gov/show/NCT04365101 |
| NCT04364737 | Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients | https://ClinicalTrials.gov/show/NCT04364737 |
| NCT04364594 | COVID-19 Search in Conjunctival Cells | https://ClinicalTrials.gov/show/NCT04364594 |
| NCT04361474 | Trial Evaluating the Efficacy of Local Budesonide Therapy in the Management of Hyposmia in COVID-19 Patients Without Signs of Severity | https://ClinicalTrials.gov/show/NCT04361474 |
| NCT04361396 | Assessment of the Presence of the SARS-COV-2 Virus in the Peritoneum of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361396 |
| NCT04361214 | Leflunomide in Mild COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361214 |
| NCT04360980 | The Effects of Standard Protocol With or Without Colchicine in Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04360980 |
| NCT04360837 | PEEP Incremental and Decremental Alveolar Recruitment of Critically Ill Corona Virus Disease-19 (COVID-19) Patients | https://ClinicalTrials.gov/show/NCT04360837 |
| NCT04360811 | Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360811 |
| NCT04373200 | Human Ab Response & immunoMONItoring of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04373200 |
| NCT04366323 | Clinical Trial to Assess the Safety and Efficacy of Intravenous Administration of Allogeneic Adult Mesenchymal Stem Cells of Expanded Adipose Tissue in Patients With Severe Pneumonia Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04366323 |
| NCT04366245 | Clinical Trial to Evaluate the Efficacy of Treatment With Hyperimmune Plasma Obtained From Convalescent Antibodies of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04366245 |
| NCT04362137 | Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID) | https://ClinicalTrials.gov/show/NCT04362137 |
| NCT04377750 | The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperinflammation | https://ClinicalTrials.gov/show/NCT04377750 |
| NCT04368793 | Clinical Effects of Internet Assisted Pulmonary Rehabilitation of COVID-2019 Pneumonia Patients After Discharge | https://ClinicalTrials.gov/show/NCT04368793 |
| NCT04368377 | Enhanced Platelet Inhibition in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04368377 |
| NCT04366947 | Intravascular Access in Suspected/Confirmed COVID-19 Patient | https://ClinicalTrials.gov/show/NCT04366947 |
| NCT04366297 | Intravascular Access of COVID-19 Patient Under Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04366297 |
| NCT04366271 | Clinical Trial of Allogeneic Mesenchymal Cells From Umbilical Cord Tissue in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04366271 |
| NCT04364022 | Efficacy of Pragmatic Same-day COVID-19 Ring Prophylaxis for Adult Individuals Exposed to SARS-CoV-2 in Switzerland | https://ClinicalTrials.gov/show/NCT04364022 |
| NCT04363502 | Use of the Interleukin-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04363502 |
| NCT04363450 | Hydroxychloroquine as Prophylaxis for COVID-19 in Healthcare Workers (HCQPreP) | https://ClinicalTrials.gov/show/NCT04363450 |
| NCT04363437 | COlchicine in Moderate-severe Hospitalized Patients Before ARDS to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04363437 |
| NCT04363346 | Study of FT516 for the Treatment of COVID-19 in Hospitalized Patients With Hypoxia | https://ClinicalTrials.gov/show/NCT04363346 |
| NCT04363203 | VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL) | https://ClinicalTrials.gov/show/NCT04363203 |
| NCT04361253 | Evaluation of SARS-CoV-2 (COVID-19) Antibody-containing Plasma thErapy | https://ClinicalTrials.gov/show/NCT04361253 |
| NCT04393961 | At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study | https://ClinicalTrials.gov/show/NCT04393961 |
| NCT04385095 | Trial of Inhaled Anti-viral (SNG001) for SARS-CoV-2 (COVID-19) Infection | https://ClinicalTrials.gov/show/NCT04385095 |
| NCT04368988 | Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS (COVID-19) Nanoparticle Vaccine With/Without Matrix-M Adjuvant | https://ClinicalTrials.gov/show/NCT04368988 |
| NCT04368923 | Management of Covid-19 Patients During Home Isolation | https://ClinicalTrials.gov/show/NCT04368923 |
| NCT04368260 | Clinical Validation of New Injection Molded Flocked Nasopharyngeal Swabs in Response to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04368260 |
| NCT04368000 | Prone Positioning in Awake Patients With COVID-19 Requiring Hospitalization | https://ClinicalTrials.gov/show/NCT04368000 |
| NCT04366960 | Comparison of Two Doses of Enoxaparin for Thromboprophylaxis in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04366960 |
| NCT04366791 | Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 | https://ClinicalTrials.gov/show/NCT04366791 |
| NCT04365972 | Attention Bias Modification for Reducing Health Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04365972 |
| NCT04365608 | Prehospital Intubation of COVID-19 Patient With Personal Protective Equipment | https://ClinicalTrials.gov/show/NCT04365608 |
| NCT04365309 | Protective Effect of Aspirin on COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04365309 |
| NCT04365257 | Prazosin to Prevent COVID-19 (PREVENT-COVID Trial) | https://ClinicalTrials.gov/show/NCT04365257 |
| NCT04365153 | Canakinumab to Reduce Deterioration of Cardiac and Respiratory Function Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04365153 |
| NCT04365127 | Progesterone for the Treatment of COVID-19 in Hospitalized Men | https://ClinicalTrials.gov/show/NCT04365127 |
| NCT04363593 | Serology COVID-19 From the Cornwall Hospital Union | https://ClinicalTrials.gov/show/NCT04363593 |
| NCT04367168 | Colchicine Twice Daily During 10 Days as an Option for the Treatment of Symptoms Induced by Inflammation in Patients With Mild and Severe Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04367168 |
| NCT04363827 | Protect: Study With Hydroxychloroquine for Prevention and Early Phase Treatment of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04363827 |
| NCT04372589 | Antithrombotic Therapy to Ameliorate Complications of COVID-19 ( ATTACC ) | https://ClinicalTrials.gov/show/NCT04372589 |
| NCT04363606 | Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability | https://ClinicalTrials.gov/show/NCT04363606 |
| NCT04362813 | Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia | https://ClinicalTrials.gov/show/NCT04362813 |
| NCT04392778 | Clinical Use of Stem Cells for the Treatment of Covid-19 | https://ClinicalTrials.gov/show/NCT04392778 |
| NCT04372017 | Hydroxychloroquine as Post-Exposure Prophylaxis Against COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04372017 |
| NCT04369742 | Treating COVID-19 With Hydroxychloroquine (TEACH) | https://ClinicalTrials.gov/show/NCT04369742 |
| NCT04365699 | Cardiovascular Effects of COVID-19 | https://ClinicalTrials.gov/show/NCT04365699 |
| NCT04364802 | COVID-19: Povidone-Iodine Intranasal Prophylaxis in Front-line Healthcare Personnel and Inpatients | https://ClinicalTrials.gov/show/NCT04364802 |
| NCT04373824 | Max Ivermectin- COVID 19 Study Versus Standard of Care Treatment for COVID 19 Cases. A Pilot Study | https://ClinicalTrials.gov/show/NCT04373824 |
| NCT04370782 | Hydroxychloroquine and Zinc With Either Azithromycin or Doxycycline for Treatment of COVID-19 in Outpatient Setting | https://ClinicalTrials.gov/show/NCT04370782 |
| NCT04365985 | Study of Immunomodulation Using Naltrexone and Ketamine for COVID-19 | https://ClinicalTrials.gov/show/NCT04365985 |
| NCT04365738 | Pulmonary Rehabilitation in Post-Acute Period of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04365738 |
| NCT04389710 | Convalescent Plasma for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04389710 |
| NCT04379453 | Robot Assisted Percutaneous Cardiovascular Intervention as a Strategy to Reduce or Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses | https://ClinicalTrials.gov/show/NCT04379453 |
| NCT04374565 | Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia | https://ClinicalTrials.gov/show/NCT04374565 |
| NCT04372693 | Unplanned Shifting to Online Distance Learning: Nursing Students’ Perception and Achievement | https://ClinicalTrials.gov/show/NCT04372693 |
| NCT04370262 | Multi-site Adaptive Trials Using Hydroxycholoroquine for COVID-19 | https://ClinicalTrials.gov/show/NCT04370262 |
| NCT04369456 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Kidney Transplant Patients | https://ClinicalTrials.gov/show/NCT04369456 |
| NCT04369365 | A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04369365 |
| NCT04369066 | COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie | https://ClinicalTrials.gov/show/NCT04369066 |
| NCT04367831 | Intermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04367831 |
| NCT04367545 | Development of a Molecular Diagnostic Strategy for SARS-CoV2 Based on Saliva in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367545 |
| NCT04367077 | MultiStem Administration for COVID-19 Induced ARDS (MACoVIA) | https://ClinicalTrials.gov/show/NCT04367077 |
| NCT04366180 | Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04366180 |
| NCT04368728 | Study to Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04368728 |
| NCT04379154 | Analysis of Volatile Organic Compounds by Electronic Noses in Hospitalised Patients for an Infection by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04379154 |
| NCT04376476 | Host-pathogen Interactions During SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04376476 |
| NCT04371640 | Sirolimus in COVID-19 Phase 1 | https://ClinicalTrials.gov/show/NCT04371640 |
| NCT04371510 | Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients | https://ClinicalTrials.gov/show/NCT04371510 |
| NCT04371419 | COVID-19 Health Messaging to Underserved Communities | https://ClinicalTrials.gov/show/NCT04371419 |
| NCT04371029 | Impact of Neck Inspiratory Muscle Activation During Sleep in ICU Patients After a COVID 19 ARDS | https://ClinicalTrials.gov/show/NCT04371029 |
| NCT04406181 | Psychological Well-being of Patients Awaiting for Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04406181 |
| NCT04371393 | MSCs in COVID-19 ARDS | https://ClinicalTrials.gov/show/NCT04371393 |
| NCT04370886 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 | https://ClinicalTrials.gov/show/NCT04370886 |
| NCT04385810 | Description of Ophthalmologic Injuries in Intensive Care During the SARS-CoV2 Epidemic - COVID19 | https://ClinicalTrials.gov/show/NCT04385810 |
| NCT04384588 | COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) | https://ClinicalTrials.gov/show/NCT04384588 |
| NCT04380532 | Tableted COVID-19 Therapeutic Vaccine | https://ClinicalTrials.gov/show/NCT04380532 |
| NCT04378712 | Hydrogen/Oxygen Mixed Gas Inhalation for Coronavirus Disease 2019 (COVID-19) | https://ClinicalTrials.gov/show/NCT04378712 |
| NCT04375202 | Colchicine in COVID-19: a Pilot Study | https://ClinicalTrials.gov/show/NCT04375202 |
| NCT04371367 | Avdoralimab an Anti-C5aR Antibody, in Patients With COVID-19 Severe Pneumonia ( FORCE ) | https://ClinicalTrials.gov/show/NCT04371367 |
| NCT04370938 | Provider Burnout During COVID-19 | https://ClinicalTrials.gov/show/NCT04370938 |
| NCT04370288 | Clinical Application of Methylene Blue for Treatment of Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04370288 |
| NCT04369820 | C5a Receptor Expression - COVID-19 (C5-COV) | https://ClinicalTrials.gov/show/NCT04369820 |
| NCT04372186 | A Study to Evaluate the Efficacy and Safety of Tocilizumab in Hospitalized Participants With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04372186 |
| NCT04379531 | LDCT in COVID-19 Pneumonia: a Prospective Moscow Study | https://ClinicalTrials.gov/show/NCT04379531 |
| NCT04374942 | Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? | https://ClinicalTrials.gov/show/NCT04374942 |
| NCT04374032 | Clinical Trial to Evaluate the Efficacy and Safety of an Immunomodulatory Therapy for the Treatment of Patients With Moderate to Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374032 |
| NCT04373161 | Home Pulse Oximeter Use in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04373161 |
| NCT04373135 | Understanding Community Considerations, Opinions, Values, Impacts, and Decisions for COVID-19 | https://ClinicalTrials.gov/show/NCT04373135 |
| NCT04372680 | WeanINg From Mechanical Ventilation for ARDS CovId-19 Patients Guided by Combined Thoracic UltraSound | https://ClinicalTrials.gov/show/NCT04372680 |
| NCT04408066 | COVID-19: A POC Test Under Research & Evaluation | https://ClinicalTrials.gov/show/NCT04408066 |
| NCT04378738 | Social Media and Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04378738 |
| NCT04377789 | Effect of Quercetin on Prophylaxis and Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04377789 |
| NCT04375124 | Treatment of Angiotensin Peptide (1-7) for COVID-19 | https://ClinicalTrials.gov/show/NCT04375124 |
| NCT04374019 | Novel Agents for Treatment of High-risk COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04374019 |
| NCT04373707 | Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 | https://ClinicalTrials.gov/show/NCT04373707 |
| NCT04374461 | A Study of N-acetylcysteine in Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04374461 |
| NCT04374786 | Effects of Mobile App in House Staff Health and Well-being During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374786 |
| NCT04374591 | Home-based Treatment of Computed Tomography and Clinically Suspected Novel COVID-19 With Adjuvant Inhalable Sodium Bicarbonate: A Preliminary Case Series | https://ClinicalTrials.gov/show/NCT04374591 |
| NCT04374539 | Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial | https://ClinicalTrials.gov/show/NCT04374539 |
| NCT04374526 | Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. | https://ClinicalTrials.gov/show/NCT04374526 |
| NCT04392531 | Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19 | https://ClinicalTrials.gov/show/NCT04392531 |
| NCT04376593 | PET/CT Imaging in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04376593 |
| NCT04375098 | Efficacy and Safety of Early COVID-19 Convalescent Plasma in Patients Admitted for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04375098 |
| NCT04376814 | Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19 | https://ClinicalTrials.gov/show/NCT04376814 |
| NCT04391712 | Cold Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease | https://ClinicalTrials.gov/show/NCT04391712 |
| NCT04385043 | Hyperimmune Plasma in Patients With COVID-19 Severe Infection | https://ClinicalTrials.gov/show/NCT04385043 |
| NCT04379336 | BCG Vaccination for Healthcare Workers in COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04379336 |
| NCT04377477 | COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19) | https://ClinicalTrials.gov/show/NCT04377477 |
| NCT04378803 | Mindfulness Training for Seniors | https://ClinicalTrials.gov/show/NCT04378803 |
| NCT04388527 | COVID-19 Convalescent Plasma for Mechanically Ventilated Population | https://ClinicalTrials.gov/show/NCT04388527 |
| NCT04377659 | Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04377659 |
| NCT04380818 | Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19 | https://ClinicalTrials.gov/show/NCT04380818 |
| NCT04377672 | Human Convalescent Plasma for High Risk Children Exposed or Infected With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04377672 |
| NCT04377620 | Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT) | https://ClinicalTrials.gov/show/NCT04377620 |
| NCT04376684 | Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease | https://ClinicalTrials.gov/show/NCT04376684 |
| NCT04375397 | Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury | https://ClinicalTrials.gov/show/NCT04375397 |
| NCT04392713 | Efficacy of Ivermectin in COVID-19 | https://ClinicalTrials.gov/show/NCT04392713 |
| NCT04389372 | Effectiveness and Acceptability of MINDFULNESS by Smartphone, for Patients With Chronic Migraine and Medication Overuse | https://ClinicalTrials.gov/show/NCT04389372 |
| NCT04383613 | Prone Positioning for Patients on General Medical Wards With COVID19 | https://ClinicalTrials.gov/show/NCT04383613 |
| NCT04381884 | Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04381884 |
| NCT04379661 | SUNLIGHT Study: Online Support Groups for MS to Address COVID-19 | https://ClinicalTrials.gov/show/NCT04379661 |
| NCT04379492 | A Study of Hydroxycholoroquine Compared to Placebo as Treatment for People With COVID-19 | https://ClinicalTrials.gov/show/NCT04379492 |
| NCT04379076 | InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort | https://ClinicalTrials.gov/show/NCT04379076 |
| NCT04378920 | A Study of Trans Crocetin in Patients With Acute Respiratory Distress Syndrome Due to COVID-19 Disease (LEAF-4L7520/4L6715) | https://ClinicalTrials.gov/show/NCT04378920 |
| NCT04382768 | Inhaled Ibuprofen to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04382768 |
| NCT04382092 | Co-infection Management in COVID-19 Critically Ill | https://ClinicalTrials.gov/show/NCT04382092 |
| NCT04381858 | Convalescent Plasma vs Human Immunoglobulin to Treat COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04381858 |
| NCT04380701 | A Trial Investigating the Safety and Effects of Four BNT162 Vaccines Against COVID-2019 in Healthy Adults | https://ClinicalTrials.gov/show/NCT04380701 |
| NCT04380519 | Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04380519 |
| NCT04380376 | Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia | https://ClinicalTrials.gov/show/NCT04380376 |
| NCT04385901 | Long Term Functional Outcomes of COVID-19 Patients Treated by Rehabilitation Services viaTelehealth | https://ClinicalTrials.gov/show/NCT04385901 |
| NCT04390477 | Study to Evaluate the Effect of a Probiotic in COVID-19 | https://ClinicalTrials.gov/show/NCT04390477 |
| NCT04390139 | Efficacy and Safety Evaluation of Mesenchymal Stem Cells for the Treatment of Patients With Respiratory Distress Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04390139 |
| NCT04390022 | Sars-CoV-2/COVID-19 Ivermectin Navarra-ISGlobal Trial | https://ClinicalTrials.gov/show/NCT04390022 |
| NCT04384497 | Convalescent Plasma for Treatment of COVID-19: An Exploratory Dose Identifying Study | https://ClinicalTrials.gov/show/NCT04384497 |
| NCT04381377 | Efficacy and Safety of Polyoxidonium® in Hospitalized Patients With Coronavirus Disease COVID-19 | https://ClinicalTrials.gov/show/NCT04381377 |
| NCT04381000 | Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04381000 |
| NCT04380961 | A Study to Evaluate the Efficacy and Safety of Sirukumab in Confirmed Severe or Critical Confirmed Coronavirus Disease (COVID)-19 | https://ClinicalTrials.gov/show/NCT04380961 |
| NCT04380909 | ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation | https://ClinicalTrials.gov/show/NCT04380909 |
| NCT04382040 | A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04382040 |
| NCT04381936 | Randomised Evaluation of COVID-19 Therapy | https://ClinicalTrials.gov/show/NCT04381936 |
| NCT04382066 | Proof of Concept Study to Evaluate the Safety Profile of Plitidepsin in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04382066 |
| NCT04390464 | mulTi-Arm Therapeutic Study in Pre-ICu Patients Admitted With Covid-19 - Repurposed Drugs (TACTIC-R) | https://ClinicalTrials.gov/show/NCT04390464 |
| NCT04389294 | HSS Covid-19 Antibody Serology Among Surgeons & Anesthesiologists | https://ClinicalTrials.gov/show/NCT04389294 |
| NCT04386694 | Photobiomodulation Therapy Combined With Static Magnetic Field in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04386694 |
| NCT04382729 | Neuromuscular Electrical Stimulation in Patients With COVID19 Associated Pneumonia | https://ClinicalTrials.gov/show/NCT04382729 |
| NCT04381988 | A Study of Hydroxychloroquine vs Placebo to Prevent COVID-19 Infection in Patients Receiving Radiotherapy | https://ClinicalTrials.gov/show/NCT04381988 |
| NCT04382547 | Treatment of Covid-19 Associated Pneumonia With Allogenic Pooled Olfactory Mucosa-derived Mesenchymal Stem Cells | https://ClinicalTrials.gov/show/NCT04382547 |
| NCT04384965 | Accelerated iTBS for Depressed Patients During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04384965 |
| NCT04405986 | Exploring Brain Damages After COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04405986 |
| NCT04394416 | Trial of Imatinib for Hospitalized Adults With COVID-19 | https://ClinicalTrials.gov/show/NCT04394416 |
| NCT04382053 | Study of Efficacy and Safety of DV890 in Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04382053 |
| NCT04389333 | Feasibility of Non-contact Magnetically-controlled Capsule Endoscopy During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389333 |
| NCT04385199 | Convalescent Plasma for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385199 |
| NCT04391140 | Prone Positioning and High-flow Nasal Cannula in COVID-19 Induced ARDS | https://ClinicalTrials.gov/show/NCT04391140 |
| NCT04385836 | Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | https://ClinicalTrials.gov/show/NCT04385836 |
| NCT04385017 | Role of Inflammasomes in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04385017 |
| NCT04388514 | Blood Ozonization in Patients With SARS-CoV-2 Respiratory Failure | https://ClinicalTrials.gov/show/NCT04388514 |
| NCT04386850 | Oral 25-hydroxyvitamin D3 and COVID-19 | https://ClinicalTrials.gov/show/NCT04386850 |
| NCT04386616 | A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04386616 |
| NCT04384900 | Accelerated Prone Position Ventilation of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04384900 |
| NCT04386291 | Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04386291 |
| NCT04391127 | Hydroxychloroquine and Ivermectin for the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04391127 |
| NCT04390191 | Early CPAP in COVID-19 Confirmed or Suspected Patients | https://ClinicalTrials.gov/show/NCT04390191 |
| NCT04389944 | Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04389944 |
| NCT04389385 | COVID-19 Specific T Cell Derived Exosomes (CSTC-Exo) | https://ClinicalTrials.gov/show/NCT04389385 |
| NCT04387292 | Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic | https://ClinicalTrials.gov/show/NCT04387292 |
| NCT04412330 | Optimizing Outcomes With Physical Therapy Treatment for IndividuALs Surviving an ICU Admission for Covid-19 | https://ClinicalTrials.gov/show/NCT04412330 |
| NCT04390412 | Low Dose Radiotherapy in COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04390412 |
| NCT04388683 | Inhaled Nitric Oxide for Preventing Progression in COVID-19 | https://ClinicalTrials.gov/show/NCT04388683 |
| NCT04405076 | Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older | https://ClinicalTrials.gov/show/NCT04405076 |
| NCT04388826 | COVID-19 Treatment of Severe Acute Respiratory Syndrome With Veru-111 | https://ClinicalTrials.gov/show/NCT04388826 |
| NCT04392414 | Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04392414 |
| NCT04389840 | Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure | https://ClinicalTrials.gov/show/NCT04389840 |
| NCT04390503 | Convalescent Plasma for COVID-19 Close Contacts | https://ClinicalTrials.gov/show/NCT04390503 |
| NCT04390516 | Respiratory Decompensation and Model for the Triage of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04390516 |
| NCT04395144 | COVid-19: Awake Proning and High-flow Nasal Cannula in respiratorY DistrEss | https://ClinicalTrials.gov/show/NCT04395144 |
| NCT04394182 | Ultra Low Doses of Therapy With Radiation Applicated to COVID-19 | https://ClinicalTrials.gov/show/NCT04394182 |
| NCT04392323 | Incidence of COVID-19 Test Conversion in Post-surgical Patients | https://ClinicalTrials.gov/show/NCT04392323 |
| NCT04392232 | A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection | https://ClinicalTrials.gov/show/NCT04392232 |
| NCT04392141 | Colchicine Plus Phenolic Monoterpenes to Treat COVID-19 | https://ClinicalTrials.gov/show/NCT04392141 |
| NCT04391179 | Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19 | https://ClinicalTrials.gov/show/NCT04391179 |
| NCT04395105 | Dexamethasone for COVID-19 Related ARDS: a Multicenter, Randomized Clinical Trial | https://ClinicalTrials.gov/show/NCT04395105 |
| NCT04393727 | Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393727 |
| NCT04407208 | Convalescent Plasma Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407208 |
| NCT04398004 | Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early | https://ClinicalTrials.gov/show/NCT04398004 |
| NCT04394442 | Hydroxychloroquine in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04394442 |
| NCT04403269 | NORMAL HUMAN IMMUNOGLOBULINS (IVIG) IN PATIENTS AGED 75 YEARS AND OVER, COVID-19 WITH SEVERE ACUTE RESPIRATORY FAILURE | https://ClinicalTrials.gov/show/NCT04403269 |
| NCT04402918 | Study of Viral Load and Maternal-fetal Serology in the Interpretation of the Vertical Transmission of SARS Cov-2 (COVID-19) During Pregnancy | https://ClinicalTrials.gov/show/NCT04402918 |
| NCT04393792 | SINUS WASH Pilot Study in Adults Testing Positive for COVID-19 | https://ClinicalTrials.gov/show/NCT04393792 |
| NCT04393038 | ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04393038 |
| NCT04405999 | Prevention of Infection and Incidence of COVID-19 in Medical Personnel Assisting Patients With New Coronavirus Disease | https://ClinicalTrials.gov/show/NCT04405999 |
| NCT04395807 | Helmet CPAP Versus HFNC in COVID-19 | https://ClinicalTrials.gov/show/NCT04395807 |
| NCT04402203 | Study on Safety and Efficacy of Favipiravir (Favipira) for COVID-19 Patient in Selected Hospitals of Bangladesh | https://ClinicalTrials.gov/show/NCT04402203 |
| NCT04399746 | Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | https://ClinicalTrials.gov/show/NCT04399746 |
| NCT04399005 | The Efficacy Comparing Daily and After-each-case Room Disinfection. | https://ClinicalTrials.gov/show/NCT04399005 |
| NCT04407286 | Vitamin D Testing and Treatment for COVID 19 | https://ClinicalTrials.gov/show/NCT04407286 |
| NCT04397757 | COVID-19 Convalescent Plasma for the Treatment of Hospitalized Patients With Pneumonia Caused by SARS-CoV-2. | https://ClinicalTrials.gov/show/NCT04397757 |
| NCT04397510 | Nebulized Heparin for the Treatment of COVID-19 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04397510 |
| NCT04416360 | Autism Spectrum Disorder or Attention Deficit Hyperactivity Disorder in Covid-19 Outbreak | https://ClinicalTrials.gov/show/NCT04416360 |
| NCT04397562 | A Clinical Trial of the Efficacy and Safety of Levilimab (BCD-089) in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04397562 |
| NCT04403477 | Convalescent Plasma Therapy in Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04403477 |
| NCT04401293 | Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04401293 |
| NCT04398277 | A Daily Coping Toolkit for Medical Personnel and First-Responders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04398277 |
| NCT04397523 | Efficacy and Safety of COVID-19 Convalescent Plasma | https://ClinicalTrials.gov/show/NCT04397523 |
| NCT04397666 | RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04397666 |
| NCT04402970 | Dornase Alfa for ARDS in Patients With SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04402970 |
| NCT04401202 | Nigella Sativa in COVID-19 | https://ClinicalTrials.gov/show/NCT04401202 |
| NCT04400305 | “Increasing Physical Activity in Canadian Adults Who Have Been Affected by COVID-19 Social Distancing Restrictions: A Feasibility Trial of an Online Intervention” | https://ClinicalTrials.gov/show/NCT04400305 |
| NCT04399980 | Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation | https://ClinicalTrials.gov/show/NCT04399980 |
| NCT04399681 | The Utility of Bedside Lung Ultrasonography on Diagnosis of COVID-19 | https://ClinicalTrials.gov/show/NCT04399681 |
| NCT04399109 | Evaluation of a Remote Monitoring Smartphone Application and Care Model of COVID-19 Patients in the Community (ReCOVER) | https://ClinicalTrials.gov/show/NCT04399109 |
| NCT04410549 | Pulmonary Optical Coherence Tomography in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04410549 |
| NCT04413006 | Self-compassion for Chronic Pain Virtual Group Treatment Program | https://ClinicalTrials.gov/show/NCT04413006 |
| NCT04412538 | Safety and Immunogenicity Study of an Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19 | https://ClinicalTrials.gov/show/NCT04412538 |
| NCT04402983 | The Effectiveness of Telerehabilitation-Based Physiotherapy in COVID 19 Patients | https://ClinicalTrials.gov/show/NCT04402983 |
| NCT04402840 | Stellate Ganglion Block (SGB) for COVID-19 Acute Respiratory Distress Syndrome (ARDS) | https://ClinicalTrials.gov/show/NCT04402840 |
| NCT04411602 | Feasibility Study of Anti-SARS-CoV-2 Plasma Transfusions in COVID-19 Patients With SRD | https://ClinicalTrials.gov/show/NCT04411602 |
| NCT04407390 | Effects of Nicotinamide Riboside on the Clinical Outcome of Covid-19 in the Elderly | https://ClinicalTrials.gov/show/NCT04407390 |
| NCT04402879 | CORONA (COvid pRONe hypoxemiA): Prone Positioning for Hypoxemic COVID-19 Patients With Do-not-intubate Goals | https://ClinicalTrials.gov/show/NCT04402879 |
| NCT04408183 | GLS-1200Topical Nasal Spray to Prevent SARS-CoV-2 Infection (COVID-19) in Health Care Personnel | https://ClinicalTrials.gov/show/NCT04408183 |
| NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-II) | https://ClinicalTrials.gov/show/NCT04401579 |
| NCT04406493 | Monitoring COVID-19 Patients’ Lung Fluid Using Impedance Technique | https://ClinicalTrials.gov/show/NCT04406493 |
| NCT04411433 | Efficacy and Safety of Hydroxychloroquine and Favipiravir in the Treatment of Mild to Moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04411433 |
| NCT04406246 | Prevention of Coronavirus Disease (COVID-19) Outbreaks With Nitazoxanide | https://ClinicalTrials.gov/show/NCT04406246 |
| NCT04403685 | Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 With Inflammatory Markers | https://ClinicalTrials.gov/show/NCT04403685 |
| NCT04408456 | Efficacy of Hydroxychloroquine (HCQ) as Post Exposure Prophylaxis (PEP) for Prevention of COVID-19 | https://ClinicalTrials.gov/show/NCT04408456 |
| NCT04412356 | Timing of Tracheotomy in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04412356 |
| NCT04407182 | Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 | https://ClinicalTrials.gov/show/NCT04407182 |
| NCT04408209 | Convalescent Plasma for the Treatment of Patients With Severe COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04408209 |
| NCT04417335 | Reducing COVID-19 Related Hospital Admission in Elderly by BCG Vaccination | https://ClinicalTrials.gov/show/NCT04417335 |
| NCT04405310 | Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial | https://ClinicalTrials.gov/show/NCT04405310 |
| NCT04410562 | Hydroxychloroquine Efficacy and Safety in Preventing SARS-CoV-2 Infection and COVID-19 Disease Severity During Pregnancy | https://ClinicalTrials.gov/show/NCT04410562 |
| NCT04405544 | Determination of Acute Encephalopathy Predictors in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04405544 |
| NCT04409496 | Chat-based Support for Preveting Smoking Relapse | https://ClinicalTrials.gov/show/NCT04409496 |
| NCT04410692 | Can the Prediction Market Improve Predictions of COVID-19? | https://ClinicalTrials.gov/show/NCT04410692 |
| NCT04416308 | COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB) | https://ClinicalTrials.gov/show/NCT04416308 |
| NCT04408131 | Morbi-mortality by COVID-19 Among Homeless People in Marseille: a Cohort Study | https://ClinicalTrials.gov/show/NCT04408131 |
| NCT04409743 | Brief Telehealth CBT-I Intervention in the Context of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04409743 |
| NCT04409522 | Evaluation of Therapeutic Effects of Melatonin by Inhibition of NLRP3 Inflammasome in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04409522 |
| NCT04409327 | Phase 3 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes | https://ClinicalTrials.gov/show/NCT04409327 |
| NCT04412486 | COVID-19 Convalescent Plasma (CCP) Transfusion | https://ClinicalTrials.gov/show/NCT04412486 |
| NCT04410458 | Recruit Blood Donors Via SMS During Epidemic of COVID-19 （Repeat Trial） | https://ClinicalTrials.gov/show/NCT04410458 |
| NCT04412343 | The Seniors COvid-19 Pandemic and Exercise Study | https://ClinicalTrials.gov/show/NCT04412343 |
| NCT04411667 | Study of Standard of Care Plus Intravenous Immunoglobulin (IVIG) Compared to Standard of Care Alone in the Treatment of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04411667 |
| NCT04415073 | A Phase 2 Study to Evaluate Axatilimab for Hospitalized Patients With Respiratory Involvement Secondary to COVID-19 | https://ClinicalTrials.gov/show/NCT04415073 |
| NCT04412018 | An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19 | https://ClinicalTrials.gov/show/NCT04412018 |
| NCT04411628 | A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19 | https://ClinicalTrials.gov/show/NCT04411628 |
| NCT04412239 | To Assess the Efficiency and Satisfaction of Pharmacist Giving Patient-centred Advice on Telephone Consultation in TB Patients: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04412239 |
| NCT04416139 | Mesenchymal Stem Cell for Acute Respiratory Distress Syndrome Due for COVID-19 | https://ClinicalTrials.gov/show/NCT04416139 |
| NCT04414371 | Tools for Wellbeing COVID-19 National Study of Undergraduate Students | https://ClinicalTrials.gov/show/NCT04414371 |
| NCT04412772 | A RCT - Safety & Efficacy of Tocilizumab - Tx of Severe COVID-19: ARCHITECTS | https://ClinicalTrials.gov/show/NCT04412772 |
| NCT04414267 | Bacillus Calmette-guérin Vaccination to Prevent COVID-19 | https://ClinicalTrials.gov/show/NCT04414267 |
| NCT04414124 | A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 | https://ClinicalTrials.gov/show/NCT04414124 |
| NCT04412668 | Study to Evaluate the Safety and Efficacy of ATYR1923 In Patients With Severe Pneumonia Related to COVID-19 | https://ClinicalTrials.gov/show/NCT04412668 |
Observational Studies
| nct_id | brief_title | link |
|---|---|---|
| NCT04245631 | Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV | https://ClinicalTrials.gov/show/NCT04245631 |
| NCT04256395 | Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of COVID-19 | https://ClinicalTrials.gov/show/NCT04256395 |
| NCT04260308 | A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04260308 |
| NCT04255940 | 2019-nCoV Outbreak and Cardiovascular Diseases | https://ClinicalTrials.gov/show/NCT04255940 |
| NCT04259892 | Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. | https://ClinicalTrials.gov/show/NCT04259892 |
| NCT04283396 | Study for Novel Coronavirus Pneumonia (NCP) | https://ClinicalTrials.gov/show/NCT04283396 |
| NCT04279782 | Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection | https://ClinicalTrials.gov/show/NCT04279782 |
| NCT04274322 | Identifying Critically-ill Patients With COVID-19 Who Will Benefit Most From Nutrition Support Therapy: Validation of the NUTRIC Nutritional Risk Assessment Tool | https://ClinicalTrials.gov/show/NCT04274322 |
| NCT04275947 | The COVID-19 Mobile Health Study (CMHS) | https://ClinicalTrials.gov/show/NCT04275947 |
| NCT04279899 | The Investigation of the Neonates With or With Risk of COVID-19 | https://ClinicalTrials.gov/show/NCT04279899 |
| NCT04279795 | Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations | https://ClinicalTrials.gov/show/NCT04279795 |
| NCT04284046 | CT Scores Predict Mortality in 2019-nCoV Pneumonia | https://ClinicalTrials.gov/show/NCT04284046 |
| NCT04292327 | Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus | https://ClinicalTrials.gov/show/NCT04292327 |
| NCT04285801 | Critically Ill Patients With COVID-19 in Hong Kong: a Multicentre Observational Cohort Study | https://ClinicalTrials.gov/show/NCT04285801 |
| NCT04292340 | Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04292340 |
| NCT04290780 | COVID-19 - Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04290780 |
| NCT04292964 | Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04292964 |
| NCT04306497 | TCM Differentiation and Treatment Protocol of COVID-19 | https://ClinicalTrials.gov/show/NCT04306497 |
| NCT04312464 | Myocardial Damage in COVID-19 | https://ClinicalTrials.gov/show/NCT04312464 |
| NCT04302688 | Accurate Classification System for Patients With COVID-19 Pneumonitis | https://ClinicalTrials.gov/show/NCT04302688 |
| NCT04306705 | Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 | https://ClinicalTrials.gov/show/NCT04306705 |
| NCT04307459 | Acute Respiratory Failure and COVID-19 in Real Life | https://ClinicalTrials.gov/show/NCT04307459 |
| NCT04316884 | Mechanisms for Organ Dysfunction in Covid-19 | https://ClinicalTrials.gov/show/NCT04316884 |
| NCT04312100 | Sequential Oxygen Therapy Strategy for Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04312100 |
| NCT04319315 | Social Media Effect on Knowledge Dissemination During COVID-19 Virus Outbreak | https://ClinicalTrials.gov/show/NCT04319315 |
| NCT04316299 | Acute Kidney Injury in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04316299 |
| NCT04314817 | Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04314817 |
| NCT04313946 | Artificial Intelligence Algorithms for Discriminating Between COVID-19 and Influenza Pneumonitis Using Chest X-Rays | https://ClinicalTrials.gov/show/NCT04313946 |
| NCT04347369 | A Retrospective Study of Neural Network Model to Dynamically Quantificate the Severity in COVID-19 Disease | https://ClinicalTrials.gov/show/NCT04347369 |
| NCT04321265 | Outcomes and Prognostic Factors in COVID-19 | https://ClinicalTrials.gov/show/NCT04321265 |
| NCT04318366 | COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor | https://ClinicalTrials.gov/show/NCT04318366 |
| NCT04316949 | Predictors of Respiratory Failure in SARS-Cov-2 Infection | https://ClinicalTrials.gov/show/NCT04316949 |
| NCT04320017 | Joint Use of Electrocardiogram and Transthoracic Echocardiography With Other Clinico-biological Parameters in an Observational Study to Monitor Cardio-vascular Events and Predict Outcomes in Patients Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04320017 |
| NCT04318301 | Hypertension in Patients Hospitalized With COVID-19 | https://ClinicalTrials.gov/show/NCT04318301 |
| NCT04322513 | Biomarkers for Identification of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04322513 |
| NCT04322487 | Simple, Safe, Same: Lung Ultrasound for COVID-19 | https://ClinicalTrials.gov/show/NCT04322487 |
| NCT04321369 | Impact of Swab Site and Sample Collector on Testing Sensitivity for COVID-19 Virus in Symptomatic Individuals | https://ClinicalTrials.gov/show/NCT04321369 |
| NCT04320732 | Risk Factors for Community- and Workplace Transmission of COVID-19 | https://ClinicalTrials.gov/show/NCT04320732 |
| NCT04320511 | Beaumont Quantitative Lung Function Imaging to Characterize Patients With SARS-COV 2 | https://ClinicalTrials.gov/show/NCT04320511 |
| NCT04325919 | Coronavirus Disease 2019 (COVID-19) Study of Hospitalized Patients in Hong Kong | https://ClinicalTrials.gov/show/NCT04325919 |
| NCT04323787 | Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04323787 |
| NCT04322279 | Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID19. | https://ClinicalTrials.gov/show/NCT04322279 |
| NCT04322188 | An Observational Study of the Use of Siltuximab (SYLVANT) in Patients Diagnosed With COVID-19 Infection Who Have Developed Serious Respiratory Complications | https://ClinicalTrials.gov/show/NCT04322188 |
| NCT04327180 | PREdiction of DIagnosed Covid-19 infecTion in IUC Patients | https://ClinicalTrials.gov/show/NCT04327180 |
| NCT04324736 | “COVID-19 and Diabetes Outcomes” | https://ClinicalTrials.gov/show/NCT04324736 |
| NCT04324684 | Prognostic Factors Keeping Track for COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04324684 |
| NCT04324047 | Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04324047 |
| NCT04323644 | Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) | https://ClinicalTrials.gov/show/NCT04323644 |
| NCT04332913 | Efficacy and Safety of Tocilizumab in the Treatment of SARS-Cov-2 Related Pneumonia | https://ClinicalTrials.gov/show/NCT04332913 |
| NCT04327804 | A Longitudinal Study of COVID-19 Positive Patients Testing Nasal Swabs and Collecting Blood Samples for Research | https://ClinicalTrials.gov/show/NCT04327804 |
| NCT04326725 | Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04326725 |
| NCT04326387 | Evaluation of Novel Diagnostic Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04326387 |
| NCT04325646 | Sero-epidemiological Study of the SARS-CoV-2 Virus Responsible for COVID-19 in France | https://ClinicalTrials.gov/show/NCT04325646 |
| NCT04331106 | Survey of the Anxiety Associated With the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04331106 |
| NCT04328454 | Clinical Characteristics and Prognostic Factors of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04328454 |
| NCT04327531 | Evaluation of Covid 19 Knowledge Anxiety and Expectation Levels of Turkish Physicians, Survey Study | https://ClinicalTrials.gov/show/NCT04327531 |
| NCT04329546 | Understanding COVID-19 | https://ClinicalTrials.gov/show/NCT04329546 |
| NCT04336384 | Impact of Covid-19 in Congenital Heart Disease | https://ClinicalTrials.gov/show/NCT04336384 |
| NCT04332016 | COVID-19 Biological Samples Collection | https://ClinicalTrials.gov/show/NCT04332016 |
| NCT04330261 | Clinical Characteristics and Outcomes of Pediatric COVID-19 | https://ClinicalTrials.gov/show/NCT04330261 |
| NCT04340219 | Oncology-patient-reported Anxiety, Mood, and QoL During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04340219 |
| NCT04335188 | COVID-19 Registry Rhineland-Palatinate (Germany) | https://ClinicalTrials.gov/show/NCT04335188 |
| NCT04331886 | An Observational Study of Patients With Coronavirus Disease 2019 | https://ClinicalTrials.gov/show/NCT04331886 |
| NCT04331509 | COVID-19 Symptom Tracker | https://ClinicalTrials.gov/show/NCT04331509 |
| NCT04333862 | Assessment of Covid-19 Infection Rates in Healthcare Workers Using a Desynchronization Strategy | https://ClinicalTrials.gov/show/NCT04333862 |
| NCT04333849 | Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 | https://ClinicalTrials.gov/show/NCT04333849 |
| NCT04336215 | Rutgers COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04336215 |
| NCT04335630 | Cardiovascular Manifestations of COVID-19 | https://ClinicalTrials.gov/show/NCT04335630 |
| NCT04334252 | Descriptive Study Regarding Ambulant Screening During COVID-19 Pandemia | https://ClinicalTrials.gov/show/NCT04334252 |
| NCT04340921 | The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury | https://ClinicalTrials.gov/show/NCT04340921 |
| NCT04337190 | Impact of Angiotensin II Receptor Blockers Treatment in Patients With COVID 19 (COVID-ARA2) | https://ClinicalTrials.gov/show/NCT04337190 |
| NCT04337151 | Blood Titanium Analysis of Patients With MAGEC Spine Rods in the COVID-19 Environment | https://ClinicalTrials.gov/show/NCT04337151 |
| NCT04337047 | Distress in Crisis Situations During COVID-19 | https://ClinicalTrials.gov/show/NCT04337047 |
| NCT04336761 | Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France | https://ClinicalTrials.gov/show/NCT04336761 |
| NCT04336657 | Corona-Like Illness: Did we Got it Before WHO Announcement of the Disease? | https://ClinicalTrials.gov/show/NCT04336657 |
| NCT04335162 | Cardiovascular Complications and COVID-19 (CovCardioVasc) | https://ClinicalTrials.gov/show/NCT04335162 |
| NCT04335747 | COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases | https://ClinicalTrials.gov/show/NCT04335747 |
| NCT04334954 | SARS-COV2 Pandemic Serosurvey and Blood Sampling | https://ClinicalTrials.gov/show/NCT04334954 |
| NCT04342702 | A Study on the Prospective Cohort Library of COVID-19 in Southeran | https://ClinicalTrials.gov/show/NCT04342702 |
| NCT04338672 | The Impact of the Covid-19 Outbreak on Emergency Room Attendances of Surgical Patients | https://ClinicalTrials.gov/show/NCT04338672 |
| NCT04337424 | Evaluation of Quickly Diagnostic Saliva Tests for SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04337424 |
| NCT04366765 | COVID-19 Survival - The COVIVA Study | https://ClinicalTrials.gov/show/NCT04366765 |
| NCT04346602 | A Study on the Clinical and Psychological Characteristics of Patients With COVID-2019 | https://ClinicalTrials.gov/show/NCT04346602 |
| NCT04339998 | Assessment of Exam Findings in Coronavirus Disease 2019 (COVID-19) With Point-of-Care Ultrasonography (POCUS) | https://ClinicalTrials.gov/show/NCT04339998 |
| NCT04339387 | COVID-19 Risk Stratification | https://ClinicalTrials.gov/show/NCT04339387 |
| NCT04337762 | Beat COVID-19 - Observational Trial | https://ClinicalTrials.gov/show/NCT04337762 |
| NCT04337502 | Clinical and Radiomic Model of COVID-19 | https://ClinicalTrials.gov/show/NCT04337502 |
| NCT04343742 | Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19 | https://ClinicalTrials.gov/show/NCT04343742 |
| NCT04342637 | COVID-19 Endoscopy Survey | https://ClinicalTrials.gov/show/NCT04342637 |
| NCT04339634 | Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy | https://ClinicalTrials.gov/show/NCT04339634 |
| NCT04339608 | Max COVID19- Study | https://ClinicalTrials.gov/show/NCT04339608 |
| NCT04338945 | Impact of Pandemic COVID-19 on Surgical Specialities Residents in Italy | https://ClinicalTrials.gov/show/NCT04338945 |
| NCT04338932 | COVID-19 and Deep Venous Thrombosis | https://ClinicalTrials.gov/show/NCT04338932 |
| NCT04347408 | Seroprevalence of SARS-Cov-2 Antibodies in Children | https://ClinicalTrials.gov/show/NCT04347408 |
| NCT04352634 | The Covid-19 HEalth caRe wOrkErS (HEROES) Study | https://ClinicalTrials.gov/show/NCT04352634 |
| NCT04347928 | Respiratory and Hemodynamic Changes Induced in Mechanically Ventilated Patients for COVID-19 | https://ClinicalTrials.gov/show/NCT04347928 |
| NCT04347460 | Establishing a COVID-19 Prospective Cohort for Identification of Secondary HLH | https://ClinicalTrials.gov/show/NCT04347460 |
| NCT04343404 | PLACE OF VENOVENOUS ECMO IN THE MANAGEMENT OF SEVERE REFRACTORY ARDS ASSOCIATED WITH SARS-COV-2 | https://ClinicalTrials.gov/show/NCT04343404 |
| NCT04343339 | Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment | https://ClinicalTrials.gov/show/NCT04343339 |
| NCT04342884 | COVID-19 Community Research Partnership | https://ClinicalTrials.gov/show/NCT04342884 |
| NCT04342195 | Acquiring Convalescent Specimens for COVID-19 Antibodies | https://ClinicalTrials.gov/show/NCT04342195 |
| NCT04342104 | NIV and CPAP Failure Predictors in COVID-19 Associated Respiratory Failure | https://ClinicalTrials.gov/show/NCT04342104 |
| NCT04341714 | Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04341714 |
| NCT04339686 | Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. | https://ClinicalTrials.gov/show/NCT04339686 |
| NCT04339790 | Mental Health Impact of COVID-19 Pandemic on NIMH Research Participants and Volunteers | https://ClinicalTrials.gov/show/NCT04339790 |
| NCT04358952 | Myocardial Involvement of Severe Acute Respiratory Syndrome-Cov-2 (Covid19) Infected Patients | https://ClinicalTrials.gov/show/NCT04358952 |
| NCT04357847 | Assessment of Endothelial and Haemostatic Changes During Severe SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04357847 |
| NCT04352556 | COVID19-hematological Malignancies: the Italian Hematology Alliance | https://ClinicalTrials.gov/show/NCT04352556 |
| NCT04350710 | Description of Respiratory Mechanics in Patients With SARS-CoV-2 Associated ARDS | https://ClinicalTrials.gov/show/NCT04350710 |
| NCT04347850 | A Cohort of Patients With Possible or Confirmed SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04347850 |
| NCT04346342 | PRactice of VENTilation in COVID-19 Patients (PRoVENT-COVID) | https://ClinicalTrials.gov/show/NCT04346342 |
| NCT04344327 | Early Risk Stratification of Patient Hospitalized for SARS-CoV2 Infection: Critical COVID-19 France CCF | https://ClinicalTrials.gov/show/NCT04344327 |
| NCT04344197 | Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey | https://ClinicalTrials.gov/show/NCT04344197 |
| NCT04344119 | Assessment of Chilbains Occuring During Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04344119 |
| NCT04343898 | Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04343898 |
| NCT04343781 | National Survey of Symptoms of People Aged 70 and Overs Diagnosed With COVID-19 | https://ClinicalTrials.gov/show/NCT04343781 |
| NCT04344145 | Exhaustion and Needs in Frontline COVID-19 Healthcare Workers: Cross-sectional Study in a Belgian Population | https://ClinicalTrials.gov/show/NCT04344145 |
| NCT04347824 | Predict Adverse Events by Covid-19 Nephritis | https://ClinicalTrials.gov/show/NCT04347824 |
| NCT04381312 | Direct and Indirect Impact of COVID-19 In Older Populations | https://ClinicalTrials.gov/show/NCT04381312 |
| NCT04352517 | Influence Physical Activity Psychological Responses COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04352517 |
| NCT04347070 | Implementation of Physiotherapy on COVID-19 Patients in ICU | https://ClinicalTrials.gov/show/NCT04347070 |
| NCT04346212 | Oropharyngeal Dysphagia in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04346212 |
| NCT04345640 | The Spectrum and Profile of COVID-19 Infection and Its Impact on Liver. | https://ClinicalTrials.gov/show/NCT04345640 |
| NCT04345315 | Correlative Study on Cancer Patients and Healthcare Professionals Exposed to Infection by Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-Cov-2), COVID-19 Causative Agent. | https://ClinicalTrials.gov/show/NCT04345315 |
| NCT04345159 | Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease | https://ClinicalTrials.gov/show/NCT04345159 |
| NCT04344171 | CovidDB: The Covid-19 Inpatient Database | https://ClinicalTrials.gov/show/NCT04344171 |
| NCT04353934 | The Ariel University Survey on Dietary Changes and Anxiety During the Coronavirus Pandemic | https://ClinicalTrials.gov/show/NCT04353934 |
| NCT04347694 | Study to Determine the Immunization Status Among Nephrological Health Care Personnel Against SARS-CoV-2 in a Single Center Over the Course of 12 Months During the Worldwide COVID-19 Pandemic. | https://ClinicalTrials.gov/show/NCT04347694 |
| NCT04373889 | COVID-19 Among Healthcare Workers in Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04373889 |
| NCT04356560 | COVID-19 Surveillance of Patients and Healthcare Workers in a Hospital Department | https://ClinicalTrials.gov/show/NCT04356560 |
| NCT04354584 | Compartmental Inflammation in Mechanically Ventilated Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04354584 |
| NCT04352582 | COVID-19 and Vaccination Attitudes | https://ClinicalTrials.gov/show/NCT04352582 |
| NCT04349163 | Resilience Evaluation of Caregivers During the SARS-CoV2 Epidemic Period : Prospective Cohort. | https://ClinicalTrials.gov/show/NCT04349163 |
| NCT04349202 | Beaumont Health Large-scale Automated Serologic Testing for COVID-19 | https://ClinicalTrials.gov/show/NCT04349202 |
| NCT04346264 | CoVid-19 - Infection and Antibody Formation in the Viennese Population | https://ClinicalTrials.gov/show/NCT04346264 |
| NCT04346056 | Retrospective Study on Severe Respiratory Illness to Access the Presence of COVID-19 | https://ClinicalTrials.gov/show/NCT04346056 |
| NCT04348214 | Screening & Risk Assessment of Healthcare Workers & Infection Control in University & COVID-19 Quarantine Hospitals | https://ClinicalTrials.gov/show/NCT04348214 |
| NCT04344977 | Collection of Anti-SARS-CoV-2 Immune Plasma | https://ClinicalTrials.gov/show/NCT04344977 |
| NCT04352699 | Outcomes of Urological Surgery During Periods of Social COVID-19 Containemnt: is it Reasonable to Limit Access to Surgical Care for All? | https://ClinicalTrials.gov/show/NCT04352699 |
| NCT04351399 | Psychological Impact of Quarantine in Rheumatoid Arthritis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351399 |
| NCT04349540 | Role of Immune and Inflammatory Response in Recipients of Allogeneic Haematopoietic Stem Cell Transplantation (SCT) Affected by Severe COVID19 | https://ClinicalTrials.gov/show/NCT04349540 |
| NCT04347876 | Outcome of COVID-19 Cases Based on Tuberculin Test: Can Previous BCG Alter the Prognosis? | https://ClinicalTrials.gov/show/NCT04347876 |
| NCT04352491 | An Online Survey to Understand Feelings Related to COVID-19 Among ILBS Patients With Liver Disease | https://ClinicalTrials.gov/show/NCT04352491 |
| NCT04351568 | Professional and Ethical Challenges of Social Media Usage in Providing Healthcare Services During the Period of 19 Covid Pandemics; | https://ClinicalTrials.gov/show/NCT04351568 |
| NCT04386109 | Neonatal Complications of Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04386109 |
| NCT04353609 | Covid-19 in Patients With Chronic Inflammatory Rheumatism, Auto-immune or Auto-inflammatory Rare and Non-rare Diseases | https://ClinicalTrials.gov/show/NCT04353609 |
| NCT04353401 | WGS ANALYSIS OF SARS-COV-2 POSITIVE PATIENTS | https://ClinicalTrials.gov/show/NCT04353401 |
| NCT04353011 | Psychological Impact of Quarantine in Chronic Pain Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04353011 |
| NCT04351633 | Psychological Impact of Quarantine in Osteoporosis Patient During COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04351633 |
| NCT04351503 | A Systems Approach to Predict the Outcome of SARS-CoV-2 in the Population of a City; COVID-19 | https://ClinicalTrials.gov/show/NCT04351503 |
| NCT04351139 | Impact of the COVID-19 Pandemic in Gynecological Oncology | https://ClinicalTrials.gov/show/NCT04351139 |
| NCT04348240 | Transmissibility and Viral Load of SARS-CoV-2 in Oral Secretions | https://ClinicalTrials.gov/show/NCT04348240 |
| NCT04376905 | Extra Vascular Lung Water and Pulmonary Permeability in Critically Ill Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04376905 |
| NCT04373109 | Stroke Rehabilitation Outcome During COVID-19 Lockdown | https://ClinicalTrials.gov/show/NCT04373109 |
| NCT04367129 | Electrocardiogram Analysis in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04367129 |
| NCT04366154 | Impact of the COVID-19 Infectious Epidemic on the Management of Oncology and Onco-hematology Patients and on the Psychological Consequences for Patients and Caregivers | https://ClinicalTrials.gov/show/NCT04366154 |
| NCT04360538 | Long Term Outcomes of Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360538 |
| NCT04359667 | Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19 Pneumonia Treated With Tocilizumab | https://ClinicalTrials.gov/show/NCT04359667 |
| NCT04357769 | COVID-19 Pandemic Burden in Severe Mental Disease Patients | https://ClinicalTrials.gov/show/NCT04357769 |
| NCT04357418 | Psychological Outcome of COVID-19 Lockdown on Psychiatric Hospital Staff and Close Relatives | https://ClinicalTrials.gov/show/NCT04357418 |
| NCT04356443 | Non-Invasive Monitoring of Respiratory Function in Spontaneously Breathing Patients With COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04356443 |
| NCT04354792 | Asymptomatic COVID-19 Infection Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04354792 |
| NCT04353141 | International Lung UltraSound Analysis (ILUSA) Study | https://ClinicalTrials.gov/show/NCT04353141 |
| NCT04352842 | Echocardiographic Manifestation in Patient With COVID-19 （EARLY-MYO COVID-19） | https://ClinicalTrials.gov/show/NCT04352842 |
| NCT04351659 | Novel Adoptive Cellular Therapy With SARS-CoV-2 Specific T Cells in Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04351659 |
| NCT04355442 | Evolution of Facial Trauma During COVID Containment Measures | https://ClinicalTrials.gov/show/NCT04355442 |
| NCT04367402 | COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION) | https://ClinicalTrials.gov/show/NCT04367402 |
| NCT04367363 | Social Media and COVID-19 | https://ClinicalTrials.gov/show/NCT04367363 |
| NCT04366921 | European/Euro-ELSO Survey on Adult and Neonatal/ Pediatric COVID-19 Patients in ECMO | https://ClinicalTrials.gov/show/NCT04366921 |
| NCT04361786 | Acral Cutaneous Thrombotic Vasculopathy and Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04361786 |
| NCT04355715 | Combination of Chest Scanography and Nasal Viral Detection Test to Detect COVID-19 Positive Patients Before Surgical Intervention in a University Hospital During Coronavirus Pandemia | https://ClinicalTrials.gov/show/NCT04355715 |
| NCT04355624 | Kidney Involvement in COVID-19 Disease (COVKID) | https://ClinicalTrials.gov/show/NCT04355624 |
| NCT04355611 | Epidemiological Characteristics of COVID-19 in Patients With MS or NMO | https://ClinicalTrials.gov/show/NCT04355611 |
| NCT04355481 | Dissemination of SARS-COV-2 (COVID-19) in the Environment of Infected Patients Admitted to Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04355481 |
| NCT04354857 | Qualitative and Quantitative Evaluation of Anosmia Over Time in Clinically Symptomatic Patients Tested for COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04354857 |
| NCT04354779 | Antibody Seroprevalence and Rate of Asymptomatic Infections With SARS-CoV-2 in Austrian Hospital Personnel. | https://ClinicalTrials.gov/show/NCT04354779 |
| NCT04354766 | COVID-19 : Neutralizing Human Monoclonal Antibodies Against SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04354766 |
| NCT04354753 | AiM COVID for Covid 19 Tracking and Prediction | https://ClinicalTrials.gov/show/NCT04354753 |
| NCT04357041 | COVID-19 Survey Study on Dietary Intake, Physical Activity and Overall Well-being | https://ClinicalTrials.gov/show/NCT04357041 |
| NCT04355702 | Covid-19 in Lupus Patients | https://ClinicalTrials.gov/show/NCT04355702 |
| NCT04358380 | Liver Injury in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04358380 |
| NCT04365166 | Study of Clinical and Immune Severity Profiles of Patients Infected With SARS-Cov2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365166 |
| NCT04363333 | Obstructive Sleep Apnea & Covid-19 Outcomes | https://ClinicalTrials.gov/show/NCT04363333 |
| NCT04359914 | Neurocognitive Impairment in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04359914 |
| NCT04356885 | COVID-19 and Psychotic Symptoms in France | https://ClinicalTrials.gov/show/NCT04356885 |
| NCT04355871 | Characteristics and Outcomes of Hospitalized Patients With COVID-19 in Spain | https://ClinicalTrials.gov/show/NCT04355871 |
| NCT04385069 | COVID-19 Hyperinflammation Syndrome (COV-HI): Protocol for a Rapidly Executed Cohort Study | https://ClinicalTrials.gov/show/NCT04385069 |
| NCT04384029 | The Geneva Covid-19 CVD Study | https://ClinicalTrials.gov/show/NCT04384029 |
| NCT04376853 | CoronaWatch - Early Detection of Cardiovascular Risks in COVID-19 Via SmartWatch | https://ClinicalTrials.gov/show/NCT04376853 |
| NCT04374123 | COVID-19 Serology Screening and Strict Protocol in the Endoscopy Unit | https://ClinicalTrials.gov/show/NCT04374123 |
| NCT04362345 | Clinical Features and Risk Factors Associated With Worse Outcome in Patients Hospitalized for Covid-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04362345 |
| NCT04361877 | Cardiovascular Prevention During COVID-19 Pandemic Lockdown in Young Adults (COLA Trial) | https://ClinicalTrials.gov/show/NCT04361877 |
| NCT04360954 | Evaluation of Antibody Tests for COVID-19 | https://ClinicalTrials.gov/show/NCT04360954 |
| NCT04359849 | Sequencing and Tracking of Phylogeny in COVID-19 Study | https://ClinicalTrials.gov/show/NCT04359849 |
| NCT04359836 | A Study to Explore the Role of Gut Flora in COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04359836 |
| NCT04358536 | Classification of COVID-19 Infection in Posteroanterior Chest X-rays | https://ClinicalTrials.gov/show/NCT04358536 |
| NCT04358510 | COVID-19 Mortality Prediction Model | https://ClinicalTrials.gov/show/NCT04358510 |
| NCT04358029 | Cardiac Arrhythmias In Patients With Coronavirus Disease (COVID-19) | https://ClinicalTrials.gov/show/NCT04358029 |
| NCT04357938 | Risk Stratification With Chest CT to Rule-out Suspected SARS-CoV-2 Infections | https://ClinicalTrials.gov/show/NCT04357938 |
| NCT04357574 | Assessing the System for High-Intensity Evaluation During Radiotherapy During Changes in Response to COVID-19 | https://ClinicalTrials.gov/show/NCT04357574 |
| NCT04359407 | Prone Positioning and Regional Ventilation in Mechanically Ventilated COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04359407 |
| NCT04403009 | The Clinical Difference Between the Nonfatal Patients and the Fatal Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04403009 |
| NCT04397835 | Psychological Impact of COVID-19 Quarantine and Worsening of Cardiovascular Risk in the French General Population | https://ClinicalTrials.gov/show/NCT04397835 |
| NCT04375748 | Hospital Registry of Acute Myocarditis: Evolution of the Proportion of Positive SARS-COV-2 (COVID19) Cases | https://ClinicalTrials.gov/show/NCT04375748 |
| NCT04366024 | A Novel Nomogram to Predict Severity of COVID-19 | https://ClinicalTrials.gov/show/NCT04366024 |
| NCT04365959 | The Prone Position in Covid-19 Affected Patients | https://ClinicalTrials.gov/show/NCT04365959 |
| NCT04363008 | COVID 19 Biomarkers | https://ClinicalTrials.gov/show/NCT04363008 |
| NCT04360850 | Use of Telehealth Technology by Mental Health Care Professionals in Times of COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04360850 |
| NCT04359121 | COVID-19 and the Developement of Phobic Fears of Disease | https://ClinicalTrials.gov/show/NCT04359121 |
| NCT04358640 | Anxiety and Work Resilience Among Tertiary University Hospital Workers During the COVID-19 Outbreak: An Online Survey | https://ClinicalTrials.gov/show/NCT04358640 |
| NCT04357431 | COVID-19 Among Egyptian Health Care Providers | https://ClinicalTrials.gov/show/NCT04357431 |
| NCT04356365 | The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI’s) | https://ClinicalTrials.gov/show/NCT04356365 |
| NCT04359693 | Impact of COVID-19 Infection on the Incidence of Ventilator-acquired Infections | https://ClinicalTrials.gov/show/NCT04359693 |
| NCT04371848 | Impact of the COVID-19 Pandemic on Diet Quality and Food Insecurity: a NutriQuébec Sub-study | https://ClinicalTrials.gov/show/NCT04371848 |
| NCT04371250 | Study of Resilience and Loneliness in Youth (18 - 25 Years Old) During the COVID-19 Pandemic Lock-down Measures. | https://ClinicalTrials.gov/show/NCT04371250 |
| NCT04369807 | Mapping Organ Health Following COVID-19 Disease Due to SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04369807 |
| NCT04366934 | Study of the Pathogenesis of Olfactory Disorders in COVID-19 | https://ClinicalTrials.gov/show/NCT04366934 |
| NCT04362995 | St. Jude Tracking of Viral and Host Factors Associated With COVID-19 | https://ClinicalTrials.gov/show/NCT04362995 |
| NCT04362943 | Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults | https://ClinicalTrials.gov/show/NCT04362943 |
| NCT04361565 | Frequency and Clinical Evolution of Olfactory and Taste Disorders in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04361565 |
| NCT04361123 | Atrium COVID-19 Syndromic and Serologic Surveillance | https://ClinicalTrials.gov/show/NCT04361123 |
| NCT04361019 | Physical Activity in University Students Around COVID-19 Confinement | https://ClinicalTrials.gov/show/NCT04361019 |
| NCT04360863 | The Impact of COVID-19 Pandemic on the Smoking Behaviour of Young Smokers and the Youth Quitline Service in Hong Kong | https://ClinicalTrials.gov/show/NCT04360863 |
| NCT04360733 | Precision Immunology to Determine the Immune Response in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04360733 |
| NCT04360707 | Solid Organ Transplant Recipients With SARS-CoV-2 French Registry | https://ClinicalTrials.gov/show/NCT04360707 |
| NCT04360278 | Plasma Collection From Convalescent and/or Immunized Donors for the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04360278 |
| NCT04393233 | Drug Management of Rheumatoid Arthritis in Covid-19 Context : Impact on Therapeutic De-escalation | https://ClinicalTrials.gov/show/NCT04393233 |
| NCT04396600 | The Professional Peer Resilience Initiative | https://ClinicalTrials.gov/show/NCT04396600 |
| NCT04381286 | Transpulmonary Driving Pressure in ARDS COVID19 Patients | https://ClinicalTrials.gov/show/NCT04381286 |
| NCT04366778 | Thrombosis and Covid-19 | https://ClinicalTrials.gov/show/NCT04366778 |
| NCT04363788 | Needle Stick Injuries in Emergency Medical Service Practice | https://ClinicalTrials.gov/show/NCT04363788 |
| NCT04363268 | ACCESS A Master Digital Surveillance Protocol for COVID-19 | https://ClinicalTrials.gov/show/NCT04363268 |
| NCT04363099 | Multicentre Observational Study on Management COVID 19 Positive Outpatients in a French Cluster. | https://ClinicalTrials.gov/show/NCT04363099 |
| NCT04362150 | Long-term Impact of Infection With Novel Coronavirus (COVID-19) | https://ClinicalTrials.gov/show/NCT04362150 |
| NCT04377815 | Finding Out if COVID-19 Infection Can be pREdicted by ChAnges in Smell and/or Taste | https://ClinicalTrials.gov/show/NCT04377815 |
| NCT04371315 | Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children | https://ClinicalTrials.gov/show/NCT04371315 |
| NCT04370678 | Changes in Preference for Surgery of Patients Signed up for Arthroscopic Procedures | https://ClinicalTrials.gov/show/NCT04370678 |
| NCT04366167 | Patient Recovery From Heart Surgery During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04366167 |
| NCT04365595 | SARS-CoV-2 Associated Respiratory Failure Recovery (COVID-19 CAir) | https://ClinicalTrials.gov/show/NCT04365595 |
| NCT04365335 | Stress Biomarkers Leading to Professional Burnout Among People Involved in a Mobile Intensive Care Unit During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04365335 |
| NCT04364698 | Observational Cohort of COVID-19 Patients at Raymond-Poincare | https://ClinicalTrials.gov/show/NCT04364698 |
| NCT04362930 | Cohort of Patients With Covid-19 Presenting Neurological or Psychiatric Disorders (CoCo-Neurosciences) | https://ClinicalTrials.gov/show/NCT04362930 |
| NCT04362865 | Investigation of the B- and T-cell Repertoire and Immune Response in Patients With Acute and Resolved COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04362865 |
| NCT04365764 | Effect of Treatments in Patients Hospitalized for Severe COVID-19 Pneumonia: a Multicenter Cohort Study | https://ClinicalTrials.gov/show/NCT04365764 |
| NCT04365725 | Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections | https://ClinicalTrials.gov/show/NCT04365725 |
| NCT04365634 | A Single-center Retrospective Study to Find Prediction Factors Related to Mortality of COVID-19 Patients. | https://ClinicalTrials.gov/show/NCT04365634 |
| NCT04365348 | The Psychological Impact of COVID-19 Outbreak on COVID-19 Survivors and Their Families | https://ClinicalTrials.gov/show/NCT04365348 |
| NCT04365361 | The Psychological Impact of the COVID-19 on Students. | https://ClinicalTrials.gov/show/NCT04365361 |
| NCT04382534 | A Cross-sectional and Cohort Study of COVID-19 Patients With Post - Discharge Dysfunction | https://ClinicalTrials.gov/show/NCT04382534 |
| NCT04373811 | One-Year Quality of Life and Functional Prognosis of COVID-19 Patients in Post-ICU Setting | https://ClinicalTrials.gov/show/NCT04373811 |
| NCT04368637 | Acute Cardiovascular Events Triggered by COVID-19-Related Stress | https://ClinicalTrials.gov/show/NCT04368637 |
| NCT04367064 | To Study the Clinical Characteristics and Treatment Outcome of COVID-19 Patients Admitted in Hospitals of Max Healthcare (SCOPe Study) | https://ClinicalTrials.gov/show/NCT04367064 |
| NCT04365881 | Loneliness During the NPIs for the COVID-19 Pandemic in Norway: Risk Factors and Associations With Psychopathology | https://ClinicalTrials.gov/show/NCT04365881 |
| NCT04365530 | Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City | https://ClinicalTrials.gov/show/NCT04365530 |
| NCT04383470 | Collaborative Outcomes Study on Health and Functioning During Infection Times During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383470 |
| NCT04368351 | Bacteriotherapy in the Treatment of COVID-19 | https://ClinicalTrials.gov/show/NCT04368351 |
| NCT04368026 | SARS-CoV-2 and Surgery | https://ClinicalTrials.gov/show/NCT04368026 |
| NCT04367896 | COVID-19 OUTBREAK AND SOLID ORGAN TRANSPLANTATION (SOT) : AN INTERNATIONAL WEB-BASED SURVEY | https://ClinicalTrials.gov/show/NCT04367896 |
| NCT04367805 | COVID-19 Infection in Patients With Hepatocellular Carcinoma | https://ClinicalTrials.gov/show/NCT04367805 |
| NCT04367792 | Cardiac Injury in COVID-19: a Pathology Study | https://ClinicalTrials.gov/show/NCT04367792 |
| NCT04367740 | ScreenNC, a Study to Determine the Number of Asymptomatic Individuals Who Have Antibodies to the Virus That Causes COVID-19 | https://ClinicalTrials.gov/show/NCT04367740 |
| NCT04366752 | Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04366752 |
| NCT04375670 | COVID19-FOIE National Observatory | https://ClinicalTrials.gov/show/NCT04375670 |
| NCT04370249 | Construction of a Composite Clinical-echo Score Predictive of a Risk of Short-term Aggravation of Respiratory Impairment in Patients Suspected of Covid-19 | https://ClinicalTrials.gov/show/NCT04370249 |
| NCT04369989 | Observational Study of COVID-19 Treatment Efficacy | https://ClinicalTrials.gov/show/NCT04369989 |
| NCT04368390 | Neuroradiolological Analysis of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368390 |
| NCT04368338 | Lung Ultrasound to Diagnose COVID-19 | https://ClinicalTrials.gov/show/NCT04368338 |
| NCT04367883 | Influenza Vaccination, ACEI and ARB in the Evolution of SARS-Covid19 Infection | https://ClinicalTrials.gov/show/NCT04367883 |
| NCT04367337 | Health Behavior Change During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04367337 |
| NCT04367870 | COVID-19 Detection Test in Oncology | https://ClinicalTrials.gov/show/NCT04367870 |
| NCT04385212 | Outcomes in Hospitalized Older Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04385212 |
| NCT04374422 | COVID-19 Pandemic and Female Sexual Behavior | https://ClinicalTrials.gov/show/NCT04374422 |
| NCT04372576 | Epidemiology and Outcome of Ventilator-associated Pneumonia Among Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04372576 |
| NCT04372472 | SQuISH-COVID: A Pilot Study | https://ClinicalTrials.gov/show/NCT04372472 |
| NCT04372056 | The COVID-ICU Healthcare Professional Study | https://ClinicalTrials.gov/show/NCT04372056 |
| NCT04370275 | Accuracy of Lung Ultrasound in the Diagnosis of covid19 Pneumonia | https://ClinicalTrials.gov/show/NCT04370275 |
| NCT04370197 | Covid-19 Epidemic on Acute Stroke Management | https://ClinicalTrials.gov/show/NCT04370197 |
| NCT04370119 | Screening for SARS-CoV-2-Infections and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers | https://ClinicalTrials.gov/show/NCT04370119 |
| NCT04369859 | Obstetric and Perinatal Outcomes of Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04369859 |
| NCT04368884 | Observational Study to Assess the Seroconversion Status of Health Care Workers and Suspected or Confirmed Cases of COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04368884 |
| NCT04370210 | Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry | https://ClinicalTrials.gov/show/NCT04370210 |
| NCT04371432 | Genetics of COVID-19 Susceptibility and Manifestations | https://ClinicalTrials.gov/show/NCT04371432 |
| NCT04380987 | Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis | https://ClinicalTrials.gov/show/NCT04380987 |
| NCT04379089 | Neurologic Manifestations of COVID 19 in Children | https://ClinicalTrials.gov/show/NCT04379089 |
| NCT04377581 | COVID-19 Health Messaging Efficacy and Its Impact on Public Perception, Anxiety, and Behavior | https://ClinicalTrials.gov/show/NCT04377581 |
| NCT04376580 | Use of the Nasal Cannula During COVID-19 | https://ClinicalTrials.gov/show/NCT04376580 |
| NCT04375761 | COVID-19: Human Epidemiology and Response to SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04375761 |
| NCT04375410 | Consequences of Intensified Handwash and Hand Disinfection Among Children During the COVID19 Pandemic | https://ClinicalTrials.gov/show/NCT04375410 |
| NCT04374071 | Early Short Course Corticosteroids in COVID-19 | https://ClinicalTrials.gov/show/NCT04374071 |
| NCT04373486 | Incidence of Acute Pulmonary Embolism in Covid-19 Patients on CT Angiography and Relationship to D-dimer Levels | https://ClinicalTrials.gov/show/NCT04373486 |
| NCT04373148 | Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 | https://ClinicalTrials.gov/show/NCT04373148 |
| NCT04371679 | Changes in Cardiac and Pulmonary Hemodynamics as Predictor of Outcome in Hospitalized COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04371679 |
| NCT04371562 | Predicting Death and ICU Admission in COVID-19 Patients in ED | https://ClinicalTrials.gov/show/NCT04371562 |
| NCT04371471 | Covid-19 Pandemic Triage Score | https://ClinicalTrials.gov/show/NCT04371471 |
| NCT04384471 | Covid-19 Pandemic: Patients’ Experience in T1D | https://ClinicalTrials.gov/show/NCT04384471 |
| NCT04378777 | Immunophenotyping Assessment in a COVID-19 Cohort | https://ClinicalTrials.gov/show/NCT04378777 |
| NCT04377035 | The Role of Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04377035 |
| NCT04374656 | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04374656 |
| NCT04374058 | Less Frequency Hemodialysis and COVID-19 | https://ClinicalTrials.gov/show/NCT04374058 |
| NCT04377412 | Risk Factors for Anxiety and Depression Among Pregnant Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04377412 |
| NCT04374617 | Risk of Venous Thromboembolism in Critically Ill Patients With Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04374617 |
| NCT04374513 | Community Pharmacists Behaviour During Covid-19 | https://ClinicalTrials.gov/show/NCT04374513 |
| NCT04374097 | Level and Predictors of Trauma-symptoms Among Health Workers and Public Service Providers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04374097 |
| NCT04375176 | Monocytes and NK Cells Activity in Covid-19 Patients | https://ClinicalTrials.gov/show/NCT04375176 |
| NCT04375137 | Correlation Between Oxidative Stress Status and COVID-19 Severity | https://ClinicalTrials.gov/show/NCT04375137 |
| NCT04382417 | Prospective Observational Cohort Study of Critically Ill Patients With Covid-19 in Sweden | https://ClinicalTrials.gov/show/NCT04382417 |
| NCT04381819 | Norwegian SARS-CoV-2 Study - Virological, Clinical and Immunological Characterisation of COVID-19 | https://ClinicalTrials.gov/show/NCT04381819 |
| NCT04380896 | COVID-19 Staff Testing of Antibody Responses Study (Co-Stars) | https://ClinicalTrials.gov/show/NCT04380896 |
| NCT04379245 | COVID-19 Infection in Patients Infected With HIV and/or on PrEP | https://ClinicalTrials.gov/show/NCT04379245 |
| NCT04379232 | Surgical Activity During the Covid-19 Pandemic: Results for 112 Patients in a French Tertiary Care Center | https://ClinicalTrials.gov/show/NCT04379232 |
| NCT04377607 | Haemoglobin Concentration on COVID-19 | https://ClinicalTrials.gov/show/NCT04377607 |
| NCT04377074 | Parental Stress During the COVID-19 Pandemic and Its Association With Depression and Anxiety | https://ClinicalTrials.gov/show/NCT04377074 |
| NCT04376996 | Slovenian National COVID-19 Prevalence Study | https://ClinicalTrials.gov/show/NCT04376996 |
| NCT04376944 | Barrier Measures to Limit Covid-19.Nosocomial Transmission: a Cross-sectional Evaluation | https://ClinicalTrials.gov/show/NCT04376944 |
| NCT04376879 | Predicting the Need for Intubation in Hospitalised COVID-19 Patients (PRED ICU COVID19) | https://ClinicalTrials.gov/show/NCT04376879 |
| NCT04376775 | Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation | https://ClinicalTrials.gov/show/NCT04376775 |
| NCT04375709 | Quality of Life and Physical Performance After Novel Coronavirus Infection (COVID-19); | https://ClinicalTrials.gov/show/NCT04375709 |
| NCT04375501 | A Study of Outcomes in Patients With Fractured Neck of Femur During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04375501 |
| NCT04379310 | Evaluation of Clinical Parameters on Admission and Medications in Covid-19 Pneumonia (Corona Virus Disease 2019) | https://ClinicalTrials.gov/show/NCT04379310 |
| NCT04382469 | Egyptian Initial Experience About 2019 Novel Corona Virus: Study of 48 Patients in Alexandria-Egypt Using Chest CT | https://ClinicalTrials.gov/show/NCT04382469 |
| NCT04382235 | Non-invasive Ventilatory Support of Patients Affected by COVID-19 | https://ClinicalTrials.gov/show/NCT04382235 |
| NCT04380870 | Describing Chinese Herbal Medicine Telehealth Care for Symptoms Related to Infectious Diseases Such as COVID-19 | https://ClinicalTrials.gov/show/NCT04380870 |
| NCT04379063 | COVID-19 Pandemic Short Interval National Survey Gauging Psychological Distress | https://ClinicalTrials.gov/show/NCT04379063 |
| NCT04378686 | Serological Testing for COVID-19 (SARS-CoV-2) in ESKD | https://ClinicalTrials.gov/show/NCT04378686 |
| NCT04378595 | Assessing Pediatric Food Insecurity During the COVID-19 Pandemic in Austin | https://ClinicalTrials.gov/show/NCT04378595 |
| NCT04377776 | Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients | https://ClinicalTrials.gov/show/NCT04377776 |
| NCT04377724 | Spread and Course of COVID-19 Infections | https://ClinicalTrials.gov/show/NCT04377724 |
| NCT04377685 | Prediction of Clinical Course in COVID19 Patients | https://ClinicalTrials.gov/show/NCT04377685 |
| NCT04377490 | Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy | https://ClinicalTrials.gov/show/NCT04377490 |
| NCT04378842 | COVID-19 and ICU-acquired MDR Bacteria | https://ClinicalTrials.gov/show/NCT04378842 |
| NCT04378582 | Characteristics and Outcomes of Patients With COVID-19 Admitted to the ICU | https://ClinicalTrials.gov/show/NCT04378582 |
| NCT04410718 | Glycaemia and Cardiac Function in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04410718 |
| NCT04393155 | Longitudinal COVID-19 Cohort Study | https://ClinicalTrials.gov/show/NCT04393155 |
| NCT04386395 | Immune Changes in Severe COVID-19 Pulmonary Infections | https://ClinicalTrials.gov/show/NCT04386395 |
| NCT04382781 | Immunosupressive Treatment in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04382781 |
| NCT04382508 | Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults. | https://ClinicalTrials.gov/show/NCT04382508 |
| NCT04381273 | Oral Health and Psychosocial Factors During the Covid-19 Pandemic | https://ClinicalTrials.gov/show/NCT04381273 |
| NCT04379297 | COvid-19 National Survey for Assessing VIral Spread by Nonaffected CarriErs (CON-VINCE) | https://ClinicalTrials.gov/show/NCT04379297 |
| NCT04383678 | Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04383678 |
| NCT04383652 | Collection of Coronavirus COVID-19 Outbreak Samples in New South Wales | https://ClinicalTrials.gov/show/NCT04383652 |
| NCT04381351 | Noncoding RNAs in COVID-19 and COVID-19 Related Kidney Dysfunction | https://ClinicalTrials.gov/show/NCT04381351 |
| NCT04380792 | Prevalence of DVT or PE in Patients Infected With COVID-19 Admitted to Hospital | https://ClinicalTrials.gov/show/NCT04380792 |
| NCT04380779 | Prevalence of Severe Bleeding in COVID-19 Patients Treated With Higher Than Recommended Thromboprophylaxis Doses | https://ClinicalTrials.gov/show/NCT04380779 |
| NCT04380714 | Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19 | https://ClinicalTrials.gov/show/NCT04380714 |
| NCT04384055 | Predicting Outcomes for Covid-19 Using Sonography | https://ClinicalTrials.gov/show/NCT04384055 |
| NCT04383886 | Evaluation of Emergency Department (ED) Staff Stress Level During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383886 |
| NCT04382794 | Sitagliptin Treatment in Diabetic COVID-19 Positive Patients | https://ClinicalTrials.gov/show/NCT04382794 |
| NCT04382196 | Impact of COVID-19 on Mental Health of Health Care Workers | https://ClinicalTrials.gov/show/NCT04382196 |
| NCT04385004 | Clinical, Biological and Histological Pulmonary and Renal Damage Associated With the SARS-CoV-2 Syndrome in Patients Admitted in ICU | https://ClinicalTrials.gov/show/NCT04385004 |
| NCT04383444 | Surveillance of Individuals Following SARS-CoV-2 Exposure | https://ClinicalTrials.gov/show/NCT04383444 |
| NCT04384250 | Genetic Basis of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04384250 |
| NCT04385238 | Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04385238 |
| NCT04383626 | Fear Among Dentists During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04383626 |
| NCT04389320 | Antimalarial and Covid 19 in Rheumatoid Arthritis | https://ClinicalTrials.gov/show/NCT04389320 |
| NCT04387786 | Dornase Alfa Administered to Patients With COVID-19 (DACOVID) | https://ClinicalTrials.gov/show/NCT04387786 |
| NCT04386720 | Measurement of Airway Opening Pressure (AOP) in Patients With Acute Respiratory Distress Syndrom and With or Without Covid 19. | https://ClinicalTrials.gov/show/NCT04386720 |
| NCT04386551 | Detection of COVID-19 in Saliva Collection | https://ClinicalTrials.gov/show/NCT04386551 |
| NCT04385823 | Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04385823 |
| NCT04385147 | Advanced Endoscopy During COVID-19 | https://ClinicalTrials.gov/show/NCT04385147 |
| NCT04384926 | Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis | https://ClinicalTrials.gov/show/NCT04384926 |
| NCT04384887 | “Investigation of the Relationship Between New Coronary Virus Disease (COVID-19) and Anxiety and Depressive Symptoms in Pregnant Women” | https://ClinicalTrials.gov/show/NCT04384887 |
| NCT04409535 | Effects of the COVID-19 Health Emergency on Biopsychosocial Health | https://ClinicalTrials.gov/show/NCT04409535 |
| NCT04388670 | Epidemiological and Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04388670 |
| NCT04388579 | Screening Patients for a Strategic Shift to Pulmonary Telerehabilitation Because of COVID-19 | https://ClinicalTrials.gov/show/NCT04388579 |
| NCT04387279 | The Impact of COVID-19 on the Health Care Utilization of Inflammatory Bowel Disease | https://ClinicalTrials.gov/show/NCT04387279 |
| NCT04387214 | COVID-19 Pandemic and Academic Performance of Veterinary Students | https://ClinicalTrials.gov/show/NCT04387214 |
| NCT04386460 | Covid-19 and Prevention of Malnutrition After Confinement by Dentists | https://ClinicalTrials.gov/show/NCT04386460 |
| NCT04392401 | COVID-19 - Study of the Kinetics of the Immune Response During the Intensive Care Unit Stay in Adult Patients Infected With SARS-CoV-2: Multicentric Non Interventional Study | https://ClinicalTrials.gov/show/NCT04392401 |
| NCT04389645 | Interferon Gamma Induced Protein 10 (IP-10) in a Clinical Decision Support Protocol in COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04389645 |
| NCT04388657 | COVID-19, bLOod Coagulation and Thrombosis | https://ClinicalTrials.gov/show/NCT04388657 |
| NCT04387799 | Negative-PCR for Covid- 19 Pneumonia (NPC-19) | https://ClinicalTrials.gov/show/NCT04387799 |
| NCT04387643 | Protecting Health Care Workers During the COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04387643 |
| NCT04389567 | Famotidine Outpatient COVID-19 Treatment Study | https://ClinicalTrials.gov/show/NCT04389567 |
| NCT04387656 | NCI COVID-19 in Cancer Patients, NCCAPS Study | https://ClinicalTrials.gov/show/NCT04387656 |
| NCT04393428 | Urinary Biomarkers for AKI Diagnosis in Patients With SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04393428 |
| NCT04392089 | Effects of Cardiovascular and Pulmonary Optimization on Cerebral Oxygenation in COVID-19 Patients With Severe ARDS | https://ClinicalTrials.gov/show/NCT04392089 |
| NCT04391738 | Association Between BMI and COVID-19 | https://ClinicalTrials.gov/show/NCT04391738 |
| NCT04390126 | COVID-19 Related Lockdown Effects On Chronic Diseases | https://ClinicalTrials.gov/show/NCT04390126 |
| NCT04389658 | Contagiousness and Immunogenicity Status of COVID-19 in Asymptomatic Population (COVID-19 CONDITION) | https://ClinicalTrials.gov/show/NCT04389658 |
| NCT04389463 | Patient Outcome of Cardiac Surgery During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04389463 |
| NCT04389489 | Postpartum Sexual Function in Pregnant Women With COVID-19 | https://ClinicalTrials.gov/show/NCT04389489 |
| NCT04410835 | Psychological Impact of the Corona Virus Pandemic in Individuals With Psychiatric Disorders | https://ClinicalTrials.gov/show/NCT04410835 |
| NCT04389515 | Postoperative Recovery Index, Patient Expectations and Satisfaction With Prenatal Care Instrument in Pregnant Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04389515 |
| NCT04395833 | National Survey on the Lockdown of Children With Disabilities | https://ClinicalTrials.gov/show/NCT04395833 |
| NCT04394026 | Imaging Feature of SARS-CoV2 Infection | https://ClinicalTrials.gov/show/NCT04394026 |
| NCT04393402 | Lung Ultrasound Score in Covid 19 Infectious Disease in Critical Care (LUS-COVID19) | https://ClinicalTrials.gov/show/NCT04393402 |
| NCT04392388 | Health, Perception, Practices, Relations and Social Inequalities in the General Population During the Covid-19 Crisis | https://ClinicalTrials.gov/show/NCT04392388 |
| NCT04392245 | Proctologic Practice and Covid-19 | https://ClinicalTrials.gov/show/NCT04392245 |
| NCT04391166 | Validity of at Home Visual Acuity Measurements for Telemedicine During Corona Virus (COVID-19) Pandemic | https://ClinicalTrials.gov/show/NCT04391166 |
| NCT04391816 | COVID-19 Pandemic Impact on Alcohol (PIA) - A Natural History Study | https://ClinicalTrials.gov/show/NCT04391816 |
| NCT04394195 | sFlt1: a Biomarker of Organ Dysfunction in Critically-ill Patients With COVID-19? | https://ClinicalTrials.gov/show/NCT04394195 |
| NCT04393558 | Wearable Sensor to Monitor COVID-19 Like Signs and Symptoms | https://ClinicalTrials.gov/show/NCT04393558 |
| NCT04396197 | Physical Activity Levels in COVID-19 Patients Admitted to Intensive Care | https://ClinicalTrials.gov/show/NCT04396197 |
| NCT04401241 | How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department | https://ClinicalTrials.gov/show/NCT04401241 |
| NCT04396210 | Patients Perspectives on Discontinuation of Their Fertility Treatment Due to the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04396210 |
| NCT04395482 | Lung CT Scan Analysis of SARS-CoV2 Induced Lung Injury | https://ClinicalTrials.gov/show/NCT04395482 |
| NCT04394429 | Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04394429 |
| NCT04393974 | COVID-19 and Cancer Patients | https://ClinicalTrials.gov/show/NCT04393974 |
| NCT04410263 | Microbiota in COVID-19 Patients for Future Therapeutic and Preventive Approaches | https://ClinicalTrials.gov/show/NCT04410263 |
| NCT04409197 | Evaluation of Changes in Weight, Sleep, and Other Psycho-behavioural Parameters During Covid-19 Confinement in Subjects Monitored by the RNPC Network | https://ClinicalTrials.gov/show/NCT04409197 |
| NCT04394078 | Impact of Covid-19 Pandemic on Depression and Quality of Life | https://ClinicalTrials.gov/show/NCT04394078 |
| NCT04414319 | Severe Acute Respiratory Syndrome-Coronavirus-2 and Loss of Autonomy in the Elderly | https://ClinicalTrials.gov/show/NCT04414319 |
| NCT04397900 | Blood Collection Study From COVID-19 Convalescents to Identify Immunogenic Viral Epitopes | https://ClinicalTrials.gov/show/NCT04397900 |
| NCT04397848 | Mental Health Outcomes in Healthcare Workers During COVID-19 | https://ClinicalTrials.gov/show/NCT04397848 |
| NCT04397822 | COVID-19: Study of INFLAmmasome and PLAtelets Functions | https://ClinicalTrials.gov/show/NCT04397822 |
| NCT04397588 | Extracorporeal Membrane Oxygenation (ECMO) and Coronavirus Disease (COVID) 19 | https://ClinicalTrials.gov/show/NCT04397588 |
| NCT04395300 | Sleep Quality in Healthcare Personnel During COVID-19 | https://ClinicalTrials.gov/show/NCT04395300 |
| NCT04395755 | Impact of COVID-19 on Psychological Status in Case of IVF Interrupted or Postponed | https://ClinicalTrials.gov/show/NCT04395755 |
| NCT04395664 | Arrhythmias in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04395664 |
| NCT04405466 | A Study to Assess the Feasibility of Screening for SARS-CoV-2 Among Healthy Workers | https://ClinicalTrials.gov/show/NCT04405466 |
| NCT04395391 | Home Usability Study of the SARS-CoV-2 (COVID-19) Test | https://ClinicalTrials.gov/show/NCT04395391 |
| NCT04395924 | Maternal-foetal Transmission of SARS-Cov-2 | https://ClinicalTrials.gov/show/NCT04395924 |
| NCT04394884 | Pathogenesis of BTK-mediated Hyper-Inflammatory Responses in COVID-19 (RESPOND) | https://ClinicalTrials.gov/show/NCT04394884 |
| NCT04400812 | Attitude and Perception Towards COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04400812 |
| NCT04400461 | Short-term Physical Function Outcomes in Severe COVID-19 Patients Admitted to ICU for Invasive Mechanical Ventilation | https://ClinicalTrials.gov/show/NCT04400461 |
| NCT04397172 | Intensive Care Associated Complications and Outcome of Acute Respiratory Distress Syndrome Due to COVID-19 | https://ClinicalTrials.gov/show/NCT04397172 |
| NCT04412460 | Echocardiography in Patients With Covid-19 | https://ClinicalTrials.gov/show/NCT04412460 |
| NCT04411511 | COVID-19, Obesity and Lifestyle in Children | https://ClinicalTrials.gov/show/NCT04411511 |
| NCT04403607 | Cardiac Imaging in SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04403607 |
| NCT04403035 | Comparison of the ID NOW and Accula Point-of-Care Assays for Detection of COVID-19 | https://ClinicalTrials.gov/show/NCT04403035 |
| NCT04402229 | Psychological Impact of the Covid-19 Pandemic on Student Nurses | https://ClinicalTrials.gov/show/NCT04402229 |
| NCT04401371 | Distance Learning for Dental Student During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04401371 |
| NCT04401228 | Predictive Models for Intensive Care Admission and Death of COVID-19 | https://ClinicalTrials.gov/show/NCT04401228 |
| NCT04400006 | Ozone Therapy in the Prevention of COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04400006 |
| NCT04401085 | COVID-19: Herd Immunity Study in the Czech Republic | https://ClinicalTrials.gov/show/NCT04401085 |
| NCT04404062 | Validation of COVID-19 Tests | https://ClinicalTrials.gov/show/NCT04404062 |
| NCT04402853 | SARS Cov-2 in Conjunctival Secretion | https://ClinicalTrials.gov/show/NCT04402853 |
| NCT04402814 | IgG/IgM Antibody Test in Patients Who Have Tested Negative or Positive for COVID-19 With Nasopharyngeal PCR Testing. | https://ClinicalTrials.gov/show/NCT04402814 |
| NCT04401449 | Cardiopulmonary Inflammation and Multi-System Imaging During the Clinical Course of COVID-19 Infection in Asymptomatic and Symptomatic Persons | https://ClinicalTrials.gov/show/NCT04401449 |
| NCT04401098 | Changing Of Egyptian Population Behaviour Towards COVID 19 Outbreak | https://ClinicalTrials.gov/show/NCT04401098 |
| NCT04401072 | Attitude of Egyptian Population Toward COVID 19 in Ramadan | https://ClinicalTrials.gov/show/NCT04401072 |
| NCT04403880 | Characterizing SARS-CoV-2-specific Immunity in Individuals Who Have Recovered From COVID-19 | https://ClinicalTrials.gov/show/NCT04403880 |
| NCT04410939 | COVID-19 PCR Test Results in Asymptomatic Pregnants | https://ClinicalTrials.gov/show/NCT04410939 |
| NCT04401436 | COVID-19 Associated Lymphopenia Pathogenesis Study in Blood (CALYPSO) | https://ClinicalTrials.gov/show/NCT04401436 |
| NCT04403438 | Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic | https://ClinicalTrials.gov/show/NCT04403438 |
| NCT04403061 | Th1/Th2/Th17/TREG and TLRs Activation/KIR for COVID 19 Prediction of Outcome | https://ClinicalTrials.gov/show/NCT04403061 |
| NCT04406233 | Muscle Mass and Strength as Predictors of Time to Discharge in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04406233 |
| NCT04407299 | COVID-19 Impact on Rheumatic Patients | https://ClinicalTrials.gov/show/NCT04407299 |
| NCT04402827 | Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19. | https://ClinicalTrials.gov/show/NCT04402827 |
| NCT04406545 | Microvascular Flow and Reactivity in Patients Presenting in the Acute Phase of COVID-19. | https://ClinicalTrials.gov/show/NCT04406545 |
| NCT04413071 | Cardiac COVID-19 Health Care Workers | https://ClinicalTrials.gov/show/NCT04413071 |
| NCT04403386 | Prospective Natural History Study of Smoking, Immune Cell Profiles, Epigenetics and COVID-19 | https://ClinicalTrials.gov/show/NCT04403386 |
| NCT04403828 | Impact of COVID-19 on Personal Protection Among Dentist in Egypt | https://ClinicalTrials.gov/show/NCT04403828 |
| NCT04406558 | Psychological Impact of the Health Measures Generated by the COVID19 in Adolescents | https://ClinicalTrials.gov/show/NCT04406558 |
| NCT04404179 | Setting up a COVID-19 Care Facility at a Prison in Pakistan | https://ClinicalTrials.gov/show/NCT04404179 |
| NCT04403932 | Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency | https://ClinicalTrials.gov/show/NCT04403932 |
| NCT04404244 | Extraordinary Measures for Egyptian Children With Hemato-Oncological Disorders During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04404244 |
| NCT04406844 | An Observational Study to Identify the Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic and the Resulting Lockdown | https://ClinicalTrials.gov/show/NCT04406844 |
| NCT04408222 | Awake Proning in COVID-19 Patients With Hypoxemic Respiratory Failure | https://ClinicalTrials.gov/show/NCT04408222 |
| NCT04407143 | Study of the Immunity of Patients With Lung Cancer and COVID-19 Infection | https://ClinicalTrials.gov/show/NCT04407143 |
| NCT04405869 | Thromboembolic Events in Severe COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04405869 |
| NCT04410107 | Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19 | https://ClinicalTrials.gov/show/NCT04410107 |
| NCT04405973 | Clinical Scores for Outcome Prediction in Patients With Severe COVID-19 Pneumonia Requiring ECMO | https://ClinicalTrials.gov/show/NCT04405973 |
| NCT04405726 | Clinical, Biological and Genetic Prognostic Factors for SARS-CoV-2 Infection in Patients Hospitalized in Strasbourg | https://ClinicalTrials.gov/show/NCT04405726 |
| NCT04413435 | Clinical Characteristics of Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04413435 |
| NCT04406090 | Endovascular Thrombectomy in COVID-19 Infected Patients | https://ClinicalTrials.gov/show/NCT04406090 |
| NCT04406038 | Study of the Spread of COVID-19 in Saint Petersburg, Russia | https://ClinicalTrials.gov/show/NCT04406038 |
| NCT04409899 | The Utility of Enhanced Pre and Post-surgical Work-out to Prevent the Spread of COVID-19 in a Large Urology Department | https://ClinicalTrials.gov/show/NCT04409899 |
| NCT04405232 | Coagulopathy in COVID19 - A Multi-Centre Observational Study in UK | https://ClinicalTrials.gov/show/NCT04405232 |
| NCT04411576 | Current and Past SARS-CoV-2 Infection and COVID-19 in Healthcare | https://ClinicalTrials.gov/show/NCT04411576 |
| NCT04416100 | Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19) | https://ClinicalTrials.gov/show/NCT04416100 |
| NCT04406571 | Reorganization of the Healthcare System During COVID-19 Pandemic: Impact on Management of Patients With Exocrine Pancreatic Cancer | https://ClinicalTrials.gov/show/NCT04406571 |
| NCT04408378 | Change in the Ratio of Mean Platelet Volume (MPV) to Platellet(PLT) in Covid-19 Pneumonia Patients | https://ClinicalTrials.gov/show/NCT04408378 |
| NCT04407663 | Outpatient Clinic in Obesity Care During COVID-19 Outbreak: Physically Far, Virtually Near | https://ClinicalTrials.gov/show/NCT04407663 |
| NCT04407572 | Evaluation of the Relationship Between Zinc Vitamin D and b12 Levels in the Covid-19 Positive Pregnant Women | https://ClinicalTrials.gov/show/NCT04407572 |
| NCT04407533 | Dietary Intake and Eating Habits During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407533 |
| NCT04407468 | Awake Prone Positioning and Oxygen Therapy in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04407468 |
| NCT04407429 | Vienna Versus SARS-CoV-2 Virus Study | https://ClinicalTrials.gov/show/NCT04407429 |
| NCT04407273 | STATIN THERAPY AND COVID-19 INFECTION | https://ClinicalTrials.gov/show/NCT04407273 |
| NCT04407117 | Appendicitis During the National Lockdown During the COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04407117 |
| NCT04407559 | COVID-SErology in Rheumatoid Arthritis (COVID-19) | https://ClinicalTrials.gov/show/NCT04407559 |
| NCT04407494 | Diagnostic Value of Patient - Reported and Clinically Verified Olfactory Disorders (COVID-19) | https://ClinicalTrials.gov/show/NCT04407494 |
| NCT04407260 | The Use of Oxygen Hoods as Compared to Conventional High-flow Oxygen Delivery Systems, the Effects on Oxygenation, Intubation and Mortality Rates in Hypoxic Patients With COVID-19. | https://ClinicalTrials.gov/show/NCT04407260 |
| NCT04413058 | Menstrual Cycle Characteristics of Healthcare Professionals | https://ClinicalTrials.gov/show/NCT04413058 |
| NCT04412473 | COVID-19 Respiratory Distress and Antithrombotic Drugs in Subject’s Habits | https://ClinicalTrials.gov/show/NCT04412473 |
| NCT04414410 | Echocardiography in Critically-ill Patients With COVID-19 Pneumonia | https://ClinicalTrials.gov/show/NCT04414410 |
| NCT04408326 | Efficacy and Safety of Angiotensin II Use in Coronavirus Disease(COVID)-19 Patients With Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04408326 |
| NCT04407923 | Drug Management of Juvenile Idiopathic Arthritis in Covid-19 Context : Impact on Therapeutical Managment | https://ClinicalTrials.gov/show/NCT04407923 |
| NCT04409275 | LUNG FIBROTIC CHANGES ASSOCIATED WITH SARS-CoV-2 INFECTION | https://ClinicalTrials.gov/show/NCT04409275 |
| NCT04409249 | Prognosis in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04409249 |
| NCT04418609 | Neuro-COVID-19: Neurological Complications of COVID-19 | https://ClinicalTrials.gov/show/NCT04418609 |
| NCT04412031 | Prediction of Unfavourable Outcome in Newly Covid-19 Hospitalized Patient | https://ClinicalTrials.gov/show/NCT04412031 |
| NCT04411784 | PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis | https://ClinicalTrials.gov/show/NCT04411784 |
| NCT04411459 | Risk Factors for Prolonged Invasive Mechanical Ventilation in COVID-19 Acute Respiratory Distress Syndrome | https://ClinicalTrials.gov/show/NCT04411459 |
| NCT04416373 | COVID-19 and Pregnancy Outcomes | https://ClinicalTrials.gov/show/NCT04416373 |
| NCT04416256 | COVID-19 Pandemic and Worldwide Organ Procurement | https://ClinicalTrials.gov/show/NCT04416256 |
| NCT04410484 | PREPARE-IBD: Physician Responses to Disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04410484 |
| NCT04410432 | Immune Response and Risk of Serious Infection to SARS-Cov2 | https://ClinicalTrials.gov/show/NCT04410432 |
| NCT04412265 | Frailty in Elderly Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04412265 |
| NCT04412304 | Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients | https://ClinicalTrials.gov/show/NCT04412304 |
| NCT04411147 | A Longitudinal Study of COVID-19 Sequelae and Immunity | https://ClinicalTrials.gov/show/NCT04411147 |
| NCT04413045 | Novel COVID-19, A National Analysis | https://ClinicalTrials.gov/show/NCT04413045 |
| NCT04412746 | Covid-19 and Diabetes in West of Algeria | https://ClinicalTrials.gov/show/NCT04412746 |
| NCT04412655 | Primary Angioplasty for STEMI During COVID-19 Pandemic (ISACS-STEMI COVID-19) Registry | https://ClinicalTrials.gov/show/NCT04412655 |
| NCT04418544 | Vocal Feature Analysis Algorithm | https://ClinicalTrials.gov/show/NCT04418544 |
| NCT04416061 | The Role of a Private Hospital in Hong Kong Amid COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04416061 |
| NCT04418193 | Patient Preference Trial for COVID-19 (PPT-COVID) | https://ClinicalTrials.gov/show/NCT04418193 |
| NCT04414657 | USZ BioResource COVID | https://ClinicalTrials.gov/show/NCT04414657 |
| NCT04419571 | Peri-Operative NLR in Emergency General Surgery During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04419571 |
| NCT04419545 | Covid Radiographic Images Data-set for A.I | https://ClinicalTrials.gov/show/NCT04419545 |
| NCT04418245 | CT Biomarkers Identification by Artificial Intelligence for COVID-19 Prognosis | https://ClinicalTrials.gov/show/NCT04418245 |
Registrires
| nct_id | brief_title | link |
|---|---|---|
| NCT04314271 | The Observational Study of Cardiac and Pulmonary Ultrasound and Evaluation of Treatment of Severe Patients With Novel Coronavirus Pneumonia | https://ClinicalTrials.gov/show/NCT04314271 |
| NCT04318314 | COVID-19: Healthcare Worker Bioresource: Immune Protection and Pathogenesis in SARS-CoV-2 | https://ClinicalTrials.gov/show/NCT04318314 |
| NCT04315870 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy: The Italian Registry on Coronavirus in Pregnancy. | https://ClinicalTrials.gov/show/NCT04315870 |
| NCT04323592 | Methylprednisolone for Patients With COVID-19 Severe Acute Respiratory Syndrome | https://ClinicalTrials.gov/show/NCT04323592 |
| NCT04319016 | Clinical Characteristics of Coronavirus Disease 2019 (COVID-19) in Pregnancy | https://ClinicalTrials.gov/show/NCT04319016 |
| NCT04320472 | Acute Encephalopathy in Critically Ill Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04320472 |
| NCT04321811 | Behavior, Environment And Treatments for Covid-19 | https://ClinicalTrials.gov/show/NCT04321811 |
| NCT04323839 | COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) | https://ClinicalTrials.gov/show/NCT04323839 |
| NCT04325412 | Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY | https://ClinicalTrials.gov/show/NCT04325412 |
| NCT04327479 | Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04327479 |
| NCT04327570 | In-depth Immunological Investigation of COVID-19. | https://ClinicalTrials.gov/show/NCT04327570 |
| NCT04327674 | The Use of Focused Lung Ultrasound in Patients Suspected of COVID-19 | https://ClinicalTrials.gov/show/NCT04327674 |
| NCT04329559 | COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study | https://ClinicalTrials.gov/show/NCT04329559 |
| NCT04336956 | Covid-19 Pediatric Observatory | https://ClinicalTrials.gov/show/NCT04336956 |
| NCT04331171 | Epidemiological Observation From a Smartphone Self-monitoring Application for Suspected COVID-19 Patients’ Triage | https://ClinicalTrials.gov/show/NCT04331171 |
| NCT04331574 | Renin-Angiotensin System Inhibitors and COVID-19 | https://ClinicalTrials.gov/show/NCT04331574 |
| NCT04333953 | COVID-19 in Patients With HIV | https://ClinicalTrials.gov/show/NCT04333953 |
| NCT04341766 | Evolution of Pulmonary Ultrasound in Patients Hospitalized for Covid (Coronavirus Disease) 19 | https://ClinicalTrials.gov/show/NCT04341766 |
| NCT04334291 | International COVID19 Clinical Evaluation Registry, | https://ClinicalTrials.gov/show/NCT04334291 |
| NCT04333875 | Morbidity and Mortality Due to Deferral of Aortic Valve Replacement in Patients With Severe Aortic Stenosis | https://ClinicalTrials.gov/show/NCT04333875 |
| NCT04336345 | Outcomes of Patients With COVID-19 in the Intensive Care Unit | https://ClinicalTrials.gov/show/NCT04336345 |
| NCT04335773 | COVID-19 in Hospitalised Norwegian Children - Risk Factors, Outcomes and Immunology | https://ClinicalTrials.gov/show/NCT04335773 |
| NCT04347278 | Observational Study of Follow-up of Hospitalized Patients Diagnosed With COVID-19 to Evaluate the Effectiveness of the Drug Treatment Used to Treat This Disease. COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04347278 |
| NCT04345536 | Prospective Quality Register of Patients With Confirmed Covid-19 at Oslo University Hospital | https://ClinicalTrials.gov/show/NCT04345536 |
| NCT04337346 | Evaluation of Covid 19 Anxiety in Endometriosis Patients | https://ClinicalTrials.gov/show/NCT04337346 |
| NCT04337320 | Evaluation of Postnatal Outcomes of Covid 19 Positive Mothers Newborns | https://ClinicalTrials.gov/show/NCT04337320 |
| NCT04354519 | The United Kingdom Multiple Sclerosis Register Covid-19 Substudy | https://ClinicalTrials.gov/show/NCT04354519 |
| NCT04353583 | Renal Outcome in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04353583 |
| NCT04340466 | French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study | https://ClinicalTrials.gov/show/NCT04340466 |
| NCT04344249 | Cohort of Patients With Inflammatory Bowel Disease During COVID-19 Pandemic | https://ClinicalTrials.gov/show/NCT04344249 |
| NCT04344002 | LunG canceR pAtients coVId19 Disease (GRAVID) | https://ClinicalTrials.gov/show/NCT04344002 |
| NCT04349982 | ICU Trial in Critical Ill COVIDâ€19 Patients | https://ClinicalTrials.gov/show/NCT04349982 |
| NCT04348227 | How COVID-19 Virus Outbreak Affects Antimicrobial Resistance in a Low-middle-income Country’s ICU? | https://ClinicalTrials.gov/show/NCT04348227 |
| NCT04344912 | Impact of COVID19 Outbreak in Cardiac Acute Care | https://ClinicalTrials.gov/show/NCT04344912 |
| NCT04347993 | A Prospective “Universal” Observational Database for COVID-19 | https://ClinicalTrials.gov/show/NCT04347993 |
| NCT04347798 | IMPACT: IMPact of Antimalarials on Covid-19 Infections in RAPPORT | https://ClinicalTrials.gov/show/NCT04347798 |
| NCT04378452 | Assessment of the Psycho-social Impact of COVID-19 Outbreak | https://ClinicalTrials.gov/show/NCT04378452 |
| NCT04357275 | The RIsk Stratification in COVID-19 Patients in the ICU Registry | https://ClinicalTrials.gov/show/NCT04357275 |
| NCT04354701 | COVID-19 and Cancer Consortium Registry | https://ClinicalTrials.gov/show/NCT04354701 |
| NCT04352764 | ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings | https://ClinicalTrials.gov/show/NCT04352764 |
| NCT04351529 | Austrian COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04351529 |
| NCT04356586 | Immune Response to Covid-19 in 300 Health Care Workers With Mild Symptoms | https://ClinicalTrials.gov/show/NCT04356586 |
| NCT04366206 | Factors Associated With Clinical Outcomes in Patients Hospitalized for Covid-19 in GHT-93 Est | https://ClinicalTrials.gov/show/NCT04366206 |
| NCT04380766 | Covid-19 Pandemic and Pancreatic Surgery in Italy | https://ClinicalTrials.gov/show/NCT04380766 |
| NCT04359927 | Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04359927 |
| NCT04359602 | COVID-19 Recovered Volunteer Research Participant Pool Registry | https://ClinicalTrials.gov/show/NCT04359602 |
| NCT04374110 | Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374110 |
| NCT04361591 | COVID-19 in Liver Transplant Recipients | https://ClinicalTrials.gov/show/NCT04361591 |
| NCT04361500 | Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter | https://ClinicalTrials.gov/show/NCT04361500 |
| NCT04364984 | ARB, ACEi, DRi in COVID-19 | https://ClinicalTrials.gov/show/NCT04364984 |
| NCT04363632 | Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection | https://ClinicalTrials.gov/show/NCT04363632 |
| NCT04365322 | Study of Specific Viral Immune Responses Induced by SARS-CoV-2 (COVID-19) | https://ClinicalTrials.gov/show/NCT04365322 |
| NCT04393142 | Serologic Testing of Household Contacts of Confirmed Cases of COVID-19 | https://ClinicalTrials.gov/show/NCT04393142 |
| NCT04370821 | COVID-19 CHAMPS Study of Healthcare, First Responder and Service Workers | https://ClinicalTrials.gov/show/NCT04370821 |
| NCT04368975 | ARDS Caused by COVID-19 | https://ClinicalTrials.gov/show/NCT04368975 |
| NCT04368234 | Duke COVID-19 Shared Data and Specimen Repository | https://ClinicalTrials.gov/show/NCT04368234 |
| NCT04368143 | COVID-19 Immune Repertoire Sequencing | https://ClinicalTrials.gov/show/NCT04368143 |
| NCT04367714 | Antibody Response Against SARS-CoV-2 in Dialysis Patients During COVID-19 | https://ClinicalTrials.gov/show/NCT04367714 |
| NCT04380727 | Almitrine and COVID-19 Related Hypoxemia | https://ClinicalTrials.gov/show/NCT04380727 |
| NCT04370067 | Hungarian COVID-19 Epidemiological Research | https://ClinicalTrials.gov/show/NCT04370067 |
| NCT04368065 | Registry to Study Factors That May Impact COVID-19 Occurrence and Severity | https://ClinicalTrials.gov/show/NCT04368065 |
| NCT04367857 | ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers | https://ClinicalTrials.gov/show/NCT04367857 |
| NCT04367350 | Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement | https://ClinicalTrials.gov/show/NCT04367350 |
| NCT04372199 | SEVERITY SCORE FOR COVID-19 PNEUMONIA | https://ClinicalTrials.gov/show/NCT04372199 |
| NCT04371328 | Emergency Management in a Dedicated Respiratory Unit of Patients With a Possible COVID Infection (Unit “COVID Possible”° | https://ClinicalTrials.gov/show/NCT04371328 |
| NCT04374045 | Testing for Dysautonomia in Patients Hospitalized for SARS-CoV-2 Infection (COVID-19) : COVIDANS Study | https://ClinicalTrials.gov/show/NCT04374045 |
| NCT04373759 | Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs | https://ClinicalTrials.gov/show/NCT04373759 |
| NCT04371744 | QT-Logs : Artificial Intelligence for QT Interval Analysis of ECG From Smartwatches in Patient Receiving Treatment for Covid-19 | https://ClinicalTrials.gov/show/NCT04371744 |
| NCT04379440 | Geriatric Population COVID-19 Observational Study (GEROCOVIDobs) | https://ClinicalTrials.gov/show/NCT04379440 |
| NCT04379544 | Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 | https://ClinicalTrials.gov/show/NCT04379544 |
| NCT04376398 | Survey: COVID-19 Patients Managed in the Operating Theatre of Belgian Hospitals | https://ClinicalTrials.gov/show/NCT04376398 |
| NCT04390555 | The Global PCHF-COVICAV Registry | https://ClinicalTrials.gov/show/NCT04390555 |
| NCT04388605 | Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic | https://ClinicalTrials.gov/show/NCT04388605 |
| NCT04388436 | Post Covid-19 Cardiopulmonary and Immunological Changes | https://ClinicalTrials.gov/show/NCT04388436 |
| NCT04386265 | Compassionate Use of Hyperbaric Oxygen Therapy | https://ClinicalTrials.gov/show/NCT04386265 |
| NCT04389996 | COVID-19 Pandemic Impact on Patients With Cancer - a Danish Survey | https://ClinicalTrials.gov/show/NCT04389996 |
| NCT04388631 | Detection Rate of SARS-CoV-2 in Male Genitourinary System and Its Impact on Male Reproductive Health. | https://ClinicalTrials.gov/show/NCT04388631 |
| NCT04397575 | The GCO-002 CACOVID-19 Cohort: a French Nationwide Multicenter Study of COVID-19 Infected Cancer Patients | https://ClinicalTrials.gov/show/NCT04397575 |
| NCT04387929 | Detection of Anti-COVID-19 Antibody Levels in an Hospital Population | https://ClinicalTrials.gov/show/NCT04387929 |
| NCT04389554 | D-dimer Levels in Pregnant With COVID-19 | https://ClinicalTrials.gov/show/NCT04389554 |
| NCT04394000 | Impact of an Intensified Thromboprofylaxis Protocol in COVID-19 | https://ClinicalTrials.gov/show/NCT04394000 |
| NCT04393324 | The Critical Care Response to the COVID-19 Pandemic in Madrid | https://ClinicalTrials.gov/show/NCT04393324 |
| NCT04394390 | Do Vitamin D Levels Really Correlated With Disease Severity in COVID-19 Patients? | https://ClinicalTrials.gov/show/NCT04394390 |
| NCT04395794 | SARS-CoV-2 Disguise Study | https://ClinicalTrials.gov/show/NCT04395794 |
| NCT04408339 | COVID-19 in Cancer Patients: Evaluation of Clinical Course and Impact on Oncological Care Including Biobanking | https://ClinicalTrials.gov/show/NCT04408339 |
| NCT04401033 | Increased Risk of SARS-CoronaVirus-2 (SARS-CoV-2) Infection Associated With Endoscopy (DECORE Study) | https://ClinicalTrials.gov/show/NCT04401033 |
| NCT04401540 | Characteristics of Neonatal Covid-19 in Turkey | https://ClinicalTrials.gov/show/NCT04401540 |
| NCT04403672 | Performance Evaluation of RealDetectâ„¢ COVID-19 RT-PCR Kit for the Detection of SARS-CoV-2 Virus | https://ClinicalTrials.gov/show/NCT04403672 |
| NCT04411563 | Epigenetic Tools as Prognostic Predictors in Covid19 | https://ClinicalTrials.gov/show/NCT04411563 |
| NCT04410471 | Humoral Immunity Against SARS-CoV-2 in Liver Transplanted Patients After COVID-19 in Comparison With Immunocompetent Patients | https://ClinicalTrials.gov/show/NCT04410471 |
| NCT04412551 | Lung Ultrasound for Assessment of Patients With Moderate to Severe Covid-19 | https://ClinicalTrials.gov/show/NCT04412551 |
| NCT04416009 | Extracellular Water in Covid 19 Pneumonia | https://ClinicalTrials.gov/show/NCT04416009 |
| NCT04418557 | COVID-19 and Obstetric Transmission | https://ClinicalTrials.gov/show/NCT04418557 |